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Non-heme oxoiron(IV) motifs have been identified as key 
intermediates that activate strong C—H bonds. Unlike the enzymatic 
intermediates however, most oxoiron(IV) complexes in synthetic 
chemistry have a triplet ground spin state and thus differ in their 
functional and electronic properties from the S = 2 units characterized 
in the enzymes. One striking exception is the complex 
[FeIV(O)(TQA)(L)]2+, where TQA = tris(2-quinolylmethyl)amine, which 
has Mössbauer parameters that closely resemble those of TauD-J, an 
enzymatic intermediate that has been relatively well-characterized. 
This oxoiron(IV) complex contains quinoline donors, and its thermal 
instability precludes its structural characterization (half-life = 15 
minutes at 233 K). In this dissertation, several oxoiron(IV) complexes 
supported by pentadentate and tetradentate ligands are characterized, 
and examined for their reactivity and spectroscopic features. 
Crystallographic characterization of a few of these molecules is also 
reported. The structurally characterized oxoiron(IV) complexes along 
with some previously reported oxoiron(IV) complexes are used to set 
up structure-reactivity and spectroscopic-reactivity relationships, and 
show linear correlations with increasing isomer shifts, λmax values as 
well as metal-ligand distances. In addition, this thesis also uses 1H-
NMR spectroscopy as an effective tool to identify solution-state 
structure as well the spin state of oxoiron(IV) complexes. We also 
characterize the first example of a spin crossover oxoiron(IV) complex, 
examples of which are only seen in iron(II) and iron(III) complexes.  
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oxoiron(IV) complexes when quinolines replace the pyridines (left), or α-methyl 
substituents (right) are introduced on each pyridine in the BnTPEN ligand. The 3-
6Me rates are increased by 3 log units to adjust for the 65 K difference in 
temperature at which they were obtained. Similar trends in HAT reactivity are 
observed for ferryl complexes with quinoline substitutions in this series. (114) 
Figure 3.14 Steric interactions of proximal hydrogen atoms in different ferryl 
complexes. Top: top-view of 50% ORTEPS of 1-B, 1-Q (DFT structure) and 0 
shown from left to right, with a mean plane drawn on the pyridine with which 
distance of the proximal H atom is measured. Middle: front-view of N4Py based 
complexes, with distance of the proximal atoms with the oxygen atom. Bottom: 
side-view of N4Py-based complexes, showing tilts induced by the ligands on the 
ferryl unit. (117) 
Figure 3.15 Correlation of reactivity (obtained from second-order rate constants at 
233 K with cyclohexane and thioanisole) with average Fe−L bond lengths of 
xvi 
different complexes. From left to right, ligands supporting FeIV(O) complexes are 
N4Py, N2Py2B, BnTPEN, B-BnDPEN, Q-BnDPEN, N2Py2Q, DQBnPEN, Me3NTB 
(represented by a ×), TMC-O, and TQA. Hollow shapes represent DFT-obtained 
structural data, whereas solid ones represent experimental data. All rate constants 
determined using stopped-flow instrument were obtained by our collaborator at 
Tufts University, Marc C. Piquette. (125) 
Figure 3.16 Correlation of oxoiron(IV) complexes’ λmax (plotted only for S = 1 
complexes) and isomer shifts with their reactivity, supported by ligand frameworks 
from left to right: N4Py, N2Py2B, BnTPEN, B-BnDPEN, N2Py2Q, Q-BnDPEN, 
DQBnPEN, TMCO, TQA. Crosses belong to [FeIV(O)(Me3NTB)(L)]2+, blue shapes 
to thioanisole and red shapes to cyclohexane. (126) 
Scheme 3.1 The synthetic route for the precursor to the monosubstituted ligands. 
(130) 
Scheme 3.2 The synthetic route for the precursor to the disubstituted ligands. 
(131) 
Scheme 3.3 Synthesis of QBnDPEN (131) 
Scheme 3.4 Synthesis of 6MeBnTPEN (132) 
Scheme 3.5 Synthesis of BBnDPEN (133) 
Scheme 3.6 Synthesis of 6Me2BnTPEN (135) 
Scheme 3.7 Synthesis of DQBnPEN (137) 
Scheme 3.8 Synthesis of 6Me3BNTPEN (138) 
Scheme 3.9 Synthesis of BnTQEN. (138)  
Figure 3.17 Second-order rate constants for the reaction of thioanisole with 0, 
measured at different temperatures (left) and Eyring plot (right) for the reaction of 
0 with thioanisole, from which the Eyring parameters listed in Table 3.7 were 
obtained. (147) 
Figure 3.18 Second-order rate constants for reactions of HAT substrates at 298 
K, and for thioanisole (OAT) at 233 K with complex 1-B. Eyring plot of 1-B with 
cyclohexane is also shown on the bottom right. The k2 were obtained by reacting 
0.8 M cyclohexane with acetonitrile solution of 1-B at different temperatures. (149) 
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Figure 3.19 Second-order rate constants for for reactions of HAT substrates at 
298 K (except cyclohexane for which these rates were determined at more than 
one temperature), and for thioanisole (OAT) at 233 K with complex 1-Q. (151) 
Figure 3.20 Second-order rate constants for reactions of HAT substrates at 298 K 
and for thioanisole (OAT) at 233 K with complex 1-6Me. (153) 
Figure 3.21 Second-order rate constants for reactions of HAT substrates at 298 K 
(except cyclohexane for which these rates were determined at more than one 
temperature), and for thioanisole (OAT) at 233 K with complex 2-Q. (155) 
Figure 3.22 Second-order rate constants for reactions of HAT substrates at 298 K 
and for thioanisole (OAT) at 233 K with deuterated complex 2-6Me-d. (156) 
Figure 3.23 Second-order rate constants for reactions of HAT substrates and 
thioanisole (OAT) at 233 K with deuterated complex 3-6Me-d. (157) 
Figure 3.24 Eyring plots for the reactions of cyclohexane with different oxoiron(IV) 
complexes. Owing to the thermal instability or reactivity of different complexes, a 
temperature range of 263 K. to 318 K was used to get the rate constants. (158) 
Figure 3.25 1H NMR spectra of Q-BnDPEN (top) in acetone-d6, and 6MeBnTPEN 
(bottom) in DCM-d2 (* indicates either solvent or artifacts.) (160) 
Figure 3.26 1H NMR spectra of 6Me2BnTPEN (top) in acetone-d6, and DQBnPEN 
(bottom) in DCM-d2 (* indicates either solvent or artifacts.) (161) 
Figure 3.27  1H NMR spectra of 6Me3BnTPEN (top) in DCM-d2, and BnTQEN 
(bottom) in chloroform-d (* indicates either solvent or artifacts.) (162) 
Figure 3.28  1H NMR spectra of iron(II) precursors with quinolines in CD2Cl2, 
[FeII(QBnDPEN)OTf]OTf (top), [FeII(DQBnPEN)OTf]OTf (middle) and 
[FeII(BnTQEN)OTf]OTf (bottom). (163) 
Figure 3.29  1H NMR spectra of [FeII(6MeBnTPEN)OTf]OTf (top) and 
[FeII(BnTPEN)OTf]OTf (bottom) in CD2Cl2. (164) 
Figure 3.30  1H NMR spectra of [FeII(6Me2BnTPEN)OTf]OTf in in CD2Cl2. The top 
spectrum has deuterated benzylic methylene and methyl protons. (164) 
Figure 3.31  1H NMR spectra of [FeII(6Me3BnTPEN)OTf]OTf in CD2Cl2. The top 
spectrum has deuterated benzylic methylene and methyl protons. (165) 
Figure 3.32 Fe K-edge X-ray absorption near-edge structures (XANES, 
fluorescence excitation) of iron(IV) complexes 1-6Me-d (top) and 1-Q (bottom) 
(167) 
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Figure 3.33 Fourier-transformed k-space EXAFS data of 1-Q at 10 K. Inset shows 
the k-space spectrum. (168) 
Figure 3.34 Crystal structures of iron(II) complexes supported by alpha-
substituted BnTPEN framework. 50% probability ORTEPS were shown for the 
heterocycles that were modified, and the remaining part was shown as sticks for 
clarity, as was the removal of all H-atoms, solvent molecules and counterions. 
(169) 
 
Figure 4.1 Oxoiron(IV) complexes examined in this work that contain increasing 
number of quinolines or pyridine donors with alpha-substituents. (178) 
Figure 4.2 UV-visible spectra of 1-mM acetonitrile solutions of oxoiron(IV) 
complexes 0 (light gray), 1 (gray) and  2 (black) on the left; and 3 (light gray), 3a 
(gray) and 3b () on the right at 233 K. (181) 
Figure 4.3 Mössbauer spectra of 1, 2 and 3a. (182)    
Figure 4.4 Stacked 1H NMR spectra of 0 (top) at 233 K, [FeIV(O)(N4Py)]2+ (middle) 
at 298 K and [FeIV(O)(BnTPEN)]2+ (bottom) at 298 K, with pyridines and 
corresponding shifts highlighted in red. (183) 
Figure 4.5 Stacked 1H NMR spectra of [FeIV(O)(N4Py)]2+ (top) and 
[FeIV(O)(N2Py2Q)]2+ (bottom) at 298 K, with quinolines shifts in red. Inset shows 
the expanded region from 0 to 21 ppm. # = solvent. Corresponding structures of 
the complexes are shown along with the spectra. (186) 
Figure 4.6 1H COSY NMR spectrum of complex [FeIV(O)(N2Py2Q)]2+ in 
acetonitrile-d3 at 233 K from 0 to 35 ppm. Only the peaks at 19 and 20.8 ppm are 
found to have relaxation properties at this temperature that allow them to talk with 
each other. The lower temperature was chosen to minimize the self-decay of 
[FeIV(O)(N2Py2Q)]2+ over the course of data collection time (over 12 h) on a 10 
mM sample. (188) 
Figure 4.7 Stacked 1H NMR spectra of [FeIV(O)(QBPA)(L)]2+ (1, top) and 
[FeIV(O)(N2Py2Q)]2+ (bottom) at 233 K, with quinolines shifts in red. Inset shows 
the expanded region from 0 to 24 ppm. (189) 
Figure 4.8 1H NMR spectra of 1a (top, 233 K), [FeIV(O)(6Me2N4Py)]2+ (middle, 233 
K; inset zooms into diamagnetic region of spectrum to reveal the signals of β 
proton), and [FeIV(O)(N4Py)]2+ (bottom, 298 K). (190) 
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Figure 4.9a 1H COSY NMR spectrum of complex [FeIV(O)(6Me2N4Py)]2+ in 
acetonitrile-d3 at 233 K from -2 to 35 ppm. T cross peaks, between the β and γ 
protons of two different pyridines are shown. (191) 
Figure 4.9b Zoomed 1H COSY NMR spectrum of 10 mM [FeIV(O)(6Me2N4Py)]2+ 
complex in acetonitrile-d3 from -2 to 15 ppm at 233 K (lower temperature was 
chosen to minimize the self-decay over 12 h). (192) 
Figure 4.10 Stacked 1H NMR spectra from top to bottom: 3, 3a, 2 and 3b obtained 
at 233 K in CD3CN. Quinoline signals are colored red. (194) 
Figure 4.11 Stacked 1H NMR spectra of oxoiron(IV) complex (top) and after its 
decay (bottom) at 233 K for complexes 2 (a), 3 (b) and 3a (c). (197) 
Figure 4.12 Evans-Polanyi plots for complexes 0 and 1 (rate constants obtained 
at 273 K), and 2 and 3 (rate constants obtained at 233 K). (200) 
Figure 4.13 k2 plots for the reactions of different HAT substrates with 
[FeIV(O)(TPA)(L)]2+. The slopes of the fitted red lines represent the second-order 
rate constants (k2) at 273 K. The oxoiron(IV) complex was generated using 1.2 eq 
of ArIO in TFE, followed by addition of substrate. (208) 
Figure 4.14 k2 plots for the reactions of different HAT substrates with 
[FeIV(O)(QBPA)(L)]2+. The slopes of the fitted red lines represent the second-order 
rate constants (k2) at 273 K. The oxoiron(IV) complex was generated using 1.2 eq 
of ArIO followed by addition of substrate. (209) 
Figure 4.15 k2 plots for the reactions of different HAT substrates with 
[FeIV(O)(BQPA)(L)]2+. The slopes of the fitted red lines represent the second-order 
rate constants (k2) at 233 K. The oxoiron(IV) complex was generated using 2 eq 
of ArIO followed by addition of substrate. (209) 
Figure 4.16 Stacked 1H NMR spectrum of complexes (top) [FeIV(O)(N2Py2Q)]2+ 
and (down) [FeIV(O)(N2Py2B)]2+ in CD3CN at 298 K from –70 to 70 ppm, along 
with assignments. Peaks for pyridines are in black and quinolines and 
benzimidazoles are in red. (211) 
Figure 4.17 Similarities between NMR peaks of different heterocycles aligned 
parallel to the ferryl unit in oxoiron(IV) complexes. (213) 
Figure 4.18 Possible orientations of the pyridine heterocycle around the FeIV=O 
unit. (214) 
Figure 4.19 1H NMR resonances for an equatorial pyridine oriented parallel to the 
S = 1 FeIV=O unit in [FeIV(O)(N4Py)]2+ (top, left); an equatorial pyridine oriented 
perpendicular to the oxoiron(IV) unit in [FeIV(O)(BnTPEN)]2+ (top, right); and an 
xx 
axial pyridine trans to the oxo atom in [FeIV(O)(TMC-Py)]2+ (bottom, left) and 
[FeIV(O)(Py5Me2)]2+ (bottom, middle). All resonances are highlighted, along with 
respective pyridines of these complexes. (215) 
Figure 4.20 1H NMR spectra of complex 3 in acetonitrile-d3 at 233 K (top), and in 
acetone-d6 at 193 K (bottom). (216) 
Figure 4.21 Structural depictions of the oxoiron(IV) complexes studied. Structures 
corresponding to the S = 1 spin state are shown. Geometries were obtained at the 
PW6B95/def2-TZVP level of theory in the gas phase. Depictions were made using 
IboView.37-38 (217) 
Figure 4.22 Plot of the computed spin state splitting energies at the PW6B95/def2-
TZVP level of theory and the number of quinoline substitutions made. Red dots 
show data for the TPA ligand framework (C1 and CS symmetric structures were 
considered for QBPA and BQPA ligands, respectively). Data computed for an 
analogous series of quinoline substitutions to the BnTPEN ligand framework (black 
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1.1 Scope and Aim of this Thesis 
Chapter 1 briefly highlights the prevalence of oxoiron(IV) intermediates in 
enzymes, and their role in the activation of strong C−H bonds. It also further details 
synthetic efforts made by bioinorganic chemists to mimic the properties and 
reactivity of these intermediates, and points to the use of different ligand 
frameworks to help in obtaining the crystal structures of reactive oxoiron(IV) 
complexes. It also details the use of these manifolds to define a broad range of 
reactivity properties for these synthetic complexes and correlate them with 
spectroscopic and structural features to bridge the gap between the complexes in 
the S = 1 and S = 2 spin state.  Finally, the chapter highlights the use of NMR 
spectroscopy as a complementary tool to elucidate solution-state structures and 
spin states of oxoiron(IV) complexes. 
Chapter 2 surveys the recent developments in reports of oxoiron(IV) complexes 
supported by the variants of the ligand N4Py, and uses a novel approach to obtain 
crystal structures of at least two reactive oxoiron(IV) complexes with up to a 1000-
fold higher reactivity. 
Chapter 3 describes synthetic efforts to expand the number of oxoiron(IV) 
complexes, so that an even wider range of reactivity can be obtained. This effort 
allows us to determine the trends observed in reactivity of oxoiron(IV) complexes 
and correlate them (over a wider scope of ligand frameworks) with the 
spectroscopy and the structure of oxoiron(IV) complexes, to formulate 
generalizable themes of properties that determine the reactivity of oxoiron(IV) 
complexes. 
Chapter 4 demonstrates the use of NMR spectroscopy as an innovative tool to 
determine solution-state structures of oxoiron(IV) complexes in different spin 
states, and lays out the foundation for its complementary use along with 




1.2 Oxoiron(IV) Intermediates in Non-Heme Iron Enzymes  
Aerobic life ranging from bacteria to complex eukaryotic organisms such as human 
beings has evolved to utilize dioxygen (O2) from air to carry out diverse oxidative 
chemistry. The oxidative power of this molecule is used in many vital metabolic 
processes critical to existence of life, including the generation of “molecular energy 
unit of currency” ATP (adenosine triphosphate), the degradation of xenobiotics, 
syntheses of important biomolecules, and many others. Non-heme and heme-
based iron enzymes are important tools employed by these organisms to use 
dioxygen and couple its oxidative capabilities with the activation of very inert 
chemical bonds. 
Many of the non-heme iron enzymes harness the power of atmospheric oxygen to 
generate oxoiron(IV) intermediates as the key substrate-activating species during 
their catalytic cycles. For example, oxoiron(IV) motifs are involved in oxidation of 
one of the strongest aliphatic C−H bonds (bond dissociation energy = 105 
kcal/mol) of methane to methanol, a transformation carried out by a diiron enzyme 
called soluble methane monooxygenase, using a diiron(IV) intermediate called Q.1 
Similar tetragonal oxoiron(IV) motifs have also been used recently generated in 
zeolites recently to achieve the same chemical transformation.2 
The first mononuclear oxoiron(IV) enzymatic intermediate TauD-J was 
characterized in 2003 by Krebs and Bollinger in the enzyme taurine/alpha-
ketoglutarate-dependent dioxygenase, which is responsible for catalyzing the 
hydroxylation of the C1 position of taurine.3 This function is used as a means of 
recycling sulfur in the cell.4 In the reduced form of the enzyme, the iron(II) active 
metal center is bound to two histidines and one aspartate residue in a facial 
arrangement. This arrangement is common to many mononuclear iron-containing 
enzymes and is referred to as the two-histidine-one-carboxylate facial triad.5-7 The 
other sites of the iron(II) center are bound to water molecules. 
The generally accepted mechanism of dioxygen activation in the active site of the 
non-heme iron enzyme called alpha-ketoglurate dependent taurine-dioxygenase 
4 
is proposed in Figure 1.1. Introduction of alpha-ketoglutarate into the active site 
results in displacement of two of the water molecules to allow it to act as a 
bidentate ligand. Subsequent addition of substrate expels the remaining water 
molecule, to give rise to a 5-coordinate iron center, which then activates dioxygen 
from the air. This activation results in the coordinative saturation of iron, and its 
oxidation to form an FeIII-superoxo intermediate. This intermediate is then 
proposed to attack the electrophilic 2-oxo carbon atom of the bidentate alpha-
ketoglutarate ligand, to now form an FeIV-alkylperoxo intermediate. Further O–O 
and C–C bond breaking steps finally result in the removal of carbon dioxide, 
succinate, and a terminal FeIV-oxo species that can cleave C–H bonds.8 This 
attack on the Fe=O bond results in formation of an iron(III) hydroxide species and 
a substrate radical, that in turn rebounds to the iron center to yield oxidized product 
and the iron(II) starting point of the catalytic cycle. 
 
Figure 1.1 Mechanism of dioxygen activation at the active site of the non-heme 
iron enzyme called alpha-ketoglurate dependent taurine-dioxygenase. 
The trapping and identification of the oxoiron(IV) intermediates in this enzyme were 
enabled by the use of perdeuterated taurine, so that its rate of reaction with the 
intermediate was significantly slowed (as demonstrated by a KIE of 50), enabling 
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it to be thoroughly characterized.3 Since then, oxoiron(IV) intermediates of several 
enzymes have been characterized using similar strategies.9-15 Incidentally, all the 
intermediates in the enzymes have a ground spin state of S = 2, and isomer shifts 
in the range of 0.22 – 0.30 mm/s, as determined by their Mössbauer spectra.  The 
S = 2 ground spin state of these ferryl intermediates is often attributed to the weak 
field ligand donors found in the active center of the enzyme and is a characteristic 
feature for these intermediates so far. Although the crystal structures of the 
enzymatic oxoiron(IV) intermediates would conclusively establish their geometry 
and structure, their thermal instability makes them harder to crystallize relative to 
the synthetic nonheme oxoiron(IV) compounds. 
1.3 Synthetic Nonheme Oxoiron(IV) Complexes 
Efforts to characterize oxoiron(IV) complexes in synthetic bioinorganic chemistry 
were jumpstarted in 2003 with the structural characterization of the first oxoiron(IV) 
intermediate supported by a macrocyclic ligand (Figure 1.2), namely 
[FeIV(O)(TMC)(MeCN)]2+ (where MeCN is the solvent acetonitrile and TMC is 
1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane).16 However, this complex 
was found to be in the S = 1 spin state using Mössbauer spectroscopy and had a 
lower isomer shift (δ = 0.17 mm/s) than that of the only enzymatic intermediate 
characterized at the time (TauD-J) which had a larger isomer shift of 0.30 mm/s. 
This synthetic complex was also found to have reactivity properties far inferior than 
those of the enzymes. Bioinorganic chemists have mounted significant efforts after 
the structural and spectroscopic characterization of this complex to model 
oxoiron(IV) motifs in enzymes, and a short summary of these synthetic endeavors 
in the context of complexes examined in this thesis is detailed below. 
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Figure 1.2 The parent oxoiron(IV) complexes supported by different ligand 
frameworks, variants of which span over half of the oxoiron(IV) complexes reported 
thus far. 
Over 90 synthetic nonheme oxoiron(IV) complexes have been reported so far in 
attempts that aimed to spectroscopically, functionally or structurally model the 
enzymatic intermediates.17-18 Almost all of these oxoiron(IV) species are supported 
by polydentate frameworks, and only 7 have been characterized in the S = 2 
ground spin state found in the enzymes, with the remaining found in the S = 1 
ground spin state. Of the complexes in the S = 2 spin state, five are supported by 
ligands with a trigonal bipyramidal fold around the iron center, and two are 
proposed to have a tetragonal geometry. The S = 1 oxoiron(IV) intermediates on 
the other hand, are all supported by ligands with tetragonal ligand field around the 
iron(IV) center (Figure 1.3). 
While one of the goals of bioinorganic chemists has been to make more S = 2 
oxoiron(IV) complexes, only one of those efforts has succeeded in achieving 
similarities to the enzymatic complexes in both reactivity and spectroscopy. This 
failure is partly rooted in the lack of stability of most of the complexes that are S = 
2 in nature, which has prevented structural insight into the factors that contribute 
to these S = 2 complexes’ reactive nature. 
 
Figure 1.3 Tetragonal (left) and trigonal (right) ligand field splitting diagrams of S 
= 1 and S = 2 oxoiron(IV) complexes, and a pie chart showing the span of 
complexes in different spin states and ligand fields. 
Therefore a number of approaches have been taken by synthetic chemists to 
synthesize oxoiron(IV) intermediates that have similarities to the signatures of 
enzymatic intermediates.19 Despite the lack of structural information available on 
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enzymatic oxoiron(IV) intermediates, over a dozen of the 90 oxoiron(IV) complexes 
have been crystallographically characterized. Many of them share a common 
ligand framework based on either the macrocyclic ligand TMC or the pyridine-rich 
N4Py and BnTPEN ligands (see next two sections and Figure 1.2). Upon perusal 
of the structurally characterized oxoiron(IV) landscape and the successful 
strategies employed to develop spectroscopic and structural analogs of enzymatic 
oxoiron(IV) intermediates, one can begin to develop correlations of their structural 
and spectroscopic signatures with their reactivity. Specifically, this effort has the 
potential to provide indirect insight into the aspects that govern the reactivity of 
enzymatic and synthetic oxoiron(IV) intermediates, as well as the role of the 
primary coordination sphere in determining the reactivity of oxoiron(IV) motifs. This 
thesis aims to explore these structural and spectroscopic correlations with 
reactivity, as will be explained in the next two sections of this chapter. 
The most successful effort in the Que lab to make a synthetic oxoiron(IV) complex 
with electronic and functional properties similar to those of the enzymatic 
intermediates is represented by [FeIV(O)(TQA)(L)]2+, where TQA = tris(2-
quinolylmethyl)amine (Figure 1.4). TQA is a tetradentate tripodal ligand containing 
three quinoline donors that supports an S = 2 oxoiron(IV) center. However, it has 
a half-life of only 15 minutes at 233 K, which has prevented its crystallographic 
characterization. Its ‘parent’ complex on the other hand, [FeIV(O)(TPA)(L)]2+, where 
TPA is (tris(2-pyridylmethyl)amine), contains three pyridine donors, has an S = 1 
spin state and is stable for over a day at 233 K.20 
 
Figure 1.4 Introduction of alpha-methyl groups on pyridines in parent S = 1 
complex [FeIV(O)(TPA)(L)]2+ (left) results in S = 2 complex [FeIV(O)(6Me3TPA)(L)]2+ 
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(middle) and replacement of its pyridines with quinolines results in 
[FeIV(O)(TQA)(L)]2+ (right). 
The reasons for the different spin states in the two tetragonal oxoiron(IV) 
complexes supported by the same general framework can be understood upon 
examination of iron(II) complexes supported by the parent TPA and 6Me3TPA 
(tris(6-methyl-2-pyridylmethyl)amine) ligands.21 The iron(II) complex supported by 
TPA is diamagnetic (as evidenced by its 1H NMR spectrum), and that supported 
by 6Me3TPA ligand is paramagnetic (evidenced by its paramagnetically shifted 
peaks), indicating its S = 2 nature. Furthermore, the iron(II) complex supported by 
6Me3TPA has its pyridyl donors 0.2 angstroms farther away from the iron center. 
This difference can be attributed to the steric interactions of the 6-methyl protons, 
which likely cause the Fe−Npy bond lengths to increase and weaken the binding of 
the pyridine donors into the metal center, resulting in a weakened ligand field that 
allows its four d-orbital electrons to adopt the unpaired S = 2 configuration. 
The quinoline H8 protons in [FeIV(O)(TQA)(L)]2+ likely have similar interactions with 
the oxoiron(IV) unit, although such effects have not been observed 
crystallographically until recently in oxoiron(IV) complexes.22 These steric 
interactions increase the Fe−N bond length, and hence the sigma-donation of 
quinoline nitrogen into the metal center, thus weakening the equatorial ligand field, 
which in a tetragonal complex would lower the energy of the dx2-y2 orbitals, and 
tune the ligand field of the oxoiron(IV) complex enough for the iron center to adapt 
the S = 2 spin state configuration. 
In this thesis, proof for such steric interactions is provided using structural 
characterization of an oxoiron(IV) complex containing quinoline rings, which 
increase the average Fe−N bond lengths of the oxoiron(IV) complex by 0.08 Å, 
and shows a ferryl unit that directly gets affected by such interactions, as detailed 
in the next section. 
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1.4 Oxoiron(IV) Complexes Supported by Modified N4Py-Based Ligands 
N4Py (1,1-di(dipyridine-2-yl)-N,N-bis(pyridine-2-ylmethyl)methanamine) is a 
pentadentate Cs-symmetric ligand that was first synthesized in the Que lab in 
1995.23 It has been recently shown to support an unexpected binding mode in a 
dinuclear platinum(II) species.24 But when it binds iron(II) metal, it supports a low-
spin, 6-coordinate and mononuclear complex with the sixth coordination site bound 
by a solvent (Figure 1.5), which can be replaced with different oxygen-related 
motifs to model intermediates related to oxygen activation. 
 
Figure 1.5 Binding modes of N4Py to transition metals in +2 oxidation state. 
Its Cs-symmetric iron(II) precursor has two pairs of equatorial pyridines, and an 
axial tertiary amine. The two pyridines attached to the bis(pyridyl)methylamine half 
of the ligand have larger torsional angles (26-28°) with the axially bound ligand 
than the pair of pyridines on the bis(pyridyl-2-methyl)amine half of the ligand 
(where these angles are 7-13°). Nevertheless, all four pyridines are approximately 
aligned parallel to the axis formed by the Fe−Namine and the axial ligand, and in the 
way these pyridines are connected, the framework is somewhat rigid and does not 
allow the pyridines to move. The ligand framework has proven its versatility in its 
ability to support reactive intermediates in both iron(III) and iron(IV) oxidation 
states, and these intermediates can oxidize strong C−H bonds of cyclohexane in 
the +4 oxidation state.23, 25 Furthermore, N4Py also has only five benzylic protons 
(which are the weakest bonds in the ligand, with a bond dissociation energy of ≈ 
10 
90 kcal/mol), which further increases its robustness as a ligand that can support 
transition metal-based species that could activate strong C-H bonds. 
TPA is a related but similar ligand, which has also been used by the Que group 
extensively to support both mononuclear and dinuclear nonheme high-valent 
intermediates.20-21, 26-27 Interestingly, the difference between the N4Py and TPA 
ligands is only the additional pyridine donor in N4Py, which replaces one of the 
methylene protons in TPA (Figure 1.6) 
 
Figure 1.6 Differences in the ligands supporting oxoiron(IV) complexes (with 
different half-lives). 
N4Py supported the first structurally characterized oxoiron(IV) intermediate that 
could activate the strong bonds of cyclohexane.28 Its thermal stability (t½ = 60 h at 
298 K) makes this ligand a very attractive candidate in pursuits of structural 
information on unstable complexes based on similar framework. The variants of 
this ligand containing a quinoline heterocycle have been recently reported, and 
utilized to make reactive oxomanganese(IV) complexes, for example.29 We have 
used this framework to stabilize and crystallographically characterize the first 
examples of unstable oxoiron(IV) complexes that contain heterocycles other than 
pyridines, namely quinolines and benzimidazoles.22 These two heterocycles have 
also been found in the ligand frameworks of very reactive oxoiron(IV) complexes, 
and hence N4Py serves as a useful tool to obtain structural information on 
complexes that contain these heterocycles. This work is presented in Chapter 2. 
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1.5 Oxoiron(IV) Complexes Supported by Modified BnTPEN-Based Ligands 
The hexadentate TPEN ligand (N,N,N’,N’-tetrakis(pyridine-2-ylmethyl)ethane-1,2-
diamine), which has an ethylenediamine linker bound to four 2-picolyl groups, can 
be made into a pentadentate ligand if one of its pyridyl arms are replaced with a 
non-coordinating benzyl group.30 Such a pentadentate ligand framework, namely 
BnTPEN (N-benzyl-N,N’,N’-tris(11yridine-2-ylmethyl)ethane-1,2-diamine) wraps 
around iron center so that the resulting complex has no element of symmetry 
(Figure 1.2), and has been used by McKenzie and coworkers extensively in their 
work on isolating intermediates related to this framework.30 A number of iron(II) 
complexes supported by this ligand have been structurally characterized, wherein 
the axial ligand is tuned to affect the properties of the iron(II) center.31 
The oxoiron(IV) complex supported by BnTPEN at the time was one of the most 
reactive oxoiron(IV) complexes which could also react with cyclohexane at room 
temperature, but owing to its 10-fold lower stability (half-life of 6 h at 298 K), it could 
not be structurally characterized. Nevertheless RTPEN (or N-alkyl-N,N′,N′-tris(2-
pyridylmethyl)ethane-1,2-diamine) ligands have been used to support various 
iron(III) peroxo intermediates, and recently, substitutions that enable hydrogen 
bonding on RTPEN’s dangling R groups have even enabled selective formation of 
an FeIV(O) or an FeIII(OOH) intermediate from the reaction of iron(II) precursor with 
H2O2, which has allowed controlled heterolytic versus homolytic O-O bond 
cleavage through a secondary coordination sphere.32 This functionality also 
speaks to the versatility of this ligand framework in providing an ability to tune 
ligand fields around the iron center and generate different intermediates. Other 
modifications on this ligand framework have involved use of acetate groups to 
replace the pyridyl arms on the TPEN framework to generate a negatively charged 
TPENA ligand (N,N,N′-tris(2-pyridylmethyl)ethylenediamine-N′-acetate). The 
iron(II) complex supported by this ligand reacts with iodosylbenzene to form a 
seven-coordinate iron(III) complex, which is considered to be a masked FeV(O) 
compound that can catalyze oxygenation of sulfides.33 Its ability to carry out 
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oxygen atom transfer catalytically has been studied extensively by Wang and 
coworkers using extensive theoretical work on the complex.34 
The complex [FeIV(O)(BnTPEN)]2+ is an order of magnitude more reactive than 
[FeIV(O)(N4Py)]2+ in its hydrogen atom transfer and oxygen atom transfer 
abilities.25 While it is just another oxoiron(IV) complex supported by a tetragonal 
ligand field, alpha-substituents on this ligand’s pyridines have not been introduced. 
Its equatorial ligand field can therefore be tuned by doing so, which would change 
the energy level of the dx2-y2 orbital. If the equatorial ligand field is weakened, the 
splitting of the d orbitals decreases, and the metal center also becomes more 
electrophilic. This electrophilicity can potentially explain the higher observed 
reactivity of resulting oxoiron(IV) complexes in this framework, and it is possible 
that one can change the spin state of the molecules in this framework and go from 
S = 1 to S = 2, like the enzymatic intermediates. 
The BnTPEN parent ligand wraps around the iron(IV) unit such that it has an 
equatorial amine and three equatorial pyridines (in contrast to four in N4Py). One 
of the three equatorial pyridines is bound ‘perpendicular’ to the axis formed by the 
sixth ligand and the iron center, and the remaining two pyridines are parallel to this 
axis. The ethylene diamine linker allows this framework to be relatively less rigid 
than that of N4Py. But overall, presence of pyridine in a different orientation 
enables examination of orientation of heterocycles and their effects on 
spectroscopy, structure and reactivity of the oxoiron(IV) complexes. This is the 
reason why oxoiron(IV) complexes supported by BnTPEN framework are of great 
interest, and will be examined in this thesis. We have sequentially replaced the 
pyridines in the complex with sterically encumbering quinolines or introduced 
alpha-substituents like methyl groups to make more reactive oxoiron(IV) 
complexes. However, this has resulted in oxoiron(IV) complexes that are 
comparably reactive to [FeIV(O)(TQA)(L)]2+ and for some of them the determination 
of rate constants required the use of stopped flow instrument. This data is 
presented in Chapter 3. 
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1.6 Solution-State NMR Spectroscopic Studies of Oxoiron(IV) Complexes 
NMR spectroscopy is a great structural tool that can probe the solution state 
structure and the electronic properties of oxoiron(IV) complexes. There are only a 
few examples of cases where it has been explored for pyridine-rich oxoiron(IV) 
complexes,28, 35 and in many of those cases, the NMR spectra are not fully 
assigned.36-39 Some studies on TMC-based oxoiron(IV) complexes have proven 
useful in the identification of different isomeric forms of an oxoiron(IV) 
intermediates, but other than that NMR spectroscopy is not generally used as a 
regular tool for characterization of oxoiron(IV) complexes, and there are no studies 
on the the NMR spectra of S = 2 oxoiron(IV) complexes. Given the number of 
unpaired electrons (Figure 1.3) and subsequently different magnetic properties of 
resulting complexes, it is worth noting that the complexes in the S = 1 and S = 2 
spin states are likely going to have very different paramagnetic shifts in their 1H 
NMR spectra. This difference in electronic properties highlights two uses for NMR 
spectroscopy: 1) in addition to Mössbauer spectroscopy, it can also serve as a tool 
to determine the spin state of the oxoiron(IV) complexes; 2) it can be used to 
determine the solution-state structure of oxoiron(IV) complexes. 
Two examples can be used to highlight both the use cases. Borgogno et al. have 
used DFT methods to predict NMR spectra of the S = 1 [FeIV(O)(TPA)(L)]2+ 
complex in two different isomeric forms (shown in Figure 1.7),40 and also used the 
same methods to predict NMR spectra of an S = 2 [FeIV(O)(tpaPh)]− complex (where 
tpaPh = tris(5‐phenylpyrrol‐2‐ylmethyl)amine) in quintet and triplet ground spin 
states (Figure 1.8), to highlight how these paramagnetic shifts are different.41 
Determination of solution-state geometry: 
There are two Cs-symmetric isomers of [FeIV(O)(TPA)(L)]2+, and one of them has 
all of its pyridines arranged equatorially around the iron center and aligned parallel 
to the oxoiron(IV) unit. In the other isomer, the pyridines have different 
configurations, such that two of them are arranged equatorially around the iron 
center but are perpendicular to the oxoiron(IV) unit, and one pyridine is trans to the 
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oxoiron(IV) unit (Figure 1.7). NMR spectroscopy can be useful in determining the 
solution state spectra for all the complexes. This set of different configurations is 
also helped by access to NMR spectra of complexes in which pyridines are in all 
three different alignments (trans, perpendicular or parallel to the ferryl unit) and 
can help further assignment of solution-state structures of these complexes. 
 
 
Figure 1.7 DFT predicted NMR spectra for different isomeric forms of the complex 
[FeIV(O)(TPA(L)]2+ in the S = 1 spin state. Figure adapted from reference 40. 
 
The predicted NMR spectra of the two isomers are reproduced in Figure 1.7 and 
indicate that the pyridine proton signals in both the isomers of the complex are 
quite distinct from each other. In the isomer A, the β’ and β proton signals of all 
three equatorial pyridines are paramagnetically shifted upfield and downfield 
respectively. But in isomer B, there are two distinct pyridines. β’ and β proton 
signals for pyridines perpendicular to the oxoiron(IV) unit are both shifted upfield 
below 0 ppm, and the pyridine trans to the oxo has its pyridine β’ and β proton 
signals shifted downfield and upfield. These variations in signals of the isomers 
are distinct enough from each other that 1H-NMR spectrum of the complex can 
shed light into the solution-state structure.  
The 1H-NMR spectrum of [FeIV(O)(tpaPh)]− looks different in quintet and triplet spin 
states, as seen from different paramagnetic shifts of Ha and Hb protons in the 
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spectrum of this complex shown in Figure 1.8. Unfortunately, the NMR spectra of 
the S = 2 complexes are not reported, so this DFT method remains to be verified 
experimentally, although it has been found to be fairly accurately predict the NMR 
spectra of S = 1 oxoiron(IV) complexes. The differences in paramagnetic shifts are 
very obvious indicators that NMR spectroscopy can be a useful tool to distinguish 
the spin state of the oxoiron(IV) complexes.  
 
Figure 1.8 DFT predicted NMR spectra of the complex [FeIV(O)(tpaPh)]− in the S = 
1 and S = 2 spin state. Figure adapted from reference 40. 
In this thesis, we use some of the complexes in the S = 2 ground spin state to test 
this method experimentally and provide yet NMR spectroscopy as yet another 
informative tool another tool for the bioinorganic community to obtain this 
information. 
Furthermore, because we know that transition to the spin state S = 2 occurs when 
all the pyridines in complex [FeIV(O)(TPA)(L)]2+ are replaced by quinolines or 
alpha-methyl substitutions are made on the pyridines, we wanted to explore at 
what point this change occurs. Just like the case of N4Py and BnTPEN series of 
oxoiron(IV) complexes, we have made sequential changes in the parent complex 
[FeIV(O)(TPA)(L)]2+ and introduced quinoline heterocycles. The resulting 
complexes have been examined by NMR spectroscopy and in doing so, we have 
identified a complex in the process that exhibits spin-crossover behavior. Detailed 
reactivity studies of these new complexes accompany these results. This data is 
presented in Chapter 4. 
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In the catalytic cycles of many oxygen activating nonheme iron oxygenases and 
oxidases, S = 2 oxoiron(IV) intermediates are often found to be directly implicated 
in a diverse range of chemical transformations.1 These transformations include 
hydroxylation of un-activated aliphatic C−H bonds, epoxidation of C=C bonds, as 
well as desaturation of C−C bonds among others.2 Bioinorganic chemists have 
mounted a significant effort to mimic the oxoiron(IV) intermediates involved in the 
catalytic cycles of these non-heme iron oxygenases, and there are now about 90 
synthetic variants, although most are found in the S = 1 ground spin state, unlike 
the S = 2 ground spin state described for the enzymes.3-6 
The few mononuclear S = 2 oxoiron(IV) complexes characterized thus far have 
been reported using two strategies.7 One strategy employed the use of sterically 
bulky tripodal ligands to support the ferryl unit. These ligand frameworks enforced 
a trigonal bipyramidal geometry around the iron(IV) center, which led the Fe d-
orbitals to arrange in two pairs of energetically degenerate singly-occupied orbitals, 
thus favoring a high-spin (S = 2) configuration (Scheme 2.1, right).8-9 The ligand 
frameworks used to enable this configuration also blocked access to the ferryl unit, 
which is responsible for activating strong C−H bonds. So, the resulting S = 2 
oxoiron(IV) complexes were found to be relatively sluggish oxidants. 
 
Scheme 2.1 d-orbital splitting diagrams of the oxoiron(IV) complexes in different 
spin states and ligand fields. 
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The second strategy used to populate S = 2 ground spin state in ferryl complexes 
employed weaker-field ligands compared with those based on tertiary amines and 
N-heterocycles like pyridines and benzimidazoles. This strategy enabled formation 
of more reactive oxoiron(IV) complexes in S = 2 ground spin state. To start, Bakac 
and coworkers10 reported the S = 2 [FeIV(O)(H2O)5]2+ ion in acidic aqueous 
solution, in which the ferryl unit was coordinated by five weak-field aqua ligands. 
While it was also found to be very reactive towards oxidation of organic substrates, 
its extremely short-lived nature (t½ ≈ only 20 seconds at room temperature) 
prevented further characterization by crystallography. 
A relatively more stable compound is the S = 2 iron(IV) complex 
[FeIV(O)(TQA)(L)]2+ (where TQA = tris(2-quinolylmethyl)amine, Figure 2.1), which 
exhibits the fastest rate of oxidation of cyclohexane found thus far for any 
mononuclear synthetic oxoiron(IV) complex, and is also a functional and 
spectroscopic model for the TauD-J intermediate.11 This complex has an axial 
amine bound to three quinoline heterocycles arranged equatorially around the 
iron(IV) center. It is proposed that the steric effects of the quinoline donors increase 
the Fe−N bond lengths, thereby weakening the iron(IV) ligand field to afford the 
observed S = 2 ground state. The change in spin state from S = 1 to S = 2 is 
achieved because sterically encumbering quinoline donors replace the strong-field 
donors of pyridines and lower the energy of the dx2-y2 orbital of the iron(IV) center, 
thus bringing it closer to the dxy orbital.  This likely enables a new configuration 
whereby an unpaired electron resides in both dxy and the dx2-y2 orbital (in addition 
to the unpaired electrons in dxz and dyz), thus resulting in a ground spin state 
change from S = 1 to S = 2. A similar effect is also enforced by the introduction of 
an alpha-methyl substituent on the pyridine, whereby steric effects of the methyl 
protons are proposed to increase the Fe−N bond lengths of the resulting complex 
[FeIV(O)(6Me3TPA)(L)]2+, where 6Me3TPA = tris((6-methylpyridin-2-
yl)methyl)amine and result in the change from S = 1 to S = 2 ground spin state. 
This is an especially interesting change, because most of the synthetic oxoiron(IV)  
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complexes have been characterized only in the S = 1 ground spin state, and the 
direct evidence for such a steric change can help design more synthetic 
oxoiron(IV) complexes with S = 2 ground spin state. 
One way to quantitatively examine the steric effects of quinolines around the ferryl 
unit is to obtain crystal structure of the oxoiron(IV) compounds containing these 
modifications. Due to their thermal instability (t½ ≈ 15 min in MeCN at −40 °C), it 
has not been possible to obtain the crystal structure or reliable XAS spectroscopic 
analyses of the highly reactive S = 2 complexes [FeIV(O)(TQA)(L)]2+ or 
[FeIV(O)(6Me3TPA)(L)]2+ (Figure 2.1). 
Interestingly, Nam and co-workers have also reported another very similarly 
reactive oxoiron(IV) complex, albeit in the S = 1 spin state, which is supported by 
N-methylbenzimidazoles, [FeIV(O)(Me3NTB)(L)]2+, (Me3NTB =  tris((1-methyl-1H-
benzo[d]imidazol-2-yl)methyl)amine) (Figure 2.1).12 Its hydrogen-atom abstraction 
ability is comparable to that of [FeIV(O)(TQA)(L)]2+, but it is even more unstable 
than the latter, with a half-life of only about 1-2 minutes in MeCN at −40 °C. Thus, 
the most reactive synthetic analogues of these intermediates are supported by 
tetradentate tripodal ligands with N-methylbenzimidazole or quinoline or 6-
methylpyridine donors, but their instability precludes structural characterization. 
 
Figure 2.1 Reactive and thermally unstable S = 1 and S = 2 FeIV(O) complexes 
supported by tetradentate ligands. 
 
We have thus embarked on a systematic effort to compare the structures and 
reactivity of a series of FeIV(O) complexes supported by pentadentate ligands, that 
contain N-methylbenzimidazoles, quinolines, or alpha-methyl substituted 
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pyridines, to determine whether such complexes can be stabilized, and possibly 
crystallized. This would enable us to establish a possible correlation of structure 
with its reactivity, in addition to lending structural insight into how these modified 
pyridines, quinolines and benzimidazoles arrange around the ferryl center. This 
chapter lays out the results of those efforts. 
As a starting point, we have chosen [FeIV(O)(N4Py)]2+ (1, N4Py = 1,1-di(pyridin-2-
yl)-N,N-bis(pyridin-2-ylmethyl)methanamine), the second oxoiron(IV) complex to 
be crystallographically characterized, which is relatively stable (t½ = 60 h at 25 °C). 
The N4Py ligand has an axial amine and four equatorial pyridines that can be 
subdivided into two distinct pairs of pyridine donors.13-14 At least four different 
groups have taken on an effort to modify one of the two pairs of pyridines to 
determine how the properties of the resulting ferryl complexes are affected.15-18 
Note: After the experimental results from this chapter were published, more groups 
have conducted reactivity studies on complexes described in this chapter, 
including measurement of kinetic isotope effects for the reactions of these 
complexes with C−H substrates,19 as well as halogenations carried out using 
iron(II) halide complexes supported by same frameworks, which occur after the 
initial hydrogen-atom-abstraction by ferryl complexes discussed in this chapter.20 
Other groups have even reported complexes similar to the ones in this chapter, 
both in the context of iron and manganese metal centers,21-22 as well as in the 
context of the ligand modifications introduced.23 Fortunately, the higher stability as 
well as purity of the complexes we reported has enabled active discussion and 
exploration of the rich chemistry provided by N4Py framework, and enhanced the 
studies conducted by other groups. In this chapter, all the experimental 
developments up to March 2019 are included to provide an insight into this 
versatile framework. 
Six different types of modifications have been reported for this ligand framework, 
and the types of the modifications and properties of the metal complexes resulting 
from them are categorized below: 
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Introduction of carboxylate donors: The first modification on N4Py framework was 
reported by the Que group in 2012, and used weak-field oxygen donors similar to 
those in [FeIV(O)(H2O)5]2+. The modified ligand introduced carboxylate ligands on 
the N4Py framework to form the ligand dubbed nBu-P2DA (nBu-P2DA = N-(1′,1′-
bis(2-pyridyl)pentyl)iminodiacetate). [FeIV(O)(nBu-P2DA)]2+ was originally 
designed to mimic the carboxylate-rich active sites of taurine dioxygenase’s ferryl 
intermediate, using a 2-carboxylate-2-pyridine set of equatorial ligands (Figure 
2.2).24 However, its thermal instability at temperatures even below −60 °C 
prevented its crystallographic characterization, and while it was a structural model 
of TauD-J, its S = 1 spin state and low reactivity prevented it from being a 
spectroscopic and functional analog of this enzymatic intermediate. 
Introduction of aryl rings on pyridines: Sahu et al. made the second modification 
on N4Py, wherein aryl groups replaced the 6-H’s of the pyridines on the 
bis(pyridyl)methylamine half of the N4Py ligand.18, 25 Out of the two aryl 
modifications, they reported the crystal structure of [FeIV(O)((ArF2)2N4Py)]2+ 
(complex 4, Figure 2.2), where the aryl groups were 2,6-difluorophenyl rings. The 
fluorine or the hydrogen atoms on the aryl rings are situated such that these ferryl 
complexes end up undergoing intramolecular hydroxylation of the aryl rings when 
warmed to higher temperatures, and likely impede their intermolecular reactivity 
studies with substrates at room temperature. 
Introduction of 6Me-groups on the pyridines: On the bis(pyridyl)methylamine half 
of the N4Py ligand, replacement of the pyridine 6-H’s with methyl groups has also 
been recently reported, but the resulting complex has reduced thermal stability and 
attempts to get its crystal structures were not successful.23 Interestingly, the effect 
of the introduction of an alpha-methyl substituent on the pyridine on the bis(pyridin-
2-ylmethyl) half has been also examined for the parent complex recently, and 
interplay of sterics and electronics was just recently reported between the two 
substitutions.26 However, the steric effects upon the introduction of an alpha-
methyl substituent on the pyridines have only been investigated using 
26 
computational methods, and crystallographic insight to experimentally quantify this 
these effects is not available. 
Introduction of N-methylbenzimidazole heterocycles: N2Py2B is an N4Py variant 
where two of the pyridines are replaced with N-methylbenzimidazoles.15 Detailed 
structural or spectroscopic characterization on oxoiron(IV) supported by this 
ligand, that is [FeIV(O)(N2Py2B)]2+ (2) (Figure 2.3) was not provided in the original 
report because of its thermal instability, but its reactivity profile was examined 
extensively. An oxomanganese(IV) complex supported by this ligand was recently 
reported and compared, but unlike its oxoiron(IV) counterpart, this complex has 
muted reactivity with hydrocarbons and with oxygen-atom transfer substrates.22 In 
this chapter, crystallographic characterization of this complex along with other 
spectroscopic details is reported. 
Introduction of electronically rich pyridines: In N4Py**, two pyridines have electron-
donating methyl groups on 3- and 5-position, and a methoxy group on the 4-
position. Although [FeIV(O)(N4Py**)]2+ (1*) has been reported before (Figure 2.2), 
detailed information on its spectroscopic characterization and reactivity profile is 
not available.16 Despite its thermal stability, structural data on this complex has not 
been obtained. The corresponding [MnIV(O)(N4Py**)]2+ is found to be much less 
reactive than its parent [MnIV(O)(N4Py)]2+ complex, but in the case of FeIV(O) 
complexes, both complexes have comparable HAT reactivity profiles with cumene 
and ethylbenzene. This complex was crystallographically characterized and 
information about its bond metrics are also discussed. 
Introduction of quinolines: N2Py2Q is an N4Py variant where two of the pyridines 
are replaced with quinolines (Figure 2.3). The complex [MnIV(O)(N2Py2Q)]2+ and 
some of its reactivity has been described by Massie et al., but the corresponding 
FeIV(O) was not reported.17, 21 We report the crystallographic characterization of 




Figure 2.2 Previously reported modifications on the N4Py framework. 
 
This chapter examines the effects of making heterocyclic modifications on the 
N4Py framework, and in this regard, some of the previously reported variants of 
the N4Py ligand have been synthesized, wherein the two pyridine donors on the 
bis(pyridyl-2-methyl)amine half are replaced either by N-methylbenzimidazoles 
(N2Py2B), quinolines (N2Py2Q), 6-methylpyridines or 4-methoxy-3,5-
dimethylpyridines (N4Py**). The complexes examined in this chapter for their 






Figure 2.3 The FeIV(O) complexes supported by ligands based on N4Py 
framework, examined in this chapter. 
2.2 Experimental Section 
All materials were bought from Sigma Aldrich or Fischer Scientific, unless 
otherwise noted. The substrates cyclohexane, cyclooctane, 2,3-dimethylbutane, 
toluene, ethylbenzene, and cumene used in kinetic experiments were passed 
through a plug of silica before use, and triphenylmethane was recrystallized from 
ethanol, and its stock solutions were made in dichloromethane in a nitrogen-filled 
glovebox. Thioanisole solution was made outside the glovebox in acetonitrile. 
FeII(OTf)2•2CH3CN was prepared according to the published procedure.28 All 
oxygen and moisture sensitive compounds were synthesized in a nitrogen-filled 
glovebox. All kinetic experiments were carried out under nitrogen.  
The ligand and iron(II) precursor, [FeII(N4Py)(MeCN)](OTf)2) of ferryl complexes 1, 
and 1* was synthesized as reported, as was the ligand and iron(II) precursor to 2, 
[FeII(N2Py2B)(MeCN)](OTf)2. N2Py2B = N,N-bis((1-methyl-1H-benzoimidazol-2-
yl)methyl)-1,1-di(pyridin-2-yl)methanamine. The ligand N2Py2Q (1,1-di(pyridin-2-
yl)-N,N-bis(quinolin-2-ylmethyl)methanamine) was synthesized based on a 
modified procedure, and the synthesis of ligand 6Me2N4Py is detailed below. 
1H NMR spectra were recorded on a Bruker 400 or 500 MHz spectrometer at 298 
K. Elemental analyses were carried out by Atlantic Microlab (Norcross, GA). UV-
vis spectra were recorded on a HP8453A diode array spectrometer equipped with 
a cryostat from Unisoku Scientific Instruments (Osaka, Japan). Electrospray 
29 
ionization mass spectrometry (ESI-MS) experiments were performed on a Bruker 
BioTOF II mass spectrometer using a spray chamber voltage of 4000 V and a 
carrier gas temperature of 200 °C. IR spectra of synthetic samples were recorded 
on a Nicolet iS5 FT-IR spectrometer with an ATR source. 
Mössbauer spectra were recorded with two spectrometers, using Janis Research 
(Wilmington, MA) SuperVaritemp dewars that allow studies in applied magnetic 
fields of up to 7.5 T in the temperature range from 1.5 to 200 K. A LakeShore Model 
331A temperature controller was used to control the temperature in experiments. 
Mössbauer spectral simulations were performed using the WMOSS software 
package (SEE Co, Edina. Minnesota). Isomer shifts are quoted relative to α-Fe 
metal at 298 K. The spectra were plotted by SpinCount developed by Prof. Michael 
Hendrich at Carnegie Mellon University.29 
The experimental setup for HFEPR and FIRMS was used as reported earlier.30-31 
2.2.1 Synthesis of the ligands and complexes 
Synthesis of the parent ligand N4Py and the iron(II) complex  
Ligand and iron(II) precursor to 1, [FeII(N4Py)(MeCN)](OTf)2 was synthesized as 
reported before.32 Iron(II) perchlorate was replaced with the iron(II) triflate to 
avoid the former’s explosive risks. 
Synthesis of the ligand N4Py** and the iron(II) complex 
The ligand and the iron(II) precursor [FeII(N4Py**)(MeCN)](OTf)2 was synthesized 
using previously reported procedure.16 
Synthesis of the ligand N2Py2B 
The ligand was synthesized using previously reported procedure.15  
Synthesis of the ligand N2Py2Q 
The ligand was synthesized using a slightly modified previously published 
procedure.17 Two equivalents of 2-(chloromethyl)quinoline hydrochloride (1.20 g, 
30 
5.64 mmol) were dissolved in 4 mL of 5M NaOH solution. To this solution, bis(2-
pyridyl)methylamine (0.52 g, 2.82 mmol, 1 equivalent) in 2 mL of acetonitrile was 
added dropwise. An additional 6 mL of acetonitrile was used to completely transfer 
the amine. After a day of stirring in open air, oily brown droplets were found to be 
floating in a light brown aqueous solution (and all acetonitrile had evaporated). To 
this solution, 2 mL of acetonitrile was added. 4 days after stirring the reaction, a 
light beige colored solid had crashed out, which was filtered, and washed with 10 
mL of water, and dried under high vacuum. The original procedure used HPF6 to 
crash out the solid from the oil as a salt, but it was not added in this case because 
the solid crashed out of the reaction mixture itself to give 1 g of product (76%). The 
ligand was characterized using 1H NMR spectroscopy and found to be pure 
enough for metalation.  
Note: Hexafluorophosphoric acid (HPF6) was used exclusively to precipitate out 
the ligands where necessary, to avoid explosive risks associated with perchloric 
acid (HClO4). Perchlorate salts used in the following procedures are shock and 
heat-sensitive explosives, and should be handled with care. Wherever possible, 
perchlorate salts were replaced with triflate or hexafluorophosphate salts. Note 
however, that while replacement of HClO4 with HPF6 avoids explosion risks of the 
former, the latter is highly toxic and appropriate safety gear must be worn and the 
compounds handled carefully. 
Synthesis of the ligand 6Me2N4Py (precursor to 3a) 
2-(chloromethyl)-6-methylpyridyl hydrochloride (1 g, 5.61 mmol) was weighed in a 
6-dram vial, followed by 4 mL of 5M NaOH. To this solution, di(pyridin-2-
yl)methanamine (0.52 g, 2.8 mmol) was added directly, followed by 2 mL of 5 M 
NaOH. This solution was stirred for 48 h. Brown globular droplets were found to 
be floating in the solution, along with a small amount of yellow powder. DCM (3 x 
10 mL) was added to this suspension to extract all the organics into the solvent 
from water. The combined fractions of DCM solutions were dried with MgSO4, and 
concentrated to obtain a brown solid. The brown solid was brought in an ice bath, 
31 
and cold hexafluorophosphoric acid solution (2 mL) was carefully pipetted into it to 
allow precipitation of a yellow solid. To use this ligand, the hexafluorophosphate 
salt had to be worked up with basic solution of sodium hydroxide, and extracted 
into the DCM layer, dried with MgSO4, and concentrated to yield a brown solid. 1H 
NMR (400 MHz, CD3CN) δ 8.48 (d, 2H, α-H), 7.73-7.69 (m, 4H, γ-H), 7.53 (t, 2H, 
β’-H), 7.37 (d, 2H, β’-H), 7.20 (td, 2H, β-H), 7.02 (m, 2H, β-H), 5.29 (s, 1H, β-H), 
3.84 (s, 4H, CH2), 2.44 (s, 6H, Me-H). 
Synthesis of FeII(N2Py2B)(CH3CN)](OTf)2 
The [FeII(N2Py2B)(CH3CN)](ClO4)2 complex was synthesized following the 
reported procedure.15 An alternative synthesis used FeII(OTf)2•2CH3CN as a metal 
source and followed the procedure reported for the perchlorate salt to give a red 
solid, but the procedure was done anaerobically. [57FeII(N2Py2B)(CH3CN)](OTf)2 
was prepared in a similar manner using 57FeII(OTf)2•2CH3CN as the metal source. 
The 1H NMR spectrum of the complex in CD3CN showed a set of paramagnetically 
shifted peaks identical to those found for the perchlorate salt. 1H NMR (400 MHz, 
CD3CN) δ 37.99, 34.50, 29.82, 26.02, 18.19, 16.37, 12.21, 8.29, 5.64, 5.06, 2.20. 
The crystal structure ORTEP and its bond metrics were reported with bound 
acetonitrile on the 6th coordination site.  
Synthesis of [FeII(N2Py2Q)(OTf)]OTf 
In a nitrogen-filled glove box, FeII(OTf)2•2CH3CN (377 mg, 0.86 mmol) was 
dissolved in 1 mL CH2Cl2, and then transferred dropwise into a solution of N2Py2Q 
(402 mg, 0.86 mmol) in 1 mL CH2Cl2 to yield a reddish-brown solution. This 
solution was stirred overnight, and then concentrated in vacuo to remove all the 
CH2Cl2. At this point, 10 mL diethyl ether was added, and the solution was stirred 
for an hour. A dirty yellow solid was isolated as a powder in approximately 70% 
yield from this solution after filtration and could be recrystallized from slow diffusion 
of diethyl ether into a concentrated acetonitrile or dichloromethane solution. Anal. 
calculated for C33H25F6FeN5O6S2•3H2O [FeII(N2Py2Q)(OTf)]OTf•3H2O: C, 45.27;  
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H, 3.57; N, 8.00. Found: C, 45.78; H, 3.25; N, 7.49. [57FeII(N2Py2Q)(OTf)]OTf was 
prepared in a similar manner using 57FeII(OTf)2•2CH3CN as the metal source. The 
1H NMR spectrum of iron(II) complex in CH3CN showed a set of paramagnetically 
shifted peaks spanning 200 ppm, some of which were assigned using COSY NMR 
spectroscopy. 1H NMR (400 MHz, CD3CN) δ 136 (1H, br py-α-H), 110 (2H, Q-
CH2), 94.68 (2H, Q-CH2), 58 (2H, py-β-H), 44.69 (2H, Q-3-H), 33.44 (py-β-H), 
27.40 (2H, Q-7-H), 22.65 (2H, Q-4-H), 18 (2H, py-γ-H), 9 (2H, Q-5-H). 
The crystal structure of this complex was reported recently20, showing a bound 
triflate counterion for this complex’s 6th coordination site. 
Synthesis of [FeII(6Me2N4Py)(OTf)]OTf  
In a nitrogen-filled glove box, FeII(OTf)2•2CH3CN (377 mg, 0.86 mmol) was 
dissolved in 1 mL CH2Cl2, and then transferred dropwise into a solution of 
6Me2N4Py (402 mg, 0.86 mmol) in 1 mL CH2Cl2 to yield a brown solution. This 
solution was left to stir overnight, and then concentrated in vacuo to remove all the 
CH2Cl2. At this point, 10 mL diethyl ether was added, and the solution was stirred 
for an hour. A dirty brown solid was isolated as a powder in approximately 70% 
yield from this solution after filtration and could be recrystallized from slow diffusion 
of diethyl ether into a concentrated acetonitrile or dichloromethane solution. 1H 
NMR (400 MHz, 298 K in CD2Cl2) δ 148.41 (1H, br py-α), 130.15 (2H, py-CH2), 
122.84 (1H, py-CH2), 59.14 (2H, py-β/β’), 54.42 (2H, py-β/β’), 47.08 (2H, 6Me-py-
β/β’), 28.40 (2H, 6Me-py-β/β’), 18.42 (2H, py-γ), 14.69 (2H, py-γ), -23.66 (6H, 6Me-
CH3). 
While elemental analysis or crystallographic information on this complex could not 
obtained, triflate is the likely counterion bound to the 6th coordination site, as is 
often found for the S = 2 iron(II) complexes supported by pentadentate ligands and 
synthesized using iron(II) triflate as the metal source. Using other iron(II) salts with 
a different counterion, a crystal structure for this complex where acetonitrile is 
bound on the 6th coordination was reported in 2004.33 
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Because the crystal structure of the iron(IV) complex could not be obtained, efforts 
to examine its reactivity in detail were not carried out. 
Synthesis of [FeIV(O)(N4Py**)](ClO4)2 (1*) and [FeIV(O)(N4Py)](ClO4)2 (1) 
NaClO4 (314 mg, 2.57 mmol) and ceric ammonium nitrate (CAN) (133 mg, 0.243 
mmol) were dissolved in 1 mL water to give a yellow solution. This mixture was 
then transferred to a solution of iron(II) precursor (0.065 mmoles) in 0.5 mL 
acetonitrile to yield a blue solution in a minute. This solution was left overnight at 
2-8 °C, and the next day blue solid crystals could be seen in light bluish green 
solution of water and acetonitrile. This solid was carefully filtered, and washed with 
1 mL water, and the resulting solid was dried overnight in high vacuum to yield a 
blue solid. Both solids are highly soluble in water, so only sparing amount of water 
was used. 
Alternative methods to make both the solids involve addition of excess amount of 
oxidants like ArIO in iron(II) acetonitrile solutions at room temperature, and stirring 
in for half-an hour, which then forms the complexes in full yield. The complexes 
are then kept in refrigerator to crash out any ArIO. 
Synthesis of [FeIV(O)(N2Py2B)](ClO4)2 (2) 
NaClO4 (314 mg, 2.57 mmol) and ceric ammonium nitrate (CAN) (133 mg, 0.243 
mmol) were dissolved in 3 mL water to give a yellow solution. This mixture was 
then transferred to a solution of [FeII(N2Py2B)(MeCN)](ClO4)2 (50 mg, 0.065 
mmoles) in 1 mL acetonitrile to yield a blue solution, which precipitated in a minute 
to give a blue solid. This solid was filtered, and washed with 2 mL water, and the 
resulting solid was dried overnight in high vacuum to yield a greenish-blue powder 
(30 mg, 62% yield). Crystals suitable for X-ray crystallography were grown by 
dissolving 10 mg of the solid in 0.2 mL acetonitrile and adding a water solution of 
NaClO4 (50 mg in 1.8 mL). Slow evaporation of acetonitrile at 2-5 °C over the 
course of 8 h formed bluish green crystals suitable for X-ray diffraction. Anal. calcd. 
34 
for C29H27Cl2FeN7O9•H2O [FeIV(O)(N2Py2B)](ClO4)2•H2O: C, 45.69; H, 3.83; N, 
12.86, Cl, 9.30. Found: C, 45.25; H, 3.88; N, 12.78, Cl, 9.39. 
About 50 mg of solid 2 for HFEPR/FIRMS experiments was prepared in a similar 
manner. 
Synthesis of [57FeIV(O)(N2Py2B)](PF6)2 
The oxoiron(IV) complex was generated from the labeled iron(II) precursor. The 
iron(II) precursor was dissolved in approximately 200 μL CH3CN. Adding 4 eq ceric 
ammonium nitrate (CAN, (NH4)2[Ce(NO3)6]) in 0.5 mL H2O to the iron(II) solution 
changed the color of the solution to bluish green within a minute. Upon addition of 
20 eq NH4PF6 in 100 μL H2O to the vial, a precipitate formed from the solution 
immediately, and the solution was kept at 2-5 °C for 10 minutes to allow more 
precipitate to form. This solid was filtered on a sintered fine frit as a blue solid, 
washed with 5 mL H2O, and dried overnight under high vacuum to give a bluish 
green solid. A 2-mM solution was made in CH3CN and passed through a syringe 
filter, transferred into a Mössbauer cup, and then frozen in liquid nitrogen. 
Synthesis of [FeIV(O)(N2Py2Q)](ClO4)2 (3) 
NaClO4 (314 mg, 2.57 mmol) and ceric ammonium nitrate (CAN) (133 mg, 0.243 
mmol) were dissolved in 3 mL water to give a yellow solution. This mixture was 
then transferred to a solution of [FeII(N2Py2Q)OTf]OTf (50 mg, 0.061 mmoles) in 
1 mL CH3CN to yield a dirty-green solution, which precipitated in a minute to give 
a dark green solid. The solution was kept for two hours at 2-5 °C to allow for further 
precipitation. This solid was filtered, and washed with 2 mL water, and the resulting 
solid was dried overnight in high vacuum to yield a green powder (25 mg, 55% 
yield). Crystals suitable for X-ray crystallography were grown by dissolving 10 mg 
of the solid in 0.2 mL CH3CN, and adding an aqueous solution of NaClO4 (50 mg 
in 1.8 mL). Slow evaporation of CH3CN at 2-5 °C over the course of a few hours 
formed green crystals suitable for X-ray diffraction. Anal. calcd. for 
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C31H25Cl2FeN5O9•3H2O [FeIV(O)(N2Py2Q)](ClO4)2•3H2O: C, 46.99; H, 3.94; N, 
8.84. Found: C, 46.87; H, 3.48; N, 9.04. 
About 50 mg of solid 3 for HFEPR/FIRMS experiments was prepared in a similar 
manner. 
Synthesis of [57FeIV(O)(N2Py2Q)](PF6)2 
The oxoiron(IV) complex was generated from corresponding labeled iron(II) 
complex. The starting ferrous precursor was dissolved in approximately 200 μL 
CH3CN, and then reacted with 4 eq ceric ammonium nitrate (CAN, 
(NH4)2[Ce(NO3)6]) in 0.5 mL water, changing the color of the solution to dark green 
in a minute. Upon addition of 20 eq NH4PF6 in 100 μL H2O to the vial, a precipitate 
formed immediately from the solution, and the solution was kept at 2-5 °C for 10 
minutes to allow more precipitate to crash out. This solid was filtered on a sintered 
fine frit, washed with 5 mL water, and then dried overnight under high vacuum to 
give a dark green solid. A 2-mM solution in CH3CN was made, transferred into a 
Mössbauer cup, and then frozen in liquid nitrogen. 
Synthesis of [FeIV(O)(6Me2N4Py)](OTf)2 (3a) 
1 mM CH3CN solutions of 3a were generated at room temperature in acetonitrile 
solution using 1-1.5 equivalents of 2-(tBuSO2)-C6H4IO (1-(tert-butylsulfonyl)-2-
iodosylbenzene in 2,2,2-trifluoroethanol or DCM-d2. Solid C6F5IO or 
pentafluoroiodosylbenzene can also be used to generate the ferryl complex. While 
its ceric ammonium nitrate solution in water could be used to generate the 
complex, it could not be used to isolate the complex. It is possible that 
benzimidazole and quinoline rings in 2 and 3 help in stacking and packing of the 
complexes 2 and 3 so that the solids crash out right away, but attempts to crash 
out 3a were not successful using cerium(IV) ammonium nitrate. Furthermore, the 
proximity of benzylic methyl groups to the ferryl unit also likely makes the ferryl 
complex unstable, thus preventing it from crashing out. The complex where the 6-
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methyl groups were introduced on the other pair of pyridines of N4Py framework 
was reported recently, and could also not be crystallized.23 
2.2.2 ESI-MS of complexes 2 and 3 
Dilute acetonitrile solutions at room temperature of each of the oxoiron(IV) 
complexes were injected into the spectrometer at 200 °C to obtain the data. ESI-
MS analysis of these solutions reveals major peaks at m/z 272.58 and 269.50 for 
2 and 3, values expected for the dicationic [FeIV(O)(L)]2+ complexes. Cationic 
peaks for complexes 1*, 3a and 3b were reported in their original reports.16, 23, 26 
 
Figure 2.4 ESI-MS of complexes 2 (left) and 3 (right). 
2.2.3 UV-Visible spectroscopy and thermal stability of the complexes 
At 25 °C, 1 mM MeCN solutions of 2 and 3 have half-lives of 150 minutes, which 
is about 20-fold shorter than for the parent complex 1 (3600 minutes). Complex 1* 
is even more stable, so its half-life of 3000 minutes was measured at a slightly 
elevated temperature of 30 °C.16 The choice of oxidant used can also impact the 
half-life, so that only solids for 2 and 3 are isolated and redissolved to measure 
half-lives, and 1 and 1* were generated using solid iodosylbenzene. 
The half-life of a 1-mM CH3CN solution of 3a at room temperature is 40 minutes 
when generated with excess solid C6F5IO, and 30 minutes when formed using 1.5 
equivalents of PhI(OAc)2 in acetonitrile solution.26 Interestingly, its isomer 3b has  
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a half-life of only 14 minutes at room temperature when generated using mCPBA,23 
but the half-life is 130 minutes when formed using 1.5 equivalents of PhI(OAc)2 in 
acetonitrile solution (Table 2.13).26 Therefore the choice of oxidant may impact the 
stability of the complexes. The half-lives of 3a and 3b are much lower than that of 
the unsubstituted parent complex 1, and can also be attributed to the greater 
number of benzylic positions (11 benzylic protons, 6 of them close to the ferryl 
unit), compared with 3 (5 benzylic protons, none close to the ferryl unit). 
Furthermore, the oxidant can also play an important role as is seen in the case of 
3b. 
Complexes 1–3 exhibit near-IR absorption bands, assigned previously in the case 
of 1 (λmax = 695 nm) to ligand field transitions.34 For 2 and 3, the absorbance 
maxima red-shift to 725 and 770 nm, respectively, suggesting a progressive 
weakening of the ligand field strength as two pyridine donors are replaced by N-
methylbenzimidazoles (in 2) and quinolines (in 3). For 3, this notion is further 
manifested by the appearance of higher-wavelength shoulders at 890 and 930 nm, 
similar to features observed for [FeIV(O)(TMC)(X)]+ complexes (TMC = 1,4,8,11-
tetramethyl-1,4,8,11-tetraazacyclotetradecane) when the axial MeCN ligand is 
replaced by anions.35 The absorption spectra of 1 and 1*, as well as those of 3 and 
3a exhibit similar λmax that do not differ by much. 3b however, has a λmax of 740 
nm, which is less red-shifted than 3 and 3a. Because the red-shifts indicate a 
weakening of the ligand field, this shows that ligand field in 3 and 3a is more 
weakened than in 3b, and also gives hints on the two pairs of heterocycles on 
pyridines being inequivalent. When two pyridines are attached on the methine-half 
of the N4Py framework, the 6-pyridine protons are farther from the oxygen atom, 
and hence making substitutions there causes the pyridines to be different, and 
have different effects (Figure 2.31). 
38 
 
Figure 2.5 Near-IR features of 1 (dashes), 2 (gray), and 3 (black) in 1 mm 
CH3CN solutions. Inset shows the region from 400 to 1100 nm. 
2.2.4 Vibrational spectroscopy 
The solid samples were directly used without grinding and placed on the diamond 
tip of the FTIR spectrometer. Complexes 2 and 3 display ν(Fe=O) features at 842 
and 834 cm−1, respectively, compared to 843 cm−1 for 1, showing that only the 
introduction of quinolines in 3 influences ν(Fe=O).36-38 Note: Perchlorate salts are 
explosive and should be handled with care. The resonance Raman spectra for 1* 
shows 839 cm−1 (Figure 2.33) and complex 2 can also be seen through this 
spectroscopy (Figure 2.32). 





































Figure 2.6 FTIR spectra of ferrous precursors of 2 (a) and 3 (b). Insets show 
expanded fingerprint region from 1700 to 650 cm-1. 
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Figure 2.7 FTIR spectra of ferryl complexes 2 (a) and 3 (b). Insets show 
expanded fingerprint region from 1700 to 650 cm-1. 
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Figure 2.8 The full FTIR spectra (left) of 2 (black) and 3 (red) overlaid, and 
zoomed in spectra (right) from 800 to 870 cm-1. 
2.2.5 Mössbauer Spectroscopy 
Complexes 2 and 3 exhibit Mössbauer spectra with parameters quite similar to 
those for 1, and those of 2 match those reported by Mitra et al.15 Their behavior in 
applied magnetic fields as detailed below indicates that they are typical of the S = 
1 non-heme oxoiron(IV) complexes described in the past fifteen years.5, 39 
Mössbauer samples containing complexes 2 or 3 were first studied at 4.2 K with a 
small external magnetic field applied along the direction of the gamma radiation 
(Figures 2.9 and 2.10). The observation of quadrupole doublets under these 
measurement conditions confirmed that 2 and 3 have integer spin ground states. 
The simulations on these low field data provided information on isomer shifts (δ) 
and quadrupole splittings (ΔEQ). The samples were then subjected to variable field 
and variable temperature measurements in order to determine the spin state and 
57Fe nuclear hyperfine interaction parameters. The spectral simulations using an 
S = 1 spin Hamiltonian with a large positive D value (D = 25 cm-1 for 2 and 26 cm-
1 for 3) satisfactorily reproduced all the variable field and variable temperature 
spectra for both complex 2 and 3 (Figures 2.9 and 2.10).  
The S = 1 spin Hamiltonian is expressed as: 
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where D and E are the axial and rhombic zero-field splitting (ZFS) parameters, ?⃗⃗?  
represents the applied magnetic field, ?̂? is the nuclear spin of 57Fe, A is the 
magnetic hyperfine tensor, Vzz is the largest principal component of the electric 
field gradient (EFG) tensor, Q is the 57Fe nuclear excited state quadrupole 
moment, and η (=(Vxx-Vyy)/Vzz) is the asymmetric parameter. The spectral 
simulation assumes that A, EFG, and ZFS tensors are collinear. In addition, the 
simulation assumes that E = 0, which is supported by HFEPR data (see the next 
section). For the simulations on 4.2 K spectra, slow electronic relaxation limit was 
assumed, and for the simulations on spectra measured at elevated temperatures, 
the fast electronic relaxation limit was assumed.  
To determine D values, high-field Mössbauer spectra were measured at 4.2 K and 
at elevated temperatures (in the temperature range between 15 K and 50 K). At 
4.2 K, the variable field spectra are determined by the magnetic hyperfine 
interactions in the xy plane, namely ?⃗⃗? (𝑖) = −< 𝑆𝑖 > 𝐴𝑖/𝑔𝑛𝛽𝑛 (i = x, y), and < 𝑆𝑥,𝑦 > 
is inversely proportional to D with electronic systems having large D values. 
Therefore, D and Ax, Ay cannot be independently deteremined by using the 4.2 K 
spectra alone. However, at elevated temperatures (20 – 50 K), < 𝑆𝑥,𝑦 > is 
independent of D, allowing one to determine Ax and Ay. Thus by group fitting both 
4.2 K spectra and spectra measured at elevated temperatures, one can determine 
D values relatively accurately. At high temperatures, such as 80 K used in this 
study, the electronic system is under the fast relaxation limit, so the 57Fe hyperfine 
field is proprotional to the thermally averaged expectation value of S, namely 
?⃗⃗? (𝑖) = −< 𝑆𝑖 >𝑡ℎ 𝐴𝑖/𝑔𝑛𝛽𝑛(i = x, y, z) and is sufficiently small due to the 1/T 
dependence on < 𝑆𝑖 >𝑡ℎ (Curie’s law behavior). As a consequence, the spectra at 
80 K are largely determined by the externally applied field and the EFG tensor. 
Therefore, the sign of ΔEQ and η can be determined by using 80 K spectra. The 
determined spin Hamiltonian parameters obtained from variable-field variable-
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temperature Mössbauer spectra of 2 and 3 are listed in the captions of Figures 2.9 
and 2.10. 
 
Figure 2.9 Mössbauer spectra of a sample containing complex 2 (black lines) 
measured under variable field and variable temperature conditions, as indicated 
in the figure. The corresponding spectral simulations (red lines) used the 
following parameters: D = 25 cm-1, E/D = 0, gx = gy = gz = 2.0, Ax/gnβn = Ay/gnβn = 
–22.2 T, δ = –0.02 mm/s, ΔEQ = 1.36 mm/s, η = 0.6. The black vertical arrows 
indicate spectral features belonging to high-spin ferric impurities that represent < 
5% of the total iron in the sample. 
 
Figure 2.10 Mössbauer spectra of a sample containing complex 3 (black lines) 
measured under variable field and variable temperature conditions, as indicated 
in the figure. The corresponding spectral simulations (red lines) used the 
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following parameters: D = 26 cm-1, E/D = 0, gx = gy = gz = 2.0, Ax/gnβn = 
Ay/gnβn = -22.5 T, δ = 0.03 mm/s, ΔEQ = 0.56 mm/s, η = 0.3. 
2.2.6 High-Frequency and -Field EPR (HFEPR) and FIRMS spectroscopy 
High-frequency and -field EPR (HFEPR) and frequency-domain spectroscopy with 
applied fixed magnetic fields (FIR magnetic spectroscopy or FIRMS) have also 
been found to be useful for characterizing the electronic structures of iron(IV) 
complexes. These techniques are optimally performed on 25–50 mg powder 
samples,40-42 although frozen solution studies are feasible in certain cases.43 
Fortunately, 2 and 3 are relatively stable solids that allow the determination of their 
zero-field splitting (zfs) parameters (axial, D; rhombic, E) with high precision by 
concerted use of these two complementary techniques. FIRMS provides a direct 
measure of the zfs in these complexes by observation of the |S, MS = |1, 0  
|1,1 transition, while HFEPR provides complementary information without the 
complication of non-magnetic vibrations (phonons) that are also found in this very 
low frequency region of interest. We have found D to increase from 22.05 cm-1 for 
140 to 23.3 and 24.3 cm-1 for 2 and 3, respectively, with E  0 in each case. This 
trend of increasing D suggests a progressive decrease in the energy gap between 
the ground S = 1 and the excited spin states, as these excited states contribute to 
the zfs in inverse proportion to their relative energies above the ground state. 
Table 2.1 Spin Hamiltonian parameters from field- and frequency-domain 
magnetic resonance spectroscopy 
Complex D (cm–1) E (cm–1) g⊥ g|| 
140 22.05(5) 0.000(25) 2.03(1) 1.95(5) 
2 23.3(1) 0.00(5) 2.08 2.006(3) 
3 24.3(1) 0.00(5) 2.08(5) 2.000(5) 
a Value assumed identical to that experimentally determined by FIRMS for 3. 
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Figure 2.11 HFEPR spectra of 3 (top, black trace), 2 (bottom, black trace) and 1 
at 4.5 K and 609.6 GHz. The red lines are simulations using spin Hamiltonian 
parameters as in Table 2.1 except for D = 24.35 cm–1 for 3. 
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Figure 2.12 Field vs. energy (frequency) maps of magnetic resonance transitions 
of 2 (top) and 3 (bottom) at 4.5 K. The squares are experimental points while the 
curves are simulations using spin Hamiltonian parameters best-fitted through the 
least-squares method as listed in Table 2.1. Black curves: parallel turning points; 
red curves: perpendicular turning points (not observed by HFEPR); green curve: 
off-axis turning point in 3 (observed by FIRMS, see Figure 2.14). The region 
above ~22 cm–1 (~660 GHz) was not probed by HFEPR given that it requires a 
non-routine setup, and the FIRMS technique was available. 
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Figure 2.13 A contour (false-color) map of magnetic transitions obtained by 
FIRMS for 3. A darker color indicates a stronger absorption. A zero-field 
magnetic transition is clearly visible at 24.3 cm–1. This transition develops into 
turning points of a powder spectrum, two of which move to higher energies with 
increasing field, reaching ~1.25 THz at 17 T, which positively allows the transition 
to be identified as magnetic (the many phonon transitions active in the FIR region 
do not respond to increasing magnetic field). The abscissa value of 15 cm–1 
represents the approximate cutoff of the FIRMS instrument; therefore, the part of 
the map below this value is left blank, but is probed in the field domain by 
HFEPR as seen in Figure 2.12. 
48 
 
Figure 2.14 Simulations of two most prominent turning points in the powder 
spectrum of 3 (dashed lines) superimposed on the FIRMS map of resonances. 
Adjusting g⊥ in the simulations provided the value of 2.08(5) as in Table 2.1. 
 
Contribution of the S = 2 Excited State to the Zero-Field-Splitting (D) 
Parameter: 
Ligand field theory (LFT) calculations were performed to explore the effect of the 
spin quintet energy.  When the quintet state contribution is ignored for both 
complexes 2 and 3, the zero-field splitting (ZFS) parameter turns out to be small 
(D ≈ +7 cm-1) and is barely dependent on the choice of Racah parameters 
(interelectronic repulsion), since the complexes are all S = 1, and their energy 
levels change only in a second-order fashion.  
This indicates that the quintet (S = 2) excited state is a key contributor to the ZFS 
parameter (D) of these tetragonal oxidoiron(IV) complexes. Specifically, it is the 
49 
relative energy of a 5A1 (in C4v) excited state, which corresponds to the hole in the 
dz2 orbital, so the spin orbit coupling (SOC) effect is an electron going from the 
filled dxy orbital (lowest in energy) to the empty dx2-y2 orbital (with a spin flip). The 
equatorial ligand-field is crucial in determining the energy of the dx2-y2 orbital, and 
thus D.  The perturbation theory for this effect is given by the following equation: 
𝐷 = ∆𝐸′(±1) − ∆𝐸′(0) =
𝜁2















The exact calculation using Racah at 70% of free-ion (where the quintet state is 
low in energy) gives D = +31 cm−1, while using triplets only gives D = +7 cm−1 (as 
above), so the total quintet contribution to D is +24 cm−1. This agrees well with the 







 ≈ 27 cm−1, which is close given that only one quintet excited 
state is used in the above equation. 
Because the spin quintet excited state has significant contributions into the zfs 
parameter D, the above complexes support the notion that such excited states 
could be involved in the hydrogen-atom abstraction abilities of the complexes 2 
and 3. However, the D values do not change by a large amount in going from 
complex 1 to 2 to 3 and the differences in HAT rates span at least two orders of 
magnitude. It is thus important to note that other effects could be playing a role in 





2.2.7 X-Ray Crystallography 
Data collection and structure refinement details for complexes 2 and 3 are detailed 
below, along with strategies to model water molecule as well as comparison of 
bond metrics with the literature data. 
Complex 2: 
A crystal (approximate dimensions: 0.15 x 0.12 x 0.1 mm) was placed onto the tip 
of a 0.5 mm MiTeGen loop and mounted on a Bruker, Photon-II CPAD 
diffractometer for a data collection at 100(2) K.44 A preliminary set of cell constants 
was calculated from reflections harvested from three sets of 12 frames. These 
initial sets of frames were oriented such that orthogonal wedges of reciprocal 
space were surveyed. This produced initial orientation matrices determined from 
691 reflections. The data collection was carried out using MoKα radiation (graphite 
monochromator) with a frame time of 30 seconds and a detector distance of 6.0 
cm. A randomly oriented region of reciprocal space was surveyed to the extent of 
one sphere and to a resolution of 0.70 Å. Four major sections of frames were 
collected with 1º steps in ω at four different φ settings and a detector position of -
28º in 2θ. The intensity data were corrected for absorption and decay.45 Final cell 
constants were calculated from the xyz centroids of 2725 strong reflections from 
the actual data collection after integration.46 Please refer to Table 2.2 for additional 
crystal and refinement information. The structure was solved using SHELXS-97 
(Sheldrick 2008)47-48 and refined using SHELXL-2018/3 (Sheldrick, 2018).49 The 
space group Pna21 was determined based on systematic absences and intensity 
statistics.  A direct-methods solution was calculated which provided most non-
hydrogen atoms from the E-map. Full-matrix least squares/difference Fourier 
cycles were performed which located the remaining non-hydrogen atoms. All non-
hydrogen atoms were refined with anisotropic displacement parameters. All C–H 
hydrogen atoms were placed in ideal positions and refined as riding atoms with 
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relative isotropic displacement parameters. The H atoms of water molecules were 
modeled as detailed below. The final full matrix least squares refinement 
converged to R1 = 0.0475 and wR2 = 0.1114 (F2, all data). 
Complex 3: 
A crystal (approximate dimensions: 0.150 x 0.120 x 0.100 mm) was placed onto 
the tip of a 0.5 mm MiTeGen loop and mounted on a Bruker photon-II CPAD 
diffractometer for a data collection at 100(2) K.44 A preliminary set of cell constants 
was calculated from reflections harvested from three sets of 12 frames.  These 
initial sets of frames were oriented such that orthogonal wedges of reciprocal 
space were surveyed.  This produced initial orientation matrices determined from 
258 reflections.  The data collection was carried out using MoKα radiation (graphite 
monochromator) with a frame time of 30 seconds and a detector distance of 6.0 
cm.  A randomly oriented region of reciprocal space was surveyed to the extent of 
one sphere and to a resolution of 0.70 Å.  Six major sections of frames were 
collected with 1º steps in ω at four different φ settings and a detector position of -
28º in 2θ.  The intensity data were corrected for absorption and decay.45 Final cell 
constants were calculated from the xyz centroids of 9988 strong reflections from 
the actual data collection after integration.46 Please refer to Table 2.2 for additional 
crystal and refinement information. The structure was solved using SHELXS-97 
(Sheldrick 2008)47-48 and refined using SHELXL-2018/3 (Sheldrick, 2018).49 The 
space group Pna21 was determined based on systematic absences and intensity 
statistics.  A direct-methods solution was calculated which provided most non-
hydrogen atoms from the E-map.  Full-matrix least squares/difference Fourier 
cycles were performed which located the remaining non-hydrogen atoms.  All non-
hydrogen atoms were refined with anisotropic displacement parameters.  No 
possible restraints on the perchlorate ions were applied for the residual electron 
density of 1.32 around the perchlorate ion, because the perchlorate ion was not 
completely disordered. All C–H hydrogen atoms were placed in ideal positions and 
refined as riding atoms with relative isotropic displacement parameters. The H 
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atoms of water molecules were modeled as detailed below. The final full matrix 
least squares refinement converged to R1 = 0.0581 and wR2 = 0.1568 (F2, all 
data).  
Table 2.2 Crystal data and structure refinement for complex 2 and 3. 
Crystallographic details Complex 2 Complex 3 
CCDC Identification Code 1835339 1835337 
Empirical formula C29H29Cl2FeN7O10 C31H27Cl2FeN5O10 
Formula weight 762.34 756.32 
Temperature 100(2) K 100(2) K 
Wavelength 0.71073 Å 0.71073 Å 
Crystal system Orthorhombic Orthorhombic 
Space group Pna21 Pna21 
Unit cell dimensions 
a = 18.684(7) Å 
 
a = 18.8809(6) Å 
b = 12.816(4) Å 
 
b = 12.7142(4) Å 
c = 12.870(5) Å 
 
c = 12.7866(4) Å 
Volume 3081.9(19) Å3 3069.49(17) Å3 
Z 4 4 
Density (calculated) 1.643 Mg/m3 1.637 Mg/m3 
Absorption coefficient 0.735 mm-1 0.735 mm-1 
F(000) 1568 1552 
Crystal color, morphology blue-green, block green, block 
Crystal size 
0.15 x 0.12 x 0.1 
mm3 
0.150 x 0.120 x 
0.100 mm3 
Theta range for data 
collection 
2.243 to 26.346° 2.259 to 30.524° 
Index ranges 
-23 ≤ h ≤ 20, -15 
≤ k ≤ 15, -16 ≤ l ≤ 
15 
-26 ≤ h ≤ 26, -18 
≤ k ≤ 18, -18 ≤ l ≤ 
18 
Reflections collected 22366 73781 
Independent reflections 
6253 [R(int) = 
0.0515] 
9374 [R(int) = 
0.0482] 
Observed reflections 5096 8108 
Completeness to theta = 
25.242° 
99.9% 99.9% 
Absorption correction Multi-scan Multi-scan 
Refinement method 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
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Crystallographic details Complex 2 Complex 3 
Data / restraints / 
parameters 
6253 / 6 / 460 9374 / 3 / 448 
Goodness-of-fit on F2 1.035 1.037 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0475, wR2 
= 0.1031 
R1 = 0.0581, 
wR2 = 0.1486 
R indices (all data) 
R1 = 0.0663, wR2 
= 0.1114 
R1 = 0.0699, 




Largest diff. peak and hole 
0.556 and -0.483 
e.Å-3 
1.320 and -0.737 
e.Å-3 
 
Modeling the H atoms of water molecules in 2 and 3 
In both the crystal structures of 2 and 3, a water molecule is within hydrogen 
bonding distances of a ferryl unit (Table 2.3), and is also proximal to the two 
perchlorate counterions (2.77 to 2.88 Å away), as shown in Figure 2.15. These 
counterions therefore likely have a significant portion of the H-bonding with the 
water molecule in their respective crystal structures. Note that the perchlorate ions 
have significantly strong H bonding with the water molecule, which then helps bring 
the negative (perchlorate) and the positive (cation) charges closer to each other in 
the lattice.  
In the absence of neutron diffraction data, X-ray crystallography cannot assign the 
hydrogen atoms, so water molecule’s hydrogen atoms were reasonably modelled 
using its distance with the oxoiron(IV) center as well as the perchlorate ions. 
In 2, one of the perchlorate ions is rotationally disordered around axis the O−Cl 
axis close to the water molecule (about 2.77 Å away). The water molecule in the 
crystal structure of 2 is just about 2.8 Å away from the other perchlorate and the 
ferryl unit and is modelled by placing the H atom between both the ferryl unit and 
the perchlorate ion. With this modelling, the refinement yields an H−O−H angle of 
about 116.5° in the water molecule. 
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In 3, the water molecule is only within moderate H-bonding distance of the ferryl 
unit (about 3.13 Å away from the water’s oxygen atom) but is even closer to the 
perchlorate counterions. Therefore, perchlorate oxygen atoms are the only ones 
involved in H-bonding with water. With this modelling, the refinement yields an 
H−O−H angle of about 130.84° in the water molecule. 
 









2 2.864 2.821 2.834 
3 2.824 2.768 3.138 
Normalized positions of C−H bonds proximal to the ferryl unit: 
For comparisons of distances of C−H atoms of pyridyl (), quinolyl (H8) and N-
methylbenzimidazolyl (H7) groups from the oxo of the ferryl unit in the crystal 
structures of 1, 2, and 3, all C−H atoms were normalized post-refinement to reflect 
the more realistic positions of the hydrogen atoms for C−H atoms (Table 2.4). 
Normalization of aromatic C−H bonds increases their bond length from 0.95 Å to 
about 1.09 Å along the bond vector, which is the average C−H bond length one 
would expect to find through neutron diffraction.50 Note however, that the crystal 
structures were not of neutron diffraction quality, and so all C−H hydrogen atoms 
were placed in ideal positions and refined as riding atoms with relative isotropic 
displacement parameters. 
Table 2.4 Distances of hydrogen atoms from the ferryl unit before and after 
normalization. Standard uncertainties are not given for average bond lengths because all 









Hpy()•••O 2.556 2.517 
Hpy()•••O 2.743 2.717 
2 
Hpy()•••O 2.811, 2.767 2.739, 2.784 
aver. Hpy()•••O 2.789 2.762 
HBn(H7)•••O 2.730, 2.680 2.657, 2.606 
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aver. HBn(H7)•••O 2.70 2.632 
3 
Hpy()•••O 2.702, 2.731 2.705, 2.676 
aver. Hpy()•••O 2.72 2.691 
HQ(H8)•••O 2.152, 2.158 2.040, 2.047 







Figure 2.15 Space filling models (top) for 2 and 3, and ORTEP showing water 
molecules (bottom) proximal to the ferryl unit as well as perchlorate ions. 
2.3 Comparisons of Crystallographic and Spectroscopic Data 
Complexes 2 and 3 can be generated by treating 1:3 CH3CN/H2O solutions of the 
corresponding iron(II) precursors with 4 equivalents of ceric ammonium nitrate 
(CAN) as the oxidant. Subsequent addition of excess sodium perchlorate to the 
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reaction mixtures results in the precipitation of solids, which can be recrystallized 
for crystallographic analysis. The crystal structures of 2 and 3 have been depicted 
in the previous section, and their bond metrics and spectroscopic properties with 
can be compared with those of 1 and 4 in Table 2.6. 
Complexes 1 and 1* have very similar bond metrics, and introduction of electron-
donating methyl and methoxy groups only slightly increases the overall average 
Fe-N bond lengths by about 0.01 Å. The Fe=O bond lengths are comparable at 
1.653(1) and 1.639(5) Å for 1* and 1 respectively, as are their vibrational stretches 
at 839-842 cm−1. The increased donation expected from introduction of methoxy 
and methyl groups on pyridines is not born out by significant changes of Fe-Npy 
bond lengths, which is also spectroscopically seen from a very slight change only 
in the UV-visible λmax. The Nax-Fe=O angle remains linear as expected, because 
alpha-H of pyridines are not substituted. This also leads to an orthogonality of the 
angle between the ferryl unit and the mean plane defined by the equatorial ligands. 
Unlike the case of complex 3, which has steric interactions with quinolyl groups, 
the ferryl units of 1* and 1 are found to be fairly linear. 
 
Table 2.5 Average Fe−N bond lengths in Å from DFT-calculated structures of the 
most reactive complexes [FeIV(O)(Me3NTB)(L)]2+ and [FeIV(O)(TQA)(L)]2+ 
Complex [FeIV(O)(TQA)(L)]2+ [FeIV(O)(Me3NTB)(L)]2+ 
Geometry Oh C3v Oh Oh C3v 
Spin State (S) 2 2 1 2 2 
Average Fe—N 2.152 2.057 2.026 2.135 2.042 













Table 2.6 Structural and spectroscopic properties of the oxoiron(IV) complexes 
Complexes 1 a 1* 2 b 3 4 c 
r(Fe=O), Å 1.639(5) 1.653(1) 1.656(4) 1.677(5) 1.6600(16) 


















r(Fe–Namine), Å 2.033(8) 2.048(2) 2.115(6) 2.084(4) 2.0511(17) 
av. r(Fe–N), Å 1.972 1.981 1.999 2.053 2.014 
∠Namine–Fe–O, ° 179.4(3) 178.1(3) 177.0(2) 170.5(2) 177.40(8) 
∠Neq. plane–Fe–O, ° 89.4 89.6 88.3 82.4 86.9 
ν(Fe=O), cm-1 d 843 839 842 834 n. d. 
δ, mm s-1 a -0.04 n. d. -0.02 0.03 0.0318, 25 
ΔEQ, mm s-1 a 0.93 n. d. 1.36 0.56 0.54 
D, cm-1 (MB) 24(2)52 n. d. 25(1) 26(2) 2318, 25 




n. d. 23.3(1) 24.3(1) n. d. 
λmax, nm 










[a] Data from refs 13-14, 36, 38, 40, 52 as noted in each case. [b] Data for 2 from 
ref 15, except for its crystal structure, D value and Fe=O stretch reported herein. [c] 
Data for 4 from ref 18, 25. The modified pyridyl rings in 4 are on the bis(pyridyl-2-
methyl)amine half of the ligand (Figure 2.2). [d] Vibrational data for 2 and 3 from 
FTIR and for 1 from resonance Raman spectroscopy. Abbreviations: MB: 
Mössbauer. n.d.: not determined. 
 
2.3.1 Discussion of crystal structures: 
Key data for 2 and 3 from their crystal structures (Figure 2.16) are listed in Table 
2.6 and compared to those of the ‘parent’ complex 1 and the related complex 4. 
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Complexes 1 – 3 have Fe=O bonds that lengthen systematically from 1.639(5) Å 
in 1 to 1.656(4) and 1.677(5) Å in 2 and 3, respectively, as two of the pyridines in 
1 are replaced by larger heterocycles, N-methylbenzimidazoles in 2 and quinolines 
in 3. The average Fe–N bond length concomitantly increases from 1.972 Å in 1 to 
1.999 Å in 2 and 2.053 Å in 3. These trends are also observed for 4, which differs 
from 2 and 3 in that a different pair of pyridines is modified (Figure 2.2 and Figure 
2.3). For the substitution in 4, the phenyl rings are found to rotate about the C–C 
bonds connecting the phenyl ring to the pyridine such that they become 
approximately perpendicular to the bound pyridines, thereby minimizing 
unfavorable steric interactions. When the bond metrics for 4 are considered 
relative to those for 1 – 3, 4 falls between 2 and 3 (Table 2.6). 
 
Figure 2.16 Front and side views of the ORTEP plots of 2 (left) and 3 (right), 
shown with thermal ellipsoids set at 50% probability. Water molecules, 
counterions, and select H atoms have been removed for clarity. The dotted line 
shows the tilt from the Fe–Nam axis. 
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The trends among complexes 1–4 discussed above very likely arise from the steric 
and electronic effects of the heterocycles that replace two of the pyridine donors 
on the N4Py framework.  The steric effect is best demonstrated in the crystal 
structure of 3, which shows that the H8 atoms of the two quinolines are on average 
only about 2.16 Å away from the oxo atom (Figure 2.16). For comparison, the 
corresponding H7 atoms of the benzimidazole donors are much farther away, at 
2.70 Å from the oxo atom in 2, a distance similar to those found for the 6-H protons 
of the unsubstituted pyridine rings in 1 – 4 (which range from ≈ 2.5-2.8 Å). As a 
consequence, the quinoline 8-H protons would appear to exert a steric effect that 
results in a tilt of the Fe=O unit in 3 away from the quinoline rings, leading to the 
observed Nam–Fe–O angle of 170.5° (Figure 2.16). For comparison, the Nam–Fe–
O angles observed for 1, 2 and 4 are much closer to that for a linear arrangement, 
namely 179.4(3)°, 177.0(2)° and 177.40(8)°, respectively. Consistent with this 
proposed steric effect, the slight tilts found for 2 and 4 relative to 1 are oriented 
away from the bulkier heterocycles. 
The basicity of the heterocycles increases from quinoline to pyridine to 
benzimidazole53, and its effects on the bond lengths of the equatorial ligands can 
be seen in the short benzimidazole Fe−N bond lengths of 1.950(5) Å in 2.  The 
stronger binding of benzimidazole induces a trans effect which increases the 
equatorial pyridine Fe−N bond lengths. This, along with the longer axial Fe−N 
2.115(5) Å, increases the average Fe−N bond length for complex 2. Steric effects 
in complex 3 are responsible for its longer Fe−N bond lengths, and outweigh the 
electronic effects of quinolines. 
2.3.2 Inequivalence of pyridine heterocycles on N4Py 
Complexes 3a and 3b are oxoiron(IV) complexes supported by the N4Py 
framework with alpha-methyl group substitutions on two different pairs of pyridines, 
but could not be crystallographically characterized owing to their thermal instability. 
This may be attributed to the proximal benzylic methyl protons that are weak C-H 
bonds prone to intramolecular hydrogen-atom-abstraction. While these alpha-
60 
methyl substituents on the pyridines are employed to impart steric bulk on the 
oxoiron(IV) complex, they are also some of the weakest C-H bonds on the 
framework. However the crystal structures of iron(II) precursors for both the 
complexes are available from the literature, and upon comparison, the 
inequivalency of the pyridines can be inferred. In both the crystal structures, the 
6th coordination site is an acetonitrile ligand, and it is affected by the sterics of the 
alpha-methyl groups, only in the case where the methyl groups are introduced on 
the bis(pyridin-2-methyl) part of the ligand. The Nam-Fe-NNCMe angle is 167.6(1)° in 
one case, but 178.6(4)° in the other (Figure 2.17A). Even in the iron(II) precursor 
of complex 3, the iron(II) crystal structure has been found to have an Nam-Fe-OOTf 
angle of 168.3(2)°.20, 23, 33 The 12.5° degree tilt observed on the 6th site of ferrous 
precursors of 3 and 3a contrasts with the iron(II) precursor of the parent ferrous 
precursor of 1 and 3b. Singh et al. found that introducing alpha-methyl 
substitutions increases the reactivity of the complexes by an order of magnitude 
for some of the subtrates. When quinoline substitutions are introduced, the overall 
rates of reaction increase by over two orders of magnitude. Introduction of 6-methyl 
groups instead of the quinolines which result in the complex 3a also result in similar 
increase in the rates of reaction.26 
Furthermore, the acetonitrile-bound zinc(II) complex supported by N2py2Q ligand 
has also been obtained, and shows a larger tilt as shown in Figure 2.17A below, 
indicating the steric effects of quinolines. The presence of tilt of acetonitrile in the 
precursor of 3a and its absence in precursor of 3b likely has to do with the way the 
pyridines are oriented around the metal center. In Figure 2.17B the ball-and-stick 
diagram obtained from the crystal structures of the complexes are overlaid such 
that the iron, nitrogen of the amine, and the methine carbon of the ligand framework 
are aligned. It clearly shows that 6-methyl groups are closer to the sixth 
coordination site when they are introduced on the precursor of 3a. 
This can further be deduced from the crystal structures of parent oxoiron(IV) 
complex 1 as well as its iron(II) precursor. In 1, the alpha protons of the pyridines 
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at the bis(pyridin-2-methyl) part of the ligand framework are closer to the metal 
center (Figure 2.31) than the corresponding protons on the other half of this ligand 
framework, thus preventing pyridines farther from the metal center from inducing 
a steric tilt on the 6th ligand that coordinates on the metal centers supported by 
these pentadentate ligands. Lastly in all the iron(II) and iron(IV) complexes 
discussed in this chapter, the torsion (or dihedral) angle across the Fe-N bond 
between the Fe-L6th and the pyridine is much smaller on the bis(pyridin-2-methyl) 
half of the ligand than the same angle between the Fe-L6th with the pyridines on 
the other side of the framework. The reduced torsion therefore forces modifications 
on these pyridine to introduce steric interactions between the alpha-substituents 
and the 6th-coordinated ligand, and can explain why steric hindrance from one side 
of the ligand is more than the other. 
 
Figure 2.17A The crystal structures of cations [ZnII(N2Py2Q)(MeCN)]2+ and 
ferrous precursors to 3, 3b, and 3a (left to right), without any H atoms for clarity. 
  
Figure 2.17B Overlaid ball-and-stick diagrams of the iron(II) precursors to 3b 
and 3a (green). Hydrogen atoms are omitted for clarity. The rightmost structure 
shows increased torsion angle between Fe-NMeCN with the left set of pyridines 
compared with the other, which prevents the former from causing steric 
hindrance. 
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2.4 Reactivity and kinetic studies for 2 and 3 
The structural differences in the 1–3 series are also reflected in their HAT and OAT 
rates. Figure 2.18 shows plots of log k2’ values for 1–3 (where k2’ is k2 divided by 
the number of equivalent substrate C−H bonds that can be attacked, Table 2.7) 
versus the C−H bond dissociation energy, which reveal reasonably linear 
correlations for the three sets of data, as observed previously for a number of 
oxoiron(IV) complexes. The rate differences among the three complexes (Table 
2.8) become larger for substrates with stronger C–H bonds, resulting in a decrease 
in the slopes from 1 to 2 and then to 3. The oxygen atom transfer rates to 
thioanisole at –40 °C also increase from 1 to 3, by over four orders of magnitude 
after extrapolating the value for 1 to –40 °C from its Eyring parameters (Table 
2.11). 
 
Figure 2.18 Evans–Polanyi plot for 3 at 25 °C, and previously published data for 




Table 2.7 Summary of 2nd-order rate constants (k2) for complex 3, as derived from 










TPM 81 25 1 1 
Cumene 84.5 25 0.16 0.16 
Ethylbenzene 87 25 0.1 0.05 
Toluene 90 25 0.012 0.004 
Cyclooctane 95.3 25 0.13 0.0081 
2,3-DMB* 96.5 25 0.054 0.027 
Cyclohexane 99.3 25 0.029 0.0024 
Thioanisole  –40 7.4  
*2,3-DMB = 2,3-dimethylbutane 
 
Table 2.8 Comparison of second order rate constants (k2) of reactions of other 
complexes with different substrates at 298 K, unless stated in parenthesis 
Substrates 113, 54 215 3 
TPM 0.037 0.27 1 
Cumene 0.002 0.06 0.16 
Ethylbenzene 0.004 0.048 0.1 
Toluene 0.00063 0.012 0.012 
Cyclooctane  0.026 0.13 
2,3-DMB 0.00012 0.0025 0.054 









2.4.1 Second-order rate constants of complex 3 
All experiments were conducted with 1 mL solutions of 1 mM ferryl complexes in 
acetonitrile at 298 K for HAT (hydrogen-atom-transfer) substrates and 233 K for 
thioanisole (OAT, or oxygen-atom-transfer substrate), unless otherwise stated. 
The pseudo-first order decay curves from absorption vs time profiles (e.g. Figure 
2.19) were obtained by monitoring the decrease in absorbance at 770 nm (e.g. 
Figure 2.19) with time. These profiles at various concentrations were fit with an 
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exponential decay function using Origin Pro 2016. The rates (kobs) were plotted 
against different concentrations of substrates, and their slopes represent 2nd order 
rate constants (k2), as shown in Figure 2.20. 









































Equation y = A1*exp(-x/t1) + y0
y0 0.02244 0.06008 0.05052 0.01735
A1 0.51038 0.43745 0.56209 0.47585
t1 34.34128 17.42017 14.10038 10.29251
R-Square(COD) 0.9997 0.99952 0.99969 0.99945
k 0.02912 0.0574 0.07092 0.09716
tau 23.80356 12.07474 9.77364 7.13422
 
Figure 2.19 Spectral changes (a) observed over time in the reaction of 3 (1.0 
mM) with a C─H substrate in CH3CN at 25 °C. Absorption vs time decay profiles 
(b) upon reaction of 3 with different concentrations of cumene obtained by 
following 770 nm. It is fitted with an exponential function shown with red curves. 
Inset shows a table with all the parameters for this function with various 
concentrations. The decay profiles from other substrates were fit similarly. 






































































Figure 2.20 k2 plots for the reactions of different substrates with 3. The slopes of 






























Residual Sum of 2.47688E-5
Pearson's r 0.99574
R-Square(COD) 0.9915




















































298 K with 2,3-DMB





Residual Sum of Sq 1.2915E-6
Pearson's r 0.99809
R-Square(COD) 0.99619





























































































Slope 0.01097 298 K
Intercept 0.00457
Slope 0.07481 318 K
Intercept 0.00119
Slope 0.03055 308 K
Intercept -1.38585
Slope 0.00478 288 K
 




























Slope 0.1248 318 K
Intercept 0.00564
Slope 0.04784 308 K
Intercept 7.53468
Slope 0.0289 298 K
Intercept 9E-5
Slope 0.00805 288 K
 
Figure 2.21 k2 plots at different temperatures for the reactions of 2 (top) and 3 
(bottom) with cyclohexane. The second order rate constants (k2) were measured 
in the temperature range of 288 K to 318 K (plots are color coded with 
temperature) using 1 mM solutions of oxoiron(IV) complexes in acetonitrile. 





Table 2.9 kobs of the reaction of 1 mM 1 with 0.8 M cyclohexane in 1 mL acetonitrile 
solution at different temperatures, which were obtained to account for the slowness 




25 4.4 × 10–5 
30 5.94 × 10–5 
35 1.08 × 10–4 
40 1.65 × 10–4 
 
























Equation y = a + b*x
Slope 0.04874 0.14554 0.42542 0.01382
Intercept 0.0011 0.00268 2.437E-4 5.1745E-4
Pearson's r 0.98975 0.99735 0.9956 0.99252
R-Square(CO 0.97961 0.99471 0.99123 0.9851
Adj. R-Square 0.97281 0.99294 0.98831 0.98014
Temp (K)
273 K 283 K 293 K 263 K
293 K
 
Figure 2.22  k2 plots for the reactions of thioanisole with 1 at different 
temperatures. The second order rate constants (k2) were measured in the 
temperature range of 263 K to 293 K (plots are color coded with temperature) 
using 1 mM solutions of complex 1 in acetonitrile. 
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3 with thioanisole (233 K)
2 with thioanisole (233 K)
Equation y = a + b*x
Intercept 0.01519 ± 0.0 0.00189 ± 4.5858
Slope 7.4225 ± 0.42 0.7845 ± 0.0312
Pearson' 0.99668 0.99842
 
Figure 2.23  k2 plots for the reactions of thioanisole with 2 (red) and 3 (black) at 
233 K. The slopes of the fitted lines represent the second-order rate constants 
(k2). 





 Eyring Plot for 3










Intercept 17.35957 Complex 2
Slope -8191.282



























Figure 2.24 Eyring plots for the oxidation of cyclohexane by 2 (black squares) 
and 3 (red squares) (a), and by 1 (b). 
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Figure 2.25   Eyring plot for the reaction of thioanisole with 1. 
Table 2.10 Eyring Parameters for reaction of substrates with complexes 1, 2 and 
3 discussed in this paper (see Figures 2.21-2.22 and 2.24-2.25, and Table 2.9), 
and rates at –40 °C. The ΔS‡ values are low in all the reactions, indicating an 







Rate at –40 
°C (k2 in M-
1 s-1) 
1 ([FeIV(O)(N4Py)]2+) 16.3 −23.5 1.9 × 10–8 
2 ([FeIV(O)(N2Py2B)]2+) 16.3 −12.7 4.5 × 10–6 
3 ([FeIV(O)(N2Py2Q)]2+) 15.3 −14.6 1.3 × 10–5 
THIOANISOLE 




2.4.2 DFT-optimized structures & spin-state splitting energies of 1, 2 and 3 
Even though crystal structures for complexes 1-3 were available, DFT-
optimizations were still done using M06-L functional with  basis set def2TZVP, and 
then spin state splitting energies were obtained. Interestingly, the energy 
difference between the triplet and the quintet state in the case of complex 1 was 
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larger than 5.7 kcal/mol, but the differences in spin state energies in complexes 2 
and 3 was just 2.8 and 2.1 kcal/mol. Interestingly in the DFT optimized structures 
of all the complexes that contain benzimidazole donors, no bending of the ferryl 
unit is observed, as expected from the lack of steric interactions proferred by the 
5-membered imidazole ring in the heterocycle. Consistent with the higher basicity 
of this heterocycle, the S = 1 and S = 2 structures both  possess the shortest Fe-
Nbenzimidazole bond lengths. Furthermore the ferryl tilt is observed in both S = 1 and 
S = 2 optimized structures of complexes 3, despite the longer Fe-N bond lengths 
of S = 2 complex 3, although this bending is slightly larger in the S = 1 structure. 
In general the S = 2 structures have Fe-N bond lengths 0.07 to 0.1 Å longer than 
those in the the S = 1 complexes. The spin state splitting energies between 
complexes 2 and 3 are essentially the same. This can be attributed to the fact that 
the bend of the ferryl unit in S = 2 complex 3 remains preserved even with longer 
Fe-N lengths, thus mitigating a potential expected difference. The bond metrics of 
these DFT-optimized structures are listed in Table 2.12. 
2.5 Correlation of reactivity with structural data 
Figure 2.26 shows a remarkable correlation between log k2’ values and the 
average Fe–N bond lengths found for 1 – 3. Such a correlation has not previously 
been possible due to the paucity of crystal structures of related non-heme 
oxoiron(IV) complexes. With the structures of 2 and 3 reported herein, in 
combination with the previously reported structure of 1, we now have three 
complexes with the same polydentate ligand framework with which to relate 
structure and function. Indeed we find that the substrate oxidation rates of 1 – 3 
increase proportionately with the average Fe–N bond length found for the 
oxoiron(IV) oxidant (Figure 2.26, Table 2.8), so the oxoiron(IV) complex with the 
longer average Fe–N bond length gives rise to the more reactive complex.  
71 
 
Figure 2.26 Correlation of log k2 values for thioanisole at −40 °C (squares) and 
log k2' values for cyclohexane at 25 °C (triangles) and at −40 °C (circles) vs the 
average Fe–N bond lengths for 1 – 3 based on crystallographic data. The bottom 
plot is extended to rav = 2.20 Å to determine whether this correlation also holds 
true for the S = 2 complex [FeIV(O)(TQA)(L)]2+ (5, open circle) and complex 
[FeIV(O)(Me3NTB)(L)]2+  (6, crosses). The average Fe–N bond length for 5 and 6 
were based on their DFT-optimized 6-coordinate structures, in S = 1 and 2 spin 
states. 5 and 6 are the first two complexes from left depicted in Figure 2.1. 
 
As a simple interpretation, the observed correlation could reflect an increase in the 
electrophilicity of the S = 1 FeIV=O unit with the increase in the average Fe–N bond 
length. A more complex argument to rationalize the HAT trends would involve the 
Two-State-Reactivity (TSR) model proposed by Shaik,55-56 where the lengthening 
of the average Fe–N bond should weaken the ligand field and thus decrease the 
energy gap between the S = 1 ground state and the S = 2 excited state that governs 
the reactivity of the FeIV=O unit. This notion is supported by our HFEPR 
measurements, which show an increase in the zero-field splitting (ZFS) parameter 
D in 1-cm-1 increments from 1 to 3 (Table 2.6). The increase in the zfs is purely an 
increase in D as the rigorously axial nature (E  0) of the electronic structure of the 
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oxoiron(IV) unit is maintained upon going from 1 to 2 to 3, despite the tilting of the 
Fe=O unit. Thus the reactivity trend observed for 1 – 3 can be fit into the TSR 
model (Figure 2.26).  
Figure 2.27 shows a series correlations where log k2’ values are plotted versus zfs 
parameters. Such correlations have not been shown previously before due to the 
paucity of accurate D values for FeIV(O) complexes in the same polydentate 
framework. 
 
Figure 2.27 Correlation of HAT reactivity with D values (see Table 2.1).   
However, accurate measurements of the D values require access to pure solids, 
which limits the number of complexes available for such an analysis to the less 
reactive subset of such complexes. While the LFT measurements discussed in the 
HFEPR section do support the notion that excited quintet spin state has significant 
contributions into the S = 1 ground spin state, more complexes with accurate D 
values are needed to support the TSR model experimentally, and lay a solid 
foundation. While variable field and temperature Mössbauer spectroscopy can be 
used to obtain such values, the values obtained by this approach have larger 
uncertainties for too small a range of D values to be useful. Even if accurate D 
values are obtained and LFT calculations are done to show a significant 
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contribution of the S = 2 quintet excited state into the ground spin state, a direct 
experimental verification of this excited state’s role in the HAT reactivity may still 
be difficult to verify because transition states are typically unobservable. 
 
Table 2.11 Table for the plots shown in Figure 2.26. On the x-axis, the Fe–
Naverage lengths are obtained from Tables 2.5 and 2.6. The log k2 (not log k2’) 
were plotted on the y-axis. The rates of reaction with cyclohexane at –40 °C were 
obtained from Eyring parameters (see Tables 2.9-10 and Figures 2.21-2.22). 
Substrates 1 2 3 
HAT k2 at 25 °C (used in Figure 2.18) 
TPM 0.037 0.27 1 
Cumene 0.002 0.06 0.16 
Ethylbenzene 0.004 0.048 0.1 
Toluene 0.00063 0.012 0.012 
Cyclooctane – 0.026 0.13 
2,3-DMB 0.00012 0.0025 0.054 
Cyclohexane 0.000055 0.0029 0.029 
k2 at −40 °C and logarithms (used in Figure 2.26) 
Thioanisole (k2) 0.0002 0.78 7.4 
Thioanisole (log k2) –3.71158 −0.10791 0.869232 
Cyclohexane (k2) 1.9 × 10-8 4.5 × 10-6 1.3 × 10-5 
Cyclohexane (log k2’) –8.80043 −6.4305 −5.91 
log k2’ at 25 °C (used in Figure 2.18) 
TPM −1.4318 −0.5686 0 
Cumene −2.70 −1.2218 −0.7959 
Ethylbenzene −2.70 −1.6198 −1.3010 
Toluene −3.6778 −2.3979 −2.3979 
Cyclooctane  −2.7891 −2.090 
2,3-DMB −4.2218 −2.9031 −1.5686 
Cyclohexane  −5.3388 −3.6168 −2.6168 
log k2’ at 25 °C (used in Figure 2.18) 
Cyclohexane −5.33882 −3.03779 −3.61678 
 
To put this structure/reactivity correlation into a broader context, we have checked 
where the HAT values reported for the S = 2 [FeIV(O)(TQA)(NCMe)]2+ (5) and S = 
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1 [FeIV(O)(Me3NTB)(NCMe)]2+ (6) might fall on this plot (Figure 2.1). These two 
complexes are the most reactive oxoiron(IV) complexes found to date, and also 
contain benzimidazole and quinoline donors, but their high reactivity has precluded 
their crystallographic characterization. Thus DFT calculations have been 
employed to obtain structural information (Table 2.5). 
Due to their thermal instability, reaction rates for 5 and 6 have been measured at 
–40 °C. For proper comparison, log k2 values for 1 – 3 at –40 °C were obtained 
from Eyring plots for cyclohexane oxidation (Figures 2.20-22, Table 2.9) and then 
plotted in Figure 2.25 versus the average Fe–N distance derived from previously 
reported DFT calculations. To our surprise, the point for 5 actually falls close to the 
line defined by the HAT values for 1 – 3, despite the fact that 5 is a bona fide S = 
2 complex and unlike the S = 1 complexes 1 – 3 used to define the correlation line. 
This apparent correlation raises the prospect that the average Fe–N bond length 
in FeIV=O complexes may serve as a useful measure for relative HAT reactivity. 
Complex 6 presents an interesting test case, as it has been characterized by Nam 
using Mössbauer spectroscopy to have an S = 1 ground spin state at 80 K and 
below but exhibits HAT rates comparable to those of S = 2 complex 5.12, 51, 57 When 
its cyclohexane HAT rate is added into Figure 2.26 using the average Fe–N 
distance of 2.026 Å calculated for the MeCN-bound S = 1 complex, the point falls 
far from the line (Figure 2.26). However, a better agreement with the line is 
obtained by using the longer average Fe–N distance of 2.135 Å calculated for the 
6-coordinate S = 2 complex, supporting the speculation by Nam that 6 becomes S 
= 2 at –40 °C to account for its observed higher HAT reactivity. However Nam has 
suggested that 6 becomes an S = 2 trigonal bipyramidal complex at this 
temperature. With this geometry, the calculated average Fe–N distance shortens 
to 2.042 Å, and the plotted point would fall far off the line. A significant shortening 
of the average Fe–N distance is also predicted for trigonal bipyramidal 5, and the 
plotted point would be similarly incongruent with the correlation. Recent XAS 
studies on 6 however, report that this complex has an Fe-N bond length of 2.04 
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angstroms, and NMR studies report that it remains 6-coordinate at higher 
temperature. Thus if we were to use the bond lengths reported from XAS studies 
on the correlation in Figure 2.25, this complex would not fall on the line. Further 
studies are thus required to rationalize the unexpectedly high reactivity of 6. 
Correlation of spin density with the reactivity of the complexes 
Saouma et al. have suggested that the spin density on the abstracting atom in 
ferryl complexes does not correlate with its HAT reactivity.58 On the other hand, 
Ye et al. propose that nonheme oxoiron(IV) intermediates gain oxyl radical 
character approaching the C–H bond activation transition state. In mononuclear 
iron enzymes, Neidig et al. postulate the existence of a similar radical character on 
the oxo atom of the oxoiron(IV) intermediates.59 
Whether there is a correlation between spin density on the oxo atom of the ferryl 
unit and the HAT reactivity is not fully settled in the literature due to differences in 
the results of the calculations.60 If the actual oxidant during the HAT process were 
to become an FeIII-O• radical when the reaction approaches to the transition state, 
then the higher unpaired spin density on the oxo atom at the ground state of the 
oxidant (FeIV=O) would translate to higher reactivity, due to the effective lowering 
of the activation barrier. Elongation of the Fe=O bond en route to the transition 
state in an HAT reaction would lower its activation barrier, hinting at a higher radical 
character and spin density on the oxo atom at this point. Complex 3 has the longest 
Fe=O bond length of the complexes crystallized in the N4Py framework. This 
geometric feature therefore may increase spin density on this complex, and be 
responsible for its higher reactivity. However, the Fe=O bond lengths found for 
oxoiron(IV) complexes 1-4 span a much smaller range of distances (0.04 Å) and 
have 3 × esd’s of 0.01-0.02 Å, so these values make these complexes less distinct 
from each other. Indeed, calculations on complexes 2, 3 and 4 (done using a 
B3LYP functional with the basis set 6-311G) reveal very similar spin density values 
(from 0.88 to 0.89 to 0.92 respectively), despite significant differences in reactivity 
between the complexes discussed in this chapter. Further studies are thus 
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required to address the issue of spin density and reactivity. On a similar note, the 
vibrational Fe=O stretching vibrations found for 1, 2, and 3 also only differ by less 
than 10 cm−1. Assuming that the Fe=O stretch reflects its bond strength, the 
expectations that the reactivity of the Fe=O unit should be reflected in its Fe=O 
bond distance or its stretching frequency are not borne out. 
 
2.6 Conclusion 
In summary, 2 and 3 represent the first oxoiron(IV) complexes with N-
methylbenzimidazole or quinoline donors to be crystallographically characterized, 
shedding light on how these modifications can affect the Fe=O environment. 
Based on this work, it is evident that the quinolyl donors of 3 exert steric effects 
that increase the average Fe–N bond length and tilt the Fe=O unit away from these 
donors, resulting in higher HAT and OAT rates relative to 1 and 2. While complex 
3a was not further explored because of its thermal instability, deuteration of the 
benzylic positions on this ligand should be considered as a potential strategy to 
increase stability and perhaps allow structural data to be obtained. Nevertheless, 
the crystal structure of the starting precursor of this complex does indicate that 
steric hindrance enforced by 6-methyl groups likely exists on 3a. 
Lastly, increasing the number of quinolines to three in complex 5 further lengthens 
the average Fe–N distance and makes the Fe=O unit change its spin state to S = 
2, further enhancing its reactivity and lending credence to the correlation between 
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Figure 2.28 1H NMR spectrum of 6Me2N4Py (top, CD3CN), N2Py2Q (middle, 
CD2Cl2) and N2Py2B (bottom, CD3CN). 
 
 
Figure 2.29 1H NMR spectrum of [FeII(N2Py2B)(CH3CN)]OTf in CD3CN with an 









Figure 2.31 Front view of complex 1 (left) and 4 (right), along with non-bonded 
contact distances from oxygen atom of the ferryl unit to the alpha-H or alpha-
carbon of the pyridines. The aryl rings are shown as stick figures. 
 
 
Figure 2.32 Resonance Raman spectrum of 5 mM isolated complex 2 dissolved 
in MeCN, measured at 233 K using two different lasers (shown above). 
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Figure 2.33 Resonance Raman spectrum of isolated complex 1* dissolved in 
CH3CN, measured as frozen solution at 77 K, using 515 nm laser. # = solvent 
 
Table 2.12 Bond metrics of DFT-optimized structures used for calculations of 
spin-state splitting energies calculated using M06-L/def2TZVP 
Complexes 
(all values in Å, 
unless stated) 
1, S = 1 1, S = 2 2, S = 1 2, S = 2 3, S = 1 3, S = 2 
N-Fe=O, ° 179.96 179.52 177.83 177.28 170.33 171.29 
Nmean-plane-Fe=O, ° 88.8 87.4 88.8 89.6 82.6 84.3 
Fe-Naverage 2.013 2.124 2.018 2.128 2.039 2.141 
aver. Fe-Nequatorial 1.993 2.122 1.983 2.11 2.029 2.149 

































Table 2.13 Half-lives of oxoiron(IV) complexes based on N4Py framework with 
generated from iron(II) precursors with different oxidants, measured at 298 K with 
1-mM acetonitrile solutions 
Complexes 1 1* 2 3 3a 3b 




half-life (min) 3600 ‡3000 150 150 14, 130 30, 40 
reference 13 16 15 27 23, 26 26 
PFIB: pentafluoroiodosylbenzene; mCPBA: meta-chloroperbenzoic acid; PhIO: 
iodosylbenzene; PhI(OAc)2: (diacetoxyiodo)benzene. ‡t½ at 303 K. 
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In the fifteen years that have followed the discovery of oxoiron(IV) intermediates in 
nonheme oxygenases and oxidases1-5, bioinorganic chemists have flocked to 
make their spectroscopic, functional and structural analogs.6 This has been driven 
in large part by the diverse reactivity enabled by these ferryl intermediates, which 
form in enzymes as a result of activation of O2 by nonheme iron(II) centers, and 
then coupling it to the oxidation of different substrates.7 Many of these oxidations 
involve inert aromatic and aliphatic C−H bonds hydroxylation, C−H halogenation, 
C−H desaturation to form C=C bonds, C=C bond epoxidation, heterocyclic ring 
formation, and decarboxylation.8 The diversity of the oxidations carried out by 
these species speak to the importance of these intermediates.7 
While bioinorganic chemists have synthesized structural, functional, and/or 
spectroscopic mimics of these intermediates, none of the analogs have modeled 
enzymatic intermediates in all three aspects.9 Furthermore, over 80% of these 
complexes have not been structurally characterized, thus encumbering formulation 
of experimentally derived structural-functional and -spectroscopic relationships for 
these compounds. 
Unlike the enzymatic ferryl intermediates, which have S = 2 ground spin states, a 
clear majority of the 90 or so synthetic models have an S = 1 ground spin state. 
Typically, all model complexes in either ground spin state are found to be less 
reactive than the S = 2 enzymatic intermediates. There is one striking exception of 
a reactive and thermally unstable S = 2 oxoiron(IV) complex, namely 
[FeIV(O)(TQA)(L)]2+, which is supported by a tripodal ligand TQA (tris(2-
quinolylmethyl)amine), containing three equatorial quinolines and an axial amine 
(Figure 3.1).10 While this intermediate spectroscopically and functionally models 
the enzymatic intermediates, its thermal instability contributes to the dearth of 
structural information on this complex. Despite its inherent instability, this 





Figure 3.1 The oxoiron(IV) complexes examined for their structure-reactivity 
relationship 
In our efforts to gain insight into enzymatic analogs, we have crystallographically 
characterized an oxoiron(IV) complex that contains quinoline heterocycles 
(Chapter 2) similar to [FeIV(O)(TQA)(L)]2+, namely [FeIV(O)(N2Py2Q)]2+, where 
N2Py2Q = 1,1-di(pyridin-2-yl)-N,N-bis(quinolin-2-ylmethyl)methanamine. In this 
complex, the quinolines are oriented parallel to the ferryl unit and their protons 
exert steric hindrance on the oxoiron(IV) unit. This steric hindrance has two 
consequences: it increases the average Fe−N bond lengths of this complex by 
over 0.08 Å compared to the parent complex which only contained pyridines, and 
tilts the oxoiron(IV) unit away from the z-axis.11 Both the effects lead to an increase 
in the electrophilicity of the iron(IV) center, thus increasing its reactivity. The 
quinoline heterocycles in the complex [FeIV(O)(TQA)(L)]2+ likely have similar steric 
effects on the oxoiron(IV) unit, making it the most reactive oxoiron(IV) complex 
reported thus far. The steric hindrance of quinolines in the case of 
[FeIV(O)(TQA)(L)]2+ also leads to a change in the spin state from S = 1 to S = 2, 
making the complex a closer analog of enzymatic intermediate. 
Introduction of 6-methyl groups on pyridines or the replacement of pyridines with 
quinolines has similar steric effects. The introduction of alpha-methyl substituents 
on pyridines in the tripodal ligand framework of TPA (tris(2-pyridylmethyl)amine) 
results in 6Me3TPA ((tris(6-methyl-2-pyridylmethyl)amine)). The iron(II) centers 
supported by these two ligands have different spin states, as evidenced by NMR 
spectroscopy.12 The S = 0 complex [FeII(TPA)(MeCN)2]2+ has Fe−Npy bond lengths 
that are 0.2 angstroms shorter on average than those in the S = 2 complex 
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[FeII(6Me3TPA)(MeCN)2]2+. Similarly, in [FeIV(O)(6MeTPA)(L)]2+ , where 6MeTPA 
contains only one 6-methylpyridine on the TPA framework, has a much more red-
shifted near-IR absorption band compared with that of the unsubstituted complex 
[FeIV(O)(TPA)(L)]2+, indicating a weakened ligand field. This weakened ligand field 
likely arises from increased Fe−N bond lengths as a result of steric effects imposed 
by the 6-methyl groups.13  
The structural data obtained for tetragonal oxoiron(IV) complexes so far shows that 
average Fe−L bond lengths extend from 1.95 Å to 2.10 Å (a span of 0.15 Å), but 
in this range, the iron center does not change its spin state from S = 1 to S = 2. To 
allow for a wider range of average Fe−L bond lengths, we can extend it from 1.95 
Å to 2.20 Å (a span of 0.25 Å). The average Fe−L bond lengths can be 
experimentally or computationally obtained for ferryl complexes and correlated 
with their hydrogen-atom transfer (HAT) and oxygen-atom transfer (OAT) reactivity 
to develop a structure-reactivity relationship and used to model enzymatic 
intermediates. 
It is likely that the oxoiron(IV) complex [FeIV(O)(TQA)(L)]2+ has longer average 
Fe−N bond lengths, as predicted by its computational model (2.15 Å). When a few 
oxoiron(IV) complexes’ reactivity (represented by log of their second-order rate 
constants) is plotted against their available structural information (Figure 3.2), the 
computational model falls close to the line defined by those points, thus 
highlighting the validity of this a model, and also indicating the need to obtain more 
structural and reactivity information to establish this correlation further. This 




Figure 3.2 Correlation of log k2’ values of cyclohexane with the average length of 
Fe−N bonds in N4Py-based ferryl complexes (solid circles). The plot is extended 
to 2.20 Å to determine if this correlation holds true for the S = 2 complex 
[FeIV(O)(TQA)(MeCN)]2+, for which raverage(Fe−N) bonds is DFT-based. 
We have sought to solidify this correlation by inclusion of additional FeIV(O) 
complexes supported by a different framework, namely BnTPEN (N-benzyl-
N,N’,N’-tris(pyridin-2-ylmethyl)ethane-1,2-diamine) to populate the correlation 
shown in Figure 3.2. The parent complex [FeIV(O)(BnTPEN)]2+ (0) is found to be 
an order of magnitude more reactive than [FeIV(O)(N4Py)]2+ in both hydrogen-atom 
and oxygen-atom transfer reactivity, and thus represents a reasonable starting 
point for making modified complexes based on this framework.14-15 This chapter 
examines seven new oxoiron(IV) complexes synthesized for this purpose and 
details the crystallographic description of two of these complexes, along with an 
examination of structure- and spectroscopy-reactivity relationships. 
The complex 0 has been shown by NMR spectroscopy to have two of its three 
equatorial pyridine rings aligned parallel to the oxoiron(IV) unit and the third 
equatorial pyridine aligned perpendicular to the FeIV=O unit.16 This arrangement of 
perpendicular pyridine ring on the BnTPEN framework is responsible for its C1 
symmetry. It also enables investigation of role of the heterocycle orientation in the 
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reactivity of these oxoiron(IV) complexes. The lack of symmetry in 0 however, 
requires systematic introduction of substitutions, to avoid formation of mixtures. 
Herein, we replace complex 0’s pyridines with different heterocycles, and introduce 
alpha-substituents on its pyridines (similar to the ones used by Snider et al.17) to 
obtain seven new complexes that tune ligand field strength of 0, and try to obtain 
structural information wherever possible (Figure 3.3). The lack of symmetry also 
requires systematic introduction of these substituents to minimize possibility of 
forming isomeric mixtures (Figure 3.4). Therefore, only the perpendicular 
heterocycle, both the parallel heterocycles, or all three heterocycles are substituted 
to obtain the newer oxoiron(IV) complexes. This attempt at systematic 
modifications is not required for [FeIV(O)(N4Py)]2+ and [FeIV(O)(TMC)(MeCN)]2+ 
(where TMC is a macrocyclic ligand), which both possess an ≈ C4v symmetry. 
Nomenclature used to define the complexes: 
In this study, the complexes are numbered from 0 to 3, to indicate the number of 
modifications made to the parent complex 0, and the letters after the numbers 
indicate the type of modification (Figure 3.3). For example, 3-6Me represents 
introduction of a 6-methyl substituent on all three pyridines; 2-Q indicates 
substitution of the two pyridines parallel to the FeIV(O) unit with quinolines; and 1-
B indicates substitution of the pyridine perpendicular to the FeIV(O) unit with N-
methylbenzimidazole on the BnTPEN framework. The structural and/or 
spectroscopic characterization of these complexes is accompanied by 
investigation into how their reactivity is affected by the arrangement of the 
heterocycles around the oxoiron(IV) center as well as how it enhances the scope 




Figure 3.3 Oxoiron(IV) complexes based on BnTPEN framework investigated. 
 
Figure 3.4 Strategy used to avoid isomeric forms in doubly and singly substituted 
oxoiron(IV) complexes, exemplified using 1-6Me and 2-6Me. 
3.2 Results 
The syntheses of the mono- and di-substituted ligands involve separate 
functionalization of the amines in ethylenediamine linkers of the BnTPEN 
framework. To selectively carry out the substitutions, a singly protected 
ethylenediamine (specifically N-acetylethylenediamine) is employed. To 
functionalize its unprotected amine, it is subjected to either reductive amination 
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with 2-substituted aldehydes of heterocycles (or benzaldehyde) or nucleophilic 
substitution with the 2-substituted methylchlorides of heterocycles. Once the two 
requisite arms are installed on the unprotected amine, the other amine is 
deprotected (with acid hydrolysis to remove the acetyl group) to reveal the other 
amine. This amine is then subjected to either nucleophilic substitutions or reductive 
amination again with the respective precursors (2-substituted aldehydes or 2-
substituted methylchlorides of heterocycles). To synthesize the parent and the tri-
substituted ligands, N-benzylethylenediamine is subjected to nucleophilic 
substitution with 2-substituted methylchlorides of heterocycles. The detailed 
syntheses, indicating the choice of base used for nucleophilic substitution, or the 
reducing agents used for reductive amination, are laid out in the experimental 
section.  
The iron(II) precursors to oxoiron(IV) complexes are generated from the anaerobic 
mixing of the equimolar amount of ligands with iron(II) triflate in dichloromethane, 
and the solution is then concentrated and stirred in diethyl ether. After filtering and 
washing the solids formed with more diethyl ether, the salts are either further 
crystallized using slow diffusion of ether into concentrated dichloromethane 
solutions, or directly taken for further experimentation. 
All the nonheme oxoiron(IV) complexes can be generated from solutions of iron(II) 
precursors in acetonitrile, using 1-2 equivalents of the oxidant 1-(tert-
butylsulfonyl)-2-iodosylbenzene ((tBuSO2)C6H4IO, or ArIO) dissolved in 2,2,2-
trifluoroethanol, at appropriate temperatures. Some oxoiron(IV) complexes can 
also be generated by the oxidation of CH3CN/H2O iron(II) solutions using 
cerium(IV) ammonium nitrate,  which can then precipitated out by treatment with 
sodium perchlorate. In some cases, crystals can also be obtained at 2-8 °C. See 
experimental section for more details. 
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3.2.1 Thermal Stability of the Ferryl Complexes 
Table 3.1 lists the half-lives of 1-mM acetonitrile solutions of the ferryl complexes 
measured at room temperature, unless otherwise specified. Complexes 0 and 1-B 
have comparable half-lives of 36014 and 270 minutes, respectively, while 1-6Me 
and 1-Q have t½ ≈ 25-30 minutes, which is a 10-fold decrease in thermal stability 
compared with 0, which likely precludes their crystallographic characterization. 
Deuteration of all 11 benzylic protons in 1-6Me increases its half-life to about 1 
hour at room temperature, but still prevents its crystallization. When the rate of 
self-decay of deuterated complex 1-6Me-d11 and non-deuterated 1-6Me-h11 is 
followed, a KIE of 2.2 at 298 K can be obtained (Figure 3.5). 
Table 3.1 Spectroscopic properties of ferryl complexes based on BnTPEN 
Complex 0 1-B 1-6Me 1-Q 2-Q 2-6Me 3-6Me 3-Q 
S 1 1 1 1 1 1 - - 
ν(Fe=O), cm−1 833 835 - - - - - - 
ΔEQ, mm s−1 0.87 0.74 +1.00 +1.00 0.40 0.40 −0.40 −0.40 







26(5) 30(5) 29(5) 29(5) - - 









ε, M−1 cm−1 400 250 220 220 
300, 
350 
250, 350   
r(Fe=O), Å 1.653(1) 1.651(3) 1.611 1.65*     

















> 6 (d17) 
< **1 
All values in italics are DFT-derived. *Values obtained from XAS analysis. **Measured at 233 K.  









Table 3.2 Spectroscopic properties of FeIV(O) complexes based on N4Py 
Ligand L = N4Py N2py2B sr2N4Py N2py2Q 6Me2-N4Py N4Py-6Me2 Ar2N4Py 
reference 14 11, 18 19 11 20 21 22 
ν(Fe=O), cm−1 843 842 839 833 - - - 
|ΔEQ|, mm s−1 0.93 1.36 - 0.56 0.62 - 0.54 
δ, mm s−1 −0.04 −0.02 - 0.03 0.05 - 0.03 
λmax, nm 695 725 692 770 740 775 750 




r(Fe=O), Å 1.639(5) 1.656(4) 1.653(1) 1.677(5) 1.619 1.654 1.660(2) 
av. r(Fe-N), Å 1.972 1.999 1.981 2.053 2.040 2.032 2.014 







DFT-derived values in italics. 
 
In the singly substituted complexes, the sole pyridine perpendicular to the ferryl 
unit in 0 is replaced with a different heterocycle, namely an N-
methylbenzimidazole, a quinoline or a 6-methylpyridine, and the 10-fold difference 
in thermal stability between 1-B and 1-Q/1-6Me contrasts with the case of 
[FeIV(O)(N4Py)]2+ family (Table 3.2), where the heterocycles are aligned parallel to 
the ferryl unit and quinoline or N-methylbenzimidazole substitutions result in 
complexes with similar half-lives (150 minutes). 
The introduction of α-substituents on two pyridines parallel to Fe=O unit in 0 results 
in considerably unstable complexes, so that 2-6Me and 2-Q have respective half-
lives of 8 seconds and 3 minutes at 298 K (Table 3.1). These disubstituted 
complexes are much more unstable than when two quinolines are introduced in 
[FeIV(O)(N4Py)]2+, which result in a 20-fold increase in thermal instability. 
Compared with 0, 2-6Me and 2-Q experience a more than 100-fold increase in 
thermal instability. Deuteration of the 14 benzylic protons in 2-6Me increases its 
half-life to 3 minutes, making it comparable to that of 2-Q. When the rate of self-
decay of deuterated complex 2-6Me-d14 and non-deuterated complex 2-6Me-h14 
is followed, a KIE of 22 at 298 K can be obtained (Figure 3.5). 
The different increase in half-lives (or thermal stability) upon deuteration of 
weakest C−H bonds in the ligands in the cases of 1-6Me and 2-6Me is remarkable, 
and the 10-fold difference in the KIE for the self-decay rates between two 
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complexes (1-6Me and 2-6Me) can be explained by different proximity of the 
benzylic bonds in 1-6Me and 2-6Me to the oxoiron(IV) unit. (Figure 3.5). 
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Figure 3.5 Absorption-time plots for self-decay of deuterated and non-deuterated 
complexes of 2-6Me and 1-6Me at different temperatures. Inset in the bottom 




The introduction of the third alpha-substituent decreases thermal stability even 
further, so that the complexes 3-6Me and 3-Q are extremely short-lived at 298 K 
and cannot be observed. Deuteration of the 17 benzylic protons in 3-6Me-h17 
results in complex 3-6Me-d17. This enables this fleeting intermediate to be 
generated at 298 K, but its half-life is only about 10 seconds, and not long enough 
for us to be able to measure its reactivity at ambient temperatures. Therefore, we 
chose to lower the temperature to 233 K, to measure its reactivity. Both 3-6Me-h17 
and 3-Q have longer half-lives of ≈ 1 minute at 233 K but are still very unstable. 
The deuterated 3-6Me-d17 however lives long enough at this temperature (t½ > 5 
min) so that its HAT reactivity can be obtained at 233 K. 
3.2.2 Structural Characterization of Ferryl Complexes 
The complexes 0 and 1-B are the first set of completely C1-symmetric ferryl 
complexes to be crystallographically characterized. Both the complexes have two 
pyridines aligned parallel to the oxoiron(IV) unit, and an equatorial heterocycle 
aligned perpendicular to the oxoiron(IV) unit (Figure 3.6). All atoms of the 
perpendicular heterocycle in 0 and 1-B are found to be in the mean plane defined 
by the four equatorial donor atoms. 
 
Figure 3.6 ORTEP plots of 0 and 1-B with thermal ellipsoids at 50% probability. 
Counterions and hydrogen atoms have been removed for clarity. 
The Fe=O bond lengths found for both 0 and 1-B are comparable at 1.653(2) and 
1.651(3) Å, and the longest bonds belong to the Fe—Nam bonds in both complexes 
 
100 
(2.045(2) to 2.096(3) Å), consistent with what is observed for all ferryl complexes.9 
Interestingly, the benzimidazole donor in 1-B has a very short Fe—N bond at 
1.964(3) Å and exerts a trans effect on the equatorial pyridine, so that its Fe—Npy 
bond length is lengthened to 1.993(3) Å, as also seen in the case of the ferryl 
complex [FeIV(O)(N2Py2B)]2+, where two benzimidazole donors (Fe—NbnzIm = 
1.950-1.954 Å) exert a trans effect on the pyridines and increase their bond lengths 
very slightly (Fe—Ntrans-py = 1.995-1.983 Å).11 This is consistent with the higher 
basicity of benzimidazoles compared with pyridines.23 In both 0 and 1-B, the Fe—
Npy bond lengths range from 1.962(3) to 1.993(3) Å, and the orientation of the 
equatorial pyridine around the ferryl center does not impact the Fe—Npy bond 
length. The average lengths of all five Fe—N bonds in 0 and 1-B are also 
comparable at 2.013 and 2.019 Å, respectively. While the Nam-Fe-O angles are 
about 173.3° and 175.2° in 0 and 1-B, respectively (which give rise to an apparent 
bending of the ferryl unit), no tilt is induced by the presence of ligands on the ferryl 
units, as evidenced from their almost ideal orthogonality with the mean plane 
formed by equatorial ligands. 
The average Fe–N bond lengths of the parent complex 0 (at 2.013 Å) rises slightly 
when one pyridine is replaced with N-methylbenzimidazole in 1-B (2.019 Å). When 
a single pyridine is replaced with quinoline in 1-Q, it is expected that the average 
Fe–N bond lengths will rise even further, due to the steric hindrance introduced 
between the H8 protons of quinoline perpendicular to the ferryl unit, and the mean 
plane of the pyridine, which would increase the quinoline’s Fe–N bond. However, 
a crystal structure to demonstrate this effect could not be obtained. When the 
quinoline is parallel to the ferryl unit, as observed in the case of 
[FeIV(O)(N2Py2Q)]2+, the average Fe–N bond lengths rise by about 0.08 Å 
compared with those in [FeIV(O)(N4Py)]2+. However, [FeIV(O)(N2Py2Q)]2+ has two 
quinolines, and 1-Q has one. In the absence of crystal structure, we must rely on 
a DFT-optimized S = 1 structure, which predicts an average Fe−N bond length = 







Table 3.3 Bond metrics (in Å) of BnTPEN-derived ferryl complexes 
Complexes 0 1-B 
1-Q 
DFT S = 1 
1-6Me 
DFT S = 1 
2-Q 
DFT S = 1 
2-6Me 
DFT S = 1 
r(Fe=O) 1.653(2) 1.651(3) 1.611 1.611 1.618 1.615 
aver. r(Fe-N) 2.0126 2.019 2.065 2.0602 2.06 2.0594 
r(Fe-Nam (ax)) 2.083(2) 2.096(3) 2.131 2.128 2.082 2.087 
r(Fe-Nam (eq)) 2.045(2) 2.080(3) 2.023 2.025 2.046 2.050 















3.2.3 Spectroscopic Characterization of Ferryl Complexes 
3.2.3.1 UV-visible Spectroscopy 
Complexes 1-B, 1-Q and 1-6Me exhibit near-IR absorption bands characteristic of 
d-d transitions that have been identified previously for other tetragonal oxoiron(IV) 
complexes, such as [FeIV(O)(N4Py)]2+ by Decker et al.24 These bands are red-
shifted from those of the parent complex 0 at λmax = 739 nm to λmax = 753 nm for 
1-B, and to 777 nm for both 1-Q and 1-6Me. The parent complex 0 also has a 
shoulder at 860 nm, which red-shifts to 890 nm for 1-B and 930 nm for both 1-Q 
and 1-6Me (Figure 3.7). The red-shifted bands indicate a weakened ligand field. 
The extinction coefficients of the major bands found for these complexes at 298 K 
in acetonitrile are about 200-250 M−1 cm−1, almost half of the value associated with 




Figure 3.7 Absorption spectra of mono-substituted (a), and disubstituted and 
trisubstituted (b) oxoiron(IV) complexes examined in this chapter. 
2-6Me and 2-Q have d-d absorption bands even more resolved into distinct 
features around ≈ 580, 810-820 and 1000 nm (Figure 3.7), similar to those in 
[FeIV(O)(TMC)(X)]+.25-26 The near-IR bands around 800 nm and 1000 nm have 
extinction coefficients around 300-350 M−1 cm−1 at room temperature in 
acetonitrile. Compared with the singly substituted complexes, the bands at 810 nm 
of 2-6Me and 2-Q are red-shifted by 30 nm, and over 70 nm when compared with 




























































the parent complex. This red-shift in the bands clearly represents even further 
weakening of the ligand field, which also makes these complexes drastically 
unstable at room temperature. Both the bands in complexes 2-6Me and 2-Q are 
even more red-shifted when new alpha-substitution is introduced, so that the 
resulting complexes 3-6Me and 3-Q have λmax = 835 nm and 1035 nm. The 
extinction coefficients cannot be obtained for these complexes, because parallel 
Mössbauer experiments which would indicate the concentration of actual 
oxoiron(IV) complex, were not successful. 
In the N4Py framework, when the pyridines are replaced with quinolines or N-
methylbenzimidazoles, there is no significant change in extinction coefficients 
measured in acetonitrile at room temperature. However, upon introduction of these 
modifications on BnTPEN framework, extinction coefficients of mono-substituted 
complexes under the same conditions are almost halved (see Table 3.1), and in 
disubstituted and trisubstituted complexes, the extinction coefficients are lower 
than the parent complex. 
3.2.3.2 Vibrational Spectroscopy 
The oxoiron(IV) complexes examined in this series exhibit a vibrational stretch 
characteristic for such complexes. These data are typically measured through 
FTIR, resonance Raman or NRVS spectroscopy. Because solid samples of both 
complexes 0 and 1-B can be accessed, the solid-state FTIR spectra (Figure 3.8) 
of both 0 and 1-B show comparable ν(Fe=O) stretches at 833 cm−1 and 835 cm−1. 
Replacement of equatorial pyridines with benzimidazoles on ferryl complexes with 
multidentate ligand frameworks such as N4Py and BnTPEN does not alter the 
vibrational stretch observed, regardless of whether the benzimidazole is oriented 
perpendicular or parallel to the ferryl unit (see Table 3.1 and 3.2). This observed 
insensitivity may be due to the lack of steric interactions with the oxo unit imposed 
by these heterocycles. Other compounds in this series can only be prepared as 
solutions, but exhibit intense fluorescence in their resonance Raman spectra, thus 
preventing detection of the vibrational stetch associated with the ferryl complexes. 
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1-Q (like 1-B) is not expected to have any interaction with the ferryl unit and would 
not show significant deviation in the ferryl vibration. However, when quinoline 
heterocycles are aligned parallel to the ferryl unit, a steric interaction likely exists 
with the ferryl unit (as also seen in the case of crystallographically characterized 
[FeIV(O)(N2Py2Q)]2+), and we can expect a change in vibrational stretch, although 

























Figure 3.8 FTIR spectra of 0 and 1-B complexes. 
3.2.3.3 Mössbauer Spectroscopy 
The 4.2 K Mössbauer spectra of unlabeled 1-B solid, and Fe-57-enriched, 1-mM 
frozen solution samples of 1-Q, 1-6Me, 2-6Me and 2-Q in acetonitrile show that 
the samples consist of over 80% oxoiron(IV) species.  These complexes reveal an 
S = 1 spin manifold when magnetic fields up to 70 kG are applied, similar to that 
reported for the parent complex 0.14 High-spin ferric (S = 5/2) components were 
first subtracted based on the magnetized six-line feature. The inner magnetized 
features were then simulated using an S = 1 Hamiltonian (for the major ferryl 
species) and an S = 0 Hamiltonian (a minor di-ferric contaminant). The 
experimental spectra and simulations of S = 1 species are plotted in Figure 3.9. All 




Figure 3.9 Mössbauer spectra and corresponding simulation of samples at 4.2 K 
with various external magnetic fields. (A) 1-6Me (14% HS-ferric subtracted); (B) 1-
Q (18% HS-ferric subtracted) The black traces represent the experimental spectra 
(0kG: raw spectra; 10-70 kG, raw spectra after removing high-spin ferric), and the 
red traces represent the simulation contributed by S = 1 species only. Ruixi Fan 
performed these experiments. 
Variable-field and variable temperature studies are not carried out on 0 and 1-B to 
determine its zero-field-splitting parameter (zfs) D or confirm its spin state. The zfs 
parameter D indicates contribution of excited spin states into the ground spin state, 
which is usually correlated with higher reactivity of complexes. Because of a dearth 
of accurate D values and the fact that correlation doesn’t necessarily imply 
causation. D values are instead determined using a combination of HFEPR and 
FIRMS spectroscopy. The D value for complex 0 and 1-B is 23.41 cm−1 and 24.35 
respectively and are less than 1 cm−1 apart. 
Complexes 1-B, 1-6Me and 1-Q have higher isomer shifts than 0.01 mm/s in 0. 
These values are consistent with those observed for typical S = 1 oxoiron(IV) 
complexes.6 While the magnitude of the quadrupole splitting decreases in going 
from 0 to 1-B, it rises in going from 0 to 1-Q and 1-6Me (see Table 3.1), indicating 
that 0 and 1-B have greater electronic symmetry compared to those of 1-Q and 1-
6Me. 
The isomer shifts further rise to 0.09 mm/s in 2-6Me and 2-Q, and the quadrupole 
splitting decreases from +1.00 mm/s in 1-Q/1-6Me to 0.40 mm/s. The zfs 
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parameters obtained from Mössbauer spectroscopy for all complexes are within 
error of each other. Between di-substituted and mono-substituted complexes, the 
modifications are made on different parts of the ligand, and thus effects on the zfs 
parameters may not show a systematic trend of increasing D value upon 
introduction of each of the subsequent modifications. Furthermore, because the 
variable field experiments were done only at 4.2 K, there is a relatively larger 
uncertainty in the D value parameters. Given that D values do not change 
drastically, Mössbauer spectroscopy may not be able to distinguish between D 
values of these complexes. 
3.2.4 Computed Spin State Splitting Energies of Ferryl Complexes 
For the series of oxoiron(IV) complexes bearing differently substituted BnTPEN 
ligands, spin-state splitting energies were computed for the S = 1 and S = 2 spin 
states. The introduction of steric bulk in the α-position leads to a systematic 
decrease in the calculated spin-state splitting energies and ultimately leads to the 
prediction of high-spin ground states for the complexes having multiple 
substitutions. As can be seen from Table 3.4, the inclusion of zero-point vibrational 
energies (ZPE) leads to a decrease in the spin-state splitting energies, an effect 
described previously in the literature.27-28 A plot of the computed spin state splitting 
energies reveals a direct correlation with the number of substitutions made and the 
spin state splitting energies (Figure 3.10). It should be noted that the introduction 
of α-Me-groups in the 6-position of the pyridine substituents or replacement with 
quinoline (Q) groups results in comparable changes to the spin state splitting 
energies. Based on the computational studies herein, 3-Q and 3-6Me are predicted 
to be high-spin complexes, although in the absence of any experimental data, we 




Figure 3.10. Structures calculated for oxoiron(IV) complexes in the S = 1 spin 
state. Geometries were obtained at the PW6B95/def2-TZVP level of theory in the 
gas phase. Depictions were made using IboView.29-30 
Table 3.4 Computed spin state splitting energies at the PW6B95/def2-TZVP level 
of theory, obtained by Dr Johannes Klein. 
Complex ΔE(Q-T) [kcal mol−1] ΔEZPE(Q-T) [kcal mol−1] 
0 3.5 2.3 
1-6Me 1.4 0.2 
2-6Me -0.3 -1.5 
3-6Me -3.4 -4.7 
1-Q 0.9 -0.2 
2-Q -0.8 -1.9 
3-Q -3.7 -4.8 
 
All calculations were performed using Turbomole v7.0.1,31-33 with the PW6B95 
functional34 and the def2-TZVP basis set.35 All calculations were carried out in the 
gas phase and numerical second derivatives were computed to confirm that a 
minimum was reached, showing no imaginary frequencies. For ZPE corrections 
small frequencies (< 100 cm-1) were raised to 100 cm-1.36-37 Calculations were 
accelerated by the MARI-J approach38 using Weigend’s fitting basis sets.39 Grid 




Figure 3.11 Plot of the computed spin state splitting energies at the PW6B95/def2-
TZVP level of theory versus the number of substitutions made to the BnTPEN 
ligand framework. The black square shows the reference value for the 
unsubstituted ligand; red dots refer to 6Me substitutions and blue triangles 




3.2.5 Reactivity of Ferryl Complexes 
Table 3.5 lists the second order rate constants obtained for the reactions of 
oxoiron(IV) complexes with different substrates at given temperatures. 
Table 3.5 HAT and OAT reactivity of BnTPEN-substituted ferryl complexes at 298 
K unless otherwise specified. 
Second order rate constants (k2), measured at 298 K, given in M−1 s−1 
Substrates 0 1-B 1-6Me 1-Q 2-6Me 2-Q *3-6Me 
TPM 0.083 0.23 0.99 3.2 6.2 9.2 1.9 
Cumene 0.042 0.042 0.034 0.069 6.2 3.6 3.1 
Ethylbenze
ne 
0.069 0.035 0.13 0.1 2.9 1.8 2.1 
Toluene 0.0089 0.0057 0.0252 0.031 0.45 0.18 0.23 
2,3-DMB 8.1×10−4 0.0035 0.023 0.031 1.1 0.97 0.24 
c-C6H12 3.9×10−4 0.0012 0.011 0.025 0.41 0.29 - 
c-C6H12  
(233 K) 
1.6×10−7 2.3×10−7 - 3.0×10−5 - 1.2×10−4 0.066 
PhSMe 
(233 K) 
0.0025 0.068 1.7 3.6 270 390 - 
*All rates for 3-6Me measured at 233 K owing to its instability at 298 K. All OAT rates 
measured at 233 K. Other 233 K HAT rates obtained from Eyring analyses. 
 
Reactivity of mono-substituted oxoiron(IV) complexes 
Complexes 1-Q and 1-6Me introduce a quinoline or 6-methylpyridine in 0 to 
replace the pyridine that lies perpendicular to the Fe=O unit, resulting in more 
reactive oxoiron(IV) complexes. This increase in reactivity resembles that seen for 
[FeIV(O)(N4Py)]2+ with similar substitutions (Figure 3.12). Interestingly, 1-B is 
mostly comparable to 0 in its HAT reactivity but is about 30 times faster at OAT to 
thioanisole than 0. However, compared to 0, 1-6Me and 1-Q are at least 2-3 orders 
of magnitude higher in their OAT reactivity, and an order of magnitude faster in 
their HAT reactivity. 
Figure 3.12 illustrates these interesting reactivity results for 1-B, 1-Q (or 1-6Me), 
showing correlations of log k2’ values (where k2’ is k2 divided by the number of 
equivalent substrate C−H bonds that can be attacked) versus the C−H bond 
dissociation energy for the complexes with the N4Py and the BnTPEN frameworks. 
These plots reveal reasonably linear correlations for the three sets of data in each 
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framework, as observed previously for a number of oxoiron(IV) complexes. The 
rate differences among the three complexes in each series become larger for 
substrates with stronger C−H bonds, resulting in a progressive decrease in the 
slopes in going from the parent complex 0 to the complexes with benzimidazole 
and quinoline substituents. In the N4Py series, the heterocycles are roughly 
aligned parallel to the oxoiron(IV) unit, whereas in the BnTPEN series, mono-
substituted complexes have the modified heterocycle aligned perpendicular to the 
ferryl unit. When the oxoiron(IV) complexes in the two frameworks are compared 
together, it appears that oxoiron(IV) complexes containing quinolines have 
increased HAT rates of reaction regardless of their orientation relative to the ferryl 
unit. However, oxoiron(IV) complexes containing benzimidazoles have higher HAT 
rates when they replace the pyridines are oriented parallel to the ferryl unit, but 
when they replace the pyridines oriented perpendicular to the ferryl unit, their HAT 




Figure 3.12 Evans-Polanyi plots showing HAT reactivity of compounds with 
benzimidazole (green) and quinoline (red) modifications in different orientations 







Reactivity of di- and tri-substituted oxoiron(IV) complexes 
The ferryl complex 2-Q abstracts hydrogen atoms from C-H substrates at a rate 
which is at least an order of magnitude faster than 1-Q. As an example, in going 
from complexes 0 to 1-Q to 2-Q at 298 K, the second order rate constants (k2) with 
cyclohexane increase by 1:50:750. 2-Q therefore has the highest HAT rates at 298 
K reported for any ferryl complex. Similarly, 2-Q transfers its oxygen atom to 
thioanisole at 233 K at least two orders of magnitude faster than 1-Q. Therefore, 
in going from 0 to 1-Q to 2-Q the rate constants for OAT to thioanisole change 
even more dramatically than those for HAT, with the ratio 1:1000:100,000 at 233 
K. In fact, the OAT rates are so high that 2-Q requires the use of a stopped-flow 
instrument to accurately determine these second-order rate constants. 
The same patterns of HAT and OAT reactivity ratios (seen for 0, 1-Q, and 2-Q) are 
observed when 6-methylpyridine substitutions are made on the parent complex 0 
to form the complexes 1-6Me and 2-6Me, as shown by their second-order rate 
constants (k2) with cyclohexane, thioanisole and other substrates (Table 3.5). 
Figure 3.13 shows the correlation of the log k2’ values (where k2’ is k2 divided by 
the number of equivalent substrate C−H bonds that can be attacked) versus the 
C−H bond dissociation energy for complexes with increasing number of 6-
methylpyridines for complex 0, 1-6Me and 2-6Me, which reveals reasonably linear 
correlations for the three sets of data in this framework, all measured at 298 K. 
The thermal instability of 3-6Me and 3-Q (t½ of a few seconds at 298 K) prevents 
measurement of the second-order rate constants for their reactions with substrates 
at room temperature. However, when benzylic positions in the ligand framework of 
3-6Me are deuterated, it is stabilized long enough at 233 K to enable determination 
of these k2 values. To draw comparisons with the parent complex 0 as well as 
mono- and di-substituted complexes, second-order rate constants for their 
reactions with substrates need to be determined at 233 K. We have found that the 
second-order rate constants for the reactions of cyclohexane with oxoiron(IV) 
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complexes supported by N4Py-based ligands vary by about 3 orders of magnitude 
between 298 K and 233 K.11 To establish this further, we extrapolated the second-
order rate constant for the reaction of 0 with cyclohexane at 233 K from its Eyring 
plot and found that 0 reacts with cyclohexane about 2400 times faster at 298 K 
than at 233 K. Similarly, further Eyring analyses of the reactions of cyclohexane 
separately with 1-B, 1-Q and 2-Q reveal that their rates of reaction with 
cyclohexane are over 1000 times faster at 298 K than at 233 K. 
With the observation that the second-order rate constants for reactions of 
oxoiron(IV) complexes with cyclohexane are 3 orders of magnitude higher at 298 
K than at 233 K, the log k2’ values of reaction of 3-6Me with substrates measured 
at 233 K are increased by 3 units and may be plotted on Figure 3.13, although a 
rigorous Eyring analysis has not been performed for all the substrates. Even so, 
we used cyclohexane as our conservative model, because its C-H bonds have 
high bond dissociation energy, and it shows this pattern of increased reactivity as 
a result of more substitutions for a series of complexes at room temperature. 
Conversely, the availability of the HAT reactivity of 0, 1-B, 1-Q, and 2-Q with 
cyclohexane at 233 K can also help draw comparisons of second-order rate 
constants with 3-6Me for which this rate is only available at 233 K. Thus, we find 
that at 233 K there is a 400,000-fold increase in the reaction rate of cyclohexane 
between 0 and 3-6Me. Given that di-substituted and mono-substituted oxoiron(IV) 
complexes with quinolines or 6-methylpyridines are comparable in their rates of 
reaction with substrates, the rates of reaction with cyclohexane at 233 K in going 
from 0 to 1-Q (or 1-6Me) to 2-Q (or 2-6Me) to 3-6Me would be in the ratio 
1:200:750:400,000. Within the same ligand framework that supports oxoiron(IV) 
units, such an increase in rates of HAT reactions of oxoiron(IV) complexes has not 
been demonstrated before. Unfortunately, complexes 3-6Me and 3-Q were 
incredibly fast in their reactions with thioanisole so their second-order rate 




Figure 3.13 Evans-Polanyi plots showing the reactivity increase observed for 
oxoiron(IV) complexes when quinolines replace the pyridines (left), or α-methyl 
substituents (right) are introduced on each pyridine in the BnTPEN ligand. The 3-
6Me rates are increased by 3 log units to adjust for the 65 K difference in 
temperature at which they were obtained. Similar trends in HAT reactivity are 
observed for ferryl complexes with quinoline substitutions in this series. 
3.3. Discussion 
The BnTPEN framework uniquely enables exploration of not only the number and the 
types of substitutions, but also their orientations around the oxoiron(IV) unit. These 
differences are reflected in the spectroscopic and reactivity properties observed for the 
resulting newer complexes. The effects on the properties are discussed with comparisons 
to oxoiron(IV) complexes based on N4Py (explored in Chapter 2) where appropriate. 
 
Effects on UV-Visible-NIR Spectral Features 
All three types of modifications introduced on the parent complex 0 result in the 
weakening of the ligand field, as evidenced by the red-shift of their near-IR 
chromophores (indicated by their λmax values). The red-shift in λmax is dependent 
on the number of substituents introduced as well as the type of substitutions made. 
In general, more substitutions lead to larger red-shifts in the near-IR bands of the 
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oxoiron(IV) complexes, and in turn further weakening of the ligand field. 
Introduction of one alpha-substituent (6-methyl group on pyridine, or replacement 
of the pyridine with a quinoline) on 0 red-shifts its λmax value by 38 nm (as shown 
in Figure 3.7). Two alpha-substituents further red-shift the λmax values, but the two 
near-IR features in the electronic absorption spectra now become resolved so that 
two λmax values are observed in di-substituted complexes, similar to the TMC-
based FeIV(O) complexes with axial anionic ligands.25, 40 This pattern persists with 
the introduction of the third alpha-substituents, but the red-shifts of the λmax values 
are somewhat less drastic when compared with the change observed between di-
substituted and the mono-substituted complexes. This trend shows that the 
heterocycles oriented parallel to the Fe=O unit have a bigger effect than those that 
are perpendicular to the Fe=O unit. A similar effect is observed for the 
[FeIV(O)(N4Py)]2+ series , where there is a red-shift of roughly 75 nm per two 
quinolines introduced.11, 21 Note however, in [FeIV(O)(N4Py)]2+ complex the alpha-
substituents were introduced as a pair rather than one at a time. The effects of 
introducing alpha-methyl groups on pyridines in [FeIV(O)(N4Py)]2+ are the same as 
the effects of replacing the corresponding quinolines. All in all, the red-shift in the 
absorption features increases when a greater number of substitutions is 
introduced. 
In addition to the number of substitutions, the nature of the substituent also affects 
the magnitude of the red-shift in the λmax values. 1-B (λmax = 753 nm) with a single 
N-methylbenzimidazole shows a much smaller red-shift in the λmax value (about 14 
nm) than 1-Q (λmax = 777 nm) with one quinoline (about 38 nm) when compared 
with 0 (Table 3.1, λmax = 739 nm). While additional N-methylbenzimidazoles were 
not introduced on 0, their systematic introduction into [FeIV(O)(N4Py)]2+ has been 
investigated by Nordlander and coworkers, and the λmax value red-shifts by 10-15 
nm per N-methylbenzimidazole introduced.18 A similar red-shift of 15 nm per N-
methylbenzimidazole is observed in [FeIV(O)(TPA)(L)]2+ (TPA = tris(2-
pyridylmethyl)amine, λmax = 724 nm) when all the pyridines are replaced by N-
methylbenzimidazoles to form [FeIV(O)(Me3NTB)(L)]2+ (Me3NTB = tris((N-
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methylbenzimidazol-2-yl)methyl)-amine, λmax = 770 nm).41 However in this case, 
the substitution was made all at once, rather than step by step. So on average, in 
TPA, N4Py and BnTPEN frameworks, the λmax value of the oxoiron(IV) complexes 
red-shifts by 10-15 nm per N-methylbenzimidazole introduced versus about 40 nm 
per alpha-substituent (quinoline/6-methylpyridine) introduced, indicating that the 
latter weaken the ligand field more than N-methylbenzimidazole. Interestingly, the 
red-shift of the λmax values is only dependent on the type or the number of 
modifications, but not the orientations of these heterocycles. This is exemplified by 
the results of these modifications on oxoiron(IV) complexes supported by TPA, 
N4Py and BnTPEN frameworks, in which BnTPEN contains differently oriented 
heterocycles but its modification results in red-shifts similar to those seen from 
modifying heterocycles parallel to the ferryl unit. Therefore, the orientation of the 
heterocycle does not appear to have a significant effect on the red-shift in the 
electronic absorption bands. 
Structural Aspects of Modified Oxoiron(IV) Complexes 
Examination of structural effects from increasing the number of substitutions in 
complex 0 is hampered by the thermal instability of the disubstituted and 
trisubstituted ferryl complexes, which has precluded their crystallographic 
characterization. This outcome is likely due to the many benzylic protons on the 
BnTPEN ligand and its substituted analogs that are prone to hydrogen atom 
abstraction by the reactive ferryl units they support. This is further exemplified by 
over 20-fold increase in lifetimes of these complexes when these protons are 
deuterated. So experimental attempts to study structural changes in oxoiron(IV) 
complexes with more than one substituents (via their solid-state structures) have 
not been successful. However, the parent complex 0 and one of its three 
monosubstituted variants (1-B) have been crystallographically characterized, and 
they enable examination of the type of substitutions made on 0 to some extent. 
Among the mono-substituted complexes, the solid-state structures of 0 and 1-B 
differ only slightly in the average length of all Fe-N bonds, which are 2.013 Å and 
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2.019 Å, respectively. For comparison, the DFT-optimized structure of 1-Q in the 
S = 1 spin state has been obtained (see Section 3.2.4), and interesting information 
can be gleaned from it. For example, the average Fe-N bond length is longer 
(2.065 Å, see Table 3.3), and unlike the perpendicular heterocycle in the solid-
state structures of 0 and 1-B, the quinoline in the DFT-optimized structure of 1-Q 
is not found to be in the plane defined by the mean equatorial donor nitrogen atoms 
(Figure 3.14 and Figure 3.10), likely because its H8 atom is closer to the nearest 





Figure 3.14 Steric interactions of proximal hydrogen atoms in different ferryl 
complexes. Top: top-view of 50% ORTEPS of 1-B, 1-Q (DFT structure) and 0 
shown from left to right, with a mean plane drawn on the pyridine with which 
distance of the proximal H atom is measured. Middle: front-view of N4Py based 
complexes, with distance of the proximal atoms with the oxygen atom. Bottom: 
side-view of N4Py-based complexes, showing tilts induced by the ligands on the 
ferryl unit. 
The normalized H8 proton of the quinoline heterocycle in the S = 1 DFT-optimized 
structure of 1-Q is found to be 2.15 Å away from the plane of the closest pyridine 
parallel to the ferryl unit (Figure 3.14, top center), which increases the Fe-Nquinoline 
bond length to 2.18 Å, an almost 0.2 Å increase in length compared with that seen 
in 0 from the perpendicular pyridine. In the crystal structure of [FeIV(O)(N2Py2Q)]2+, 
the quinoline H8 protons are found to be about 2.16 Å (when C−H bond lengths 
are normalized, this distance is 2.05 Å) away from the oxygen atom, which results 
in a tilted ferryl unit (as detailed in Chapter 2). In the DFT-optimized structure of 1-
Q, the H8 atom of quinoline is 3.9 Å away from the oxygen atom because of its 
perpendicular orientation, and therefore there are no steric interactions between 
this proton and the ferryl unit, unlike what was found in the structure of 
[FeIV(O)(N2Py2Q)]2+. Similarly in 0, the H6 atom of the perpendicular pyridine is 
3.6 Å away from the oxygen atom, and in 1-B the H7 atom of the perpendicular N-
methylbenzimidazole is 4.1 Å away, so there are steric interactions that would 
affect the oxoiron(IV) unit. In fact, the mean plane defined by the equatorial ligands 
and the ferryl unit in 1-B and 0 are almost orthogonal to each other. 
The BnTPEN framework is not as rigid as N4Py, and therefore it is possible that 
the flexibility provided by the ethylene diamine linkers in this framework may allow 
the heterocycles more leeway to reduce the steric interactions that 6-
methylpyridines or quinolines would have with the oxygen in the ferryl unit. Indeed, 
in the DFT-optimized structures of S = 1 complexes 2-6Me and 2-Q the quinolines 
and the 6-methylpyridines are found to be torsionally rotated around the N-Fe axis 
and this rotation likely compensates for the steric interactions with the ferryl unit. 
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Similar torsional rotations are seen in the tri-substituted complexes, which are even 
less stable than 2-Q and 2-6Me. 
In general, the structural features (observed from the bond metrics of the 
crystallographic and in silico DFT-optimized structures of modified FeIV(O) 
complexes in both N4Py and BnTPEN frameworks) indicate a weakening of the 
ligand field. These features show an increased average Fe−N bond length that 
correlates with the red-shifts observed in their λmax values (Table 3.1 and Table 
3.3). 
 Effects of Alpha-Substituents on Ferryl Vibrations 
The effects of the number of substitutions and the type of substitutions on the Fe=O 
stretch could not be probed for all the oxoiron(IV) complexes in the BnTPEN series. 
This is because of the intense fluorescence observed in frozen solution state in all 
the complexes. However, as both 0 and 1-B can be isolated as solids, vibrational 
data could be obtained from FTIR spectroscopy. Interestingly, the ν(Fe=O) 
vibrations shown in Figure 3.8 for 0 and 1-B are comparable to each other at 
around 833-835 cm-1. In this case the pyridine replaced in 0 is perpendicular to the 
ferryl unit. Even when the pyridines and the N-methylbenzimidazoles (replacing 
the pyridines) are parallel to the ferryl unit, as seen in the case of [FeIV(O)(N4Py)]2+ 
and [FeIV(O)(N2Py2B)]2+, the ν(Fe=O) vibrations at 842-843 cm-1 do not change 
significantly (Table 3.2), indicating that the introduction of an N-
methylbenzimidazole to replace pyridines in any orientation does not affect the 
bond strength of the ferryl unit.  
When the quinoline substituent replaces pyridines in [FeIV(O)(N4Py)]2+, the steric 
hindrance of quinolines likely weakens the Fe=O bond, as observed from the 
longer Fe=O bond in the crystal structure of [FeIV(O)(N2Py2Q)]2+ and its smaller 
ν(Fe=O) stretch. In 1-Q the quinoline modification is not expected to have direct 
steric interactions with the ferryl unit, and so it would not be expected to influence 
ν(Fe=O) just like the case of 1-B, but in the absence of crystallographic and 
 
120 
vibrational data, a possible conclusion is difficult to draw for any alpha-substituted 
oxoiron(IV) complexes in the BnTPEN series. 
Effects of Substitutions on Reactivity of the Oxoiron(IV) Complexes 
The reactivity of the resulting new oxoiron(IV) complexes generally increases with 
the number of pyridines in 0 that are modified or replaced. This trend is in line with 
the overall increased electrophilicity of the iron(IV) center, as substantiated by the 
increased Fe−N bond lengths and the red-shifted near-IR chromophores. In fact 
some of the more reactive intermediates require use of a stopped-flow instrument 
to reliably measure the OAT rates to thioanisole at 233 K. These complexes also 
exhibit HAT rates that are the highest reported to date at 298 K (Table 3.5). 
In addition to the number of substitutions, reactivity is also modulated by the type 
of heterocycle introduced on the ligand frameworks (in the same way they affect 
absorption features of these complexes), and its orientation relative to the Fe=O 
unit. 
 The introduction of one or two alpha-substituents in 0 increases its HAT reactivity 
by roughly an order of magnitude per alpha-substituent introduced, and is 
independent of the type and the orientation of the modified heterocycles, because 
the alpha-substituents’ proximal hydrogen atoms enforce steric hindrance on 
different parts of the BnTPEN ligand framework to result in longer Fe-N bonds, 
whether the modified heterocycles are aligned parallel or perpendicular to the 
FeIV=O unit. Unfortunately, introduction of three alpha-substituents makes the 
resulting complexes 3-Q and 3-6Me extremely unstable with half-lives of a few 
seconds only at room temperature, so that we are unable to measure the rate 
constants under these conditions with the instruments at our disposal. We can 
measure these rates for deuterated 3-6Me at 233 K and, after extrapolation of the 
second-order rate constant for cyclohexane oxidation by 0 to 233 K using the 
Eyring plot, we find that there is a 5 orders of magnitude difference in these rates! 
So, both the quinoline and the α-methyl substitutions on pyridines (independent of 
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their orientation) are found to affect the OAT and HAT reactivity comparably in the 
BnTPEN series. 
 However, when one N-methylbenzimidazole is introduced on 0, it does not affect 
the OAT and HAT reactivity as much. As an example, 1-B is just an order of 
magnitude faster in OAT to thioanisole than 0, but 1-Q and 1-6Me are up to 3 
orders of magnitude faster than 0 in OAT to thioanisole. 1-B and 0 are similar in 
their HAT reactivity, and an order of magnitude less reactive than 1-6Me and 1-Q. 
So the type of substitutions can play an important role in determining the reactivity 
of the molecules. These differences in observed reactivity are also complicated by 
the orientation of heterocycles, as explained below. 
Although an N-methylbenzimidazole aligned parallel to the ferryl unit has not been 
introduced in 0, it has been introduced in this orientation by Mitra et al. in 
[FeIV(O)(N4Py)]2+.18 The orientation of N-methylbenzimidazoles when introduced 
in 0 and [FeIV(O)(N4Py)]2+ has different effects on the HAT reactivity of resulting 
complexes when compared with their corresponding parent complexes. After 
examination of the reactivity in the BnTPEN and N4Py frameworks, we can 
conclude that N-methylbenzimidazole aligned perpendicular to the ferryl unit does 
not impact HAT reactivity significantly, but when it is aligned parallel to the ferryl 
unit, it increases OAT and HAT reactivity of the resulting oxoiron(IV) complexes. 
The orientation of the N-methylbenzimidazole therefore needs to be explored 
further. Possible aspects to consider could include the differences in donicity of the 
heterocycles, as well as access to the ferryl unit in the complexes. 
A perusal of the crystal structures of both 0 and 1-B in the BnTPEN framework 
reported herein reveals that pyridine H6 and N-methylbenzimidazole H7 protons 
of perpendicular heterocycles in these complexes are about 2.42-2.45 Å away from 
the mean plane defined by the pyridine parallel to the ferryl unit (Figure 3.14), 
which is where the steric interactions would be expected to occur. In 
[FeIV(O)(N4Py)]2+ and [FeIV(O)(N2Py2B)]2+ however, the steric interactions of the 
heterocycles could occur directly between corresponding pyridyl H6 and N-
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methylbenzimidazolyl H7 protons, and they do have slightly different proximities to 
the ferryl unit. However, this difference is not enough to warrant the huge changes 
seen in reactivity based on orientation, and a more rigorous analysis is needed to 
probe the structural and electronic effects of N-methylbenzimidazoles in the 
reactivity of the complexes. 
The half-lives of the complexes examined in this series changes at ambient 
conditions from hours to minutes to seconds for some of the most reactive 
complexes. This has not been demonstrated before for reactive compounds. The 
stability of some of the complexes can be improved upon deuteration of the 
benzylic protons. This increase in stability is not unprecedented, as it enabled 
enabled our group to report the first crystal structure of an S = 2 ferryl complex.42 
Moreover deuteration of benzylic positions on a ligand that supports one of the 
best water oxidation catalysts has been recently demonstrated to result in an 
improvement of its turnover frequency.43 Some C-H bond activation catalysts 
based on similar frameworks also show an increased robustness in catalysis.44 
The approaches we have used to deuterate the benzylic positions of complexes in 
this chapter are different from the reported methods and are arguably cheaper and 
easier, as detailed in the experimental section. Nevertheless, the increased half-
lives of oxoiron(IV) complexes upon deuteration of their ligands’ benzylic positions 
have allowed the measurement of their rate constants with different substrates at 
ambient conditions. 
Deuteration of the α-methyl protons and other benzylic protons in the complexes 
1-6Me and 2-6Me, and following the self-decay rate for each of the complexes 
shows a 10-fold higher kinetic isotopic effect in 2-6Me compared with 1-6Me. This 
can be explained by closer proximity of the ferryl unit to the α-methyl groups in 2-
6Me compared with 1-6Me. The self-decay of 2-6Me likely proceeds via an 
intramolecular HAT mechanism, whereas the 2-fold increase in stability 
represented by a 2.2 KIE of self-decay in 1-6Me can be attributed to contributions 
from some intermolecular attack of the ferryl unit. In 3-6Me, the self-decay of the 
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normal 3-6Me is so fast that it only fleetingly exists at room temperature, and the 
room temperature half-life of 3-6Me with deuterated benzylic protons is about 10 
seconds. This demonstrates that increasing the number of benzylic positions in 2-
6Me by introduction of another alpha-methyl group on the remaining pyridine 
makes the resulting complex 3-6Me quite unstable, so that it is quite difficult to 
obtain it in high yields at higher temperatures and hence examine reactivity. 
 3.3.1 Correlation of Structure and Reactivity 
The oxoiron(IV) complexes supported by pentadentate ligands described in this 
chapter cover a wide ground in terms of OAT and HAT reactivity. The structural 
data for some of the oxoiron(IV) complexes supported by pentadentate ligands 
enable their correlations with the reactivity trends observed for these complexes. 
We first reported a structural correlation of oxoiron(IV) complexes with reactivity in 
Chapter 2, using average length of Fe-N bonds and the logarithms of rate 
constants with cyclohexane (to represent HAT) and thioanisole (for OAT). 
However, this correlation was limited to three complexes, and applied to 
systematic changes only in the N4Py framework. The wide range of reactivity 
available with BnTPEN framework is ideally suited to expand this correlation of 
structure with reactivity. Figure 3.15 expands this correlation to generalize it to 
more oxoiron(IV) complexes with different types of ligand fields, and a vast range 
of oxidative reactivity. This correlation now includes complexes in the BnTPEN, 
TMC, TPA and N4Py frameworks, variants of which together comprise more than 
half of the 90 or so synthetic oxoiron(IV) complexes reported so far. Such a 
correlation is needed because there is a general dearth of structural data available 
for oxoiron(IV) complexes, and the inclusion of experimental points from different 
frameworks further grounds this correlation. 
This correlation is defined by complexes for which experimental average Fe-L 
bond length is available, either from their solid-state structures or XAS 
spectroscopy. As seen from the correlation of HAT reactivity, most of the points 
fall close to the line. The unstable compounds without solid-state structural 
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information have been included by using their DFT-optimized structures in the 
appropriate spin states (as determined by Mössbauer spectroscopy) and shown 
has hollow dots or squares. All the rate constants used in this correlation were 
obtained at 233 K, either by directly measuring the rates at those temperatures, or 
by using Eyring analyses. We did not use the available rate constant of complex 
3-6Me’s reaction with cyclohexane, because its spin state could not be determined, 
and DFT-optimized structures of these complexes in different spin states have very 
different bond lengths. 
The complex [FeIV(O)(Me3NTB)(L)]2+ is an important exception in the HAT 
correlation, in that it has an average Fe-N bond length of 2.06 Å (as confirmed via 
EXAFS analysis recently by Banerjee et al.45), but is one of the most reactive 
oxoiron(IV) complexes reported to date.41, 46-47 Its rate of reaction with cyclohexane 
is about the same as that of the S = 2 complex [FeIV(O)(TQA)(L)]2+. However, when 
we plot this rate against the average of its Fe-N bond lengths, it is found to be 3 
log units higher (or 3 orders of magnitude faster) in its rates of reaction with 
cyclohexane than predicted by its bond metrics. Interestingly, the other 
benzimidazole-containing pentadentate ligands that support oxoiron(IV) 
complexes are closer to the line and react as expected with cyclohexane. Recently, 
an oxomanganese(IV) complex supported by a benzimidazole rich complex has 
also been shown to defy the expected trends in reactivity.48 It is possible that 
additional effects are at play with these complexes. Thus, benzimidazole-rich 
complexes need to be further explored for their HAT reactivity, and possibly 
thermodynamic factors at play in addition to the structural correlations should also 
be examined to establish a fuller picture of the reactivity landscape painted for 
these oxoiron(IV) complexes in different ligand fields. 
The rate of OAT to thioanisole by the complex [FeIV(O)(Me3NTB)(L)]2+ is the fastest 
reported so far (k2 = 21000 M-1 s-1).41 The original report did not provide the plot of 
rates versus concentrations to support this amazing value.  In our efforts to 
reproduce this work, we obtained a much lower second-order rate constant of k2 = 
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940 M-1 s-1 for this complex, which is 20-fold slower than reported. We also 
determined an OAT rate to thioanisole of 1940 M-1s-1 for [FeIV(O)(TQA)(L)]2+ and 
found that it was lower than expected by this correlation. 
 
Figure 3.15 Correlation of reactivity (obtained from second-order rate constants at 
233 K with cyclohexane and thioanisole) with average Fe−L bond lengths of 
different complexes. From left to right, ligands supporting FeIV(O) complexes are 
N4Py, N2Py2B, BnTPEN, B-BnDPEN, Q-BnDPEN, N2Py2Q, DQBnPEN, Me3NTB 
(represented by a ×), TMC-O, and TQA. Hollow shapes represent DFT-obtained 
structural data, whereas solid ones represent experimental data. All rate constants 
determined using stopped-flow instrument were obtained by our collaborator at 
Tufts University, Marc C. Piquette. 
Except for the complexes [FeIV(O)(TQA)(L)] and [FeIV(O)(Me3NTB)(L)], the 
experimental HAT rates correlate well with the DFT-predicted average Fe-N bond 
lengths found for most of the complexes.  
3.3.2 Correlation of Spectroscopy and Reactivity 
Interestingly, the series of complexes supported by BnTPEN and N4Py 
frameworks also provide a remarkable correlation of reactivity with spectroscopic 





























represented by λmax for S = 1 oxoiron(IV) complexes (Figure 3.16). As these bands 
correspond to the d-d transitions of the Fe=O unit, a longer wavelength and a lower 
energy indicate a weakened ligand field that gives rise to a more electrophilic and 
therefore more reactive oxoiron(IV) complex. So a larger red-shift can represent a 
more reactive ferryl complex in this series of ferryl complexes supported by 
pentadentate ligands. Another measure of overall spectroscopic change is the 
Mossbauer isomer shift, which also becomes more positive with increased 
reactivity of these complexes, as seen in Figure 3.16.  
 All the rates were obtained at 233 K in the correlation and form a particularly 
remarkable fit of HAT reactivity with isomer shifts for complexes supported by 
different ligand frameworks! The point with the highest isomer shift belongs to 
[FeIV(O)(TQA)]2+ which is a functional and spectroscopic model of enzymatic 
intermediate TauD-J and posseses an S = 2 spin state. Such a correlation with 
reactivity has not been shown before for Mössbauer parameters and allows us to 
use Mössbauer spectroscopy to possibly predict reactivity and vice versa. 
 
Figure 3.16 Correlation of oxoiron(IV) complexes’ λmax (plotted only for S = 1 
complexes) and isomer shifts with their reactivity, supported by ligand frameworks 
from left to right: N4Py, N2Py2B, BnTPEN, B-BnDPEN, N2Py2Q, Q-BnDPEN, 
DQBnPEN, TMCO, TQA. Crosses belong to [FeIV(O)(Me3NTB)(L)]2+, blue shapes 




In conclusion, this series of oxoiron(IV) complexes supported by pentadentate 
ligands represent a systematic modification on donors on the polydentate ligand 
frameworks of N4Py and BnTPEN, encompassing reaction rates that span at least 
7 orders of magnitude (with OAT). The vast range of reactivity reflects a difference 
in the average Fe-L bond length of just over 0.2 Å (where to find?). We 
demonstrate this remarkable correlation for the first time for a family of ferryl 
complexes. Within this spectrum of average Fe-N bond lengths, we also observe 
a change in spin states from S = 1 to S = 2, as we approach the reported reactivity 
of enzymatic nonheme FeIV=O intermediates, which all have been shown to have 
S = 2.spin states. 
In going from 0 to 1-6Me to 2-6Me, we obtain the highest rates of reaction with 
cyclohexane and other HAT substrates that are reported at room temperature for 
any ferryl complex (1:30:740). This trend also applies to the HAT rates for 
cyclohexane in going from 0 to 1-Q to 2-Q, with a 1:50:750 ratio of increasing rates. 
 Furthermore, correlation of reactivity with isomer shifts is unprecedented, and 
remains valid across N4Py and BnTPEN frameworks, which are relatively different 
from each other. Our crystallographic data in this report also provides the first 
examples of completely ferryl complexes with no symmetry whatsoever, and 
probes their reactivity with established complexes, to lay out foundations of a 
landscape on which different ferryl modifications are made. It also allows us to 
probe for the first time the effects of orientation of benzimidazole on reactivity and 
spectroscopy. We also highlight the different types of heterocycles and how they 






3.5 Experimental Section 
Instrumentation:  
1H NMR spectra were recorded on a Bruker 400 or 500 MHz spectrometer at 298 
K, unless otherwise stated. Elemental analyses were carried out by Atlantic 
Microlab (Norcross, GA). UV-vis spectra were recorded on a HP8453A diode array 
spectrometer equipped with a cryostat from Unisoku Scientific Instruments 
(Osaka, Japan), which permits monitoring of the temperature of the experiments 
from −90 to 100 °C. All UV-vis spectra were measured in 1 cm quartz cell. 
Electrospray ionization mass spectrometry (ESI-MS) experiments were performed 
on a Bruker BioTOF II mass spectrometer using a spray chamber voltage of 4000 
V and a carrier gas temperature of 200 °C. Mössbauer spectra were recorded with 
two spectrometers, using Janis Research (Wilmington, MA) SuperVaritemp 
dewars that allow studies in applied magnetic fields of up to 7.5 T in the 
temperature range from 1.5 to 200 K. A LakeShore Model 331A temperature 
controller was used to control the temperature in experiments. Mössbauer spectral 
simulations were performed using the WMOSS software package (SEE Co, Edina. 
Minnesota). Isomer shifts are quoted relative to α-Fe metal at 298 K. The spectra 
were plotted by SpinCount developed by Prof. Michael Hendrich at Carnegie 
Mellon University.  
Materials:  
All solvents and chemicals were purchased from Sigma-Aldrich or TCI Chemicals, 
and used without further purification unless otherwise stated. All liquid HAT 
substrates were passed through a plug of silica or alumina before use. 
Triphenylmethane was crystallized from ethanol, and its stock solution was made 
in deuterated dichloromethane. Thioanisole was either used neat, or its stock 
solutions prepared in acetonitrile. All iron(II) complexes were synthesized under 
the inert atmosphere of nitrogen or argon. FeII(OTf)2•2CH3CN was prepared 
according to the published procedure.49 All oxygen and moisture sensitive 





3.5.1 Syntheses and Characterization 
3.5.1.1 Synthesis of ligands 
The parent ligand and triply substituted ligands: 
The ligand BnTPEN was synthesized as reported.50 Its trisubstituted variants 
6Me3BnTPEN and BnTQEN, were synthesized using a method adapted for the 
parent BnTPEN ligand, and required nucleophilic substitution of N-
benzylethylenediamine with either 2-(chloromethyl)-6-methylpyridyl or 2-
(chloromethyl)quinolyl hydrochloride salts in the presence of excess base, to 
obtain the title ligands for 3-6Me and 3-Q respectively. Alternatively, reductive 
amination of N-benzylethylenediamine with the corresponding aldehydes also 
yields the same ligands but in lower yields. 
The monosubstituted ligands: 
The 1-precursor (Scheme 3.1, N-benzyl-N’,N’-bis(pyridin-2-ylmethyl)ethane-1,2-
diamine) was synthesized as reported before.16, 51-52 Its synthesis involves use of 
reductive amination to attach two picolyl groups to N-acetylethylenediamine, 
followed by removal of acetyl group from the other amine (deprotection using acid 
hydrolysis). The benzyl group is then attached to the deprotected amine to yield 
the precursor for mono-substituted ligands. The brown oil 1-precursor is stored at 
–40 °C. 
Nucleophilic substitution of 1-precursor can be carried out separately, with 2-
(chloromethyl)-6-methylpyridyl, 2-(chloromethyl)quinolyl and 2-(chloromethyl)-N-
methylbenzimidazolyl hydrochloride salts, in order to obtain the mono-substituted 
ligands for 1-6Me (6MeBnTPEN), 1-Q (QBnDPEN) and 1-B (BBnDPEN) 
respectively. Reductive amination of 1-precursor can also be employed with 6-




Scheme 3.1 The synthetic route for the precursor to the monosubstituted ligands. 
The disubstituted ligands: 
The disubstituted ligands for 2-6Me and 2-Q, titled 6Me2BnTPEN and DQBnPEN 
respectively, were synthesized from their precursor, N-benzyl-N-(pyridin-2-
ylmethyl)ethane-1,2-diamine (2-precursor). This precursor was obtained from 
successive reductive aminations of the amino groups of N-acetylethylenediamine 
with benzaldehyde and picolinaldehyde, followed by deprotection of the other 
amine using acid hydrolysis to remove the acetyl group (Scheme 3.2). 
6Me2BnTPEN and DQBnPEN for 2-6Me and 2-Q respectively were obtained from 
this precursor’s nucleophilic substitution with either 2-(chloromethyl)-6-





Scheme 3.2 The synthetic route for the precursor to the disubstituted ligands. 
 
The deuteration of benzylic positions in ligands: 
6MeBnTPEN-d11, 6Me2BnTPEN-d14 and 6Me3BnTPEN-d17 are variations of the 
ligands with perdeuterated benzylic positions, including methyl groups as well as 
all the benzylic methylene groups, and were synthesized from an adapted 
method. Only the benzylic positions of the ligands supporting 1-6Me, 2-6Me, and 
3-6Me could be perdeuterated using an adapted procedure.53 
The detailed ligand syntheses along with their characterizations, are laid out below. 
1H NMR of ligands are shown in the end of this chapter. 
Syntheses of Monosubstituted Ligands 
 
Scheme 3.3 Synthesis of QBnDPEN 
N’-benzyl-N’’,N’’-bis(pyridin-2-ylmethyl)-N’-(quinolin-2-ylmethyl)ethane-1,2-
diamine (QBnDPEN). 1-precursor (0.76 g, 2.3 mmol) and 2-
quinolinecarboxaldehyde (276 mg, 2.27 mmol) were dissolved in 15 mL of 1,2-
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dichloroethane, in that order, followed by excess of sodium triacetoxyborohydride 
(675 mg, 3.2 mmol). The reaction mixture was stirred under argon for 3 hours, and 
then quenched with 10 mL of 2 M NaOH, followed by extraction with 
dichloromethane (3 × 40 mL). After drying with MgSO4 and filtering off the solution, 
the solvent was removed using rotary evaporation, and then the resulting oil was 
recrystallized twice using hexanes to give an off-white solid. An alternative method 
to make this compound involved dissolving the 1-precursor (0.842 g, 2.53 mmol) 
in 50 mL of acetonitrile, followed by (2-chloromethyl)quinoline hydrochloride salt 
(2.53 mmol, 0.542 g) and finally a 30 mL sodium hydroxide solution of water (7.6 
mmol). The solution mixture was left under an argon purge and stirred for two days, 
and the solid ligand crashed out, which was washed with water and dried, to give 
the solid in 70% yield. The orange ligand was further recrystallized twice with 
hexanes to give 0.55 g of final ligand as a solid (46% yield).  1H NMR (CD2Cl2, 400 
MHz): δ 8.42 (d, J = 8 Hz, 2H, py-H () ), 8.04 (d, J = 8 Hz, 1H, 4-Q-H), 7.97 (d, J 
= 8 Hz, 1H, 9-Q-H), 7.79 (d, J = 8 Hz, 1H, 6-Q-H), 7.68 (td, J = 4 Hz, 8 Hz 1H, 8-
Q-H), 7.61 (d, J = 8 Hz, 1H, 3-Q-H), 7.51 (td, J = 8 Hz, 4 Hz, 3H, 2 4-py-H (), 1 7-
Q-H), 7.38 (d, J = 8 Hz, 2H, 3-py-H () ), 7.32-7.19 (m, 5H, Ph-H), 7.08 (td, J = 8 
Hz, 4 Hz, 2H, 5-py-H () ), 3.83 (s, 2H, QCH2), 3.72 (s, 2H, pyCH2), 3.61 (s, 2H, 
QCH2), 2.72 (m, J = 8 Hz, 4H, en CH2CH2). 13C NMR (CD2Cl2) δ 161.0, 159.9, 
148.8, 139.5, 136.05, 135.93, 129.1, 128.89, 128.85, 128.1, 127.5, 127.4, 126.8, 
125.9, 122.6, 121.7, 121.0, 61.2, 60.7, 59.1, 52.2, 52.0. 
 
Scheme 3.4 Synthesis of 6MeBnTPEN 
N’-benzyl-N’-((6-methylpyridin-2-yl)methyl)-N’’,N’’-bis(pyridin-2-
ylmethyl)ethane-1,2-diamine) (6MeBnTPEN). The 1-precursor (0.76 g, 2.28 
mmol) and 6-methylpyridine-2-carboxaldehyde (276 mg, 2.28 mmol) were 
dissolved in 15 mL of 1,2-dichloroethane, in that order, followed by excess of 
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sodium triacetoxyborohydride (675 mg, 3.2 mmol). The reaction mixture was 
stirred under argon for 3 hours, and then quenched with 10 mL of 2 M NaOH, 
followed by extraction with dichloromethane, and washing with a saturated NaCl 
solution. After drying the combined organic layers with MgSO4 and filtering off the 
solution, the solvent was removed using rotary evaporation, and recrystallized from 
hexanes to give the title compound in 79% yield. 1H NMR (CDCl3, 400 MHz): δ 
8.48 (d, J = 8 Hz, 2H, py-H () ), 7.56 (td, J = 8 Hz, 4 Hz, 2H, 2 4-py-H () ), 7.44 
(td, J = 8 Hz, 4 Hz, 3H, py-H () ), 7.36 (d, J = 8 Hz, 1H, py-H), 7.31-7.19 (m, J = 8 
Hz, 5H, Ph-H), 7.10 (d, J = 8 Hz, 2H, py-H), 6.95 (d, J = 8 Hz, 1H, py-H), 3.76 (s, 
4H, pyCH2), 3.68 (s, 2H, PhCH2), 3.57 (s, 2H, 6Me-py-CH2), 2.71 (m, J = 8 Hz, 4H, 
en CH2CH2), 2.49 (s, 3H, 6Me-H). 13C NMR (CD2Cl2) δ 160.6, 160.1, 157.9, 149.4, 
140.2, 136.9, 136.6, 129.3, 128.6, 127.3, 123.2, 122.3, 121.5, 119.9, 61.3, 61.1, 
59.5, 52.7, 52.5, 24.7. 
 
Scheme 3.5 Synthesis of BBnDPEN 
N-benzyl-N-((1-methyl-1H-benzoimidazol-2-yl)methyl)-N’,N’-bis(pyridin-2-
ylmethyl-)ethane-1,2-diamine. The 1-precursor (0.508 g, 1.55 mmol) and 2-
(chloromethyl)-1-methyl-1H-benzo[d]imidazole (280 mg, 1.55 mmol) were 
dissolved in 30 mL of acetonitrile to give a brown solution, in that order, followed 
by 30 mL of 1.25 M sodium hydroxide solution. The solution was stirred for 24 h at 
50 °C. The next day, the reaction mixture was extracted with ethyl acetate (3 × 30 
mL), and combined organic fraction was dried with magnesium sulfate and 
concentrated under vacuum. The left over solid was subject to high vacuum for 24 
h and recrystallized from hexane to give an off-white solid. 1H NMR ((CD3)2CO, 
400 MHz): δ 8.34 (d, 2H, -Py-H), 7.50 (t, 2H, -Py-H), 7.48 (d, 1H, BnIm-H), 7.29 
(d, 1H, BnIm-H), 7.26 (t, 2H, -Py-H), 7.26-7.04 (m, 9H, Ph-H and ’-Py-H), 3.78 
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(s, 2H, BnIm-CH2), 3.63 (s, 7H, NCH2Py and Me-BnIm), 3.54 (s, 2H, Bn-CH2), 2.66 
(m, 4H, N-CH2CH2). 
Syntheses of Disubstituted Ligands 
The steps to synthesize 2-precursor are laid out below, as per Scheme 3.2. Once 
formed, it was separately reacted with 2 equivalents of 2-(chloromethyl)-6-
methylpyridyl or 2-(chloromethyl)quinolyl hydrochloride salts in the presence of 
excess base to yield the title ligands 6Me2BnTPEN and DQBnPEN respectively. 
Reductive amination on 2-precursor could also be employed with 2 equivalents 
of 6-methyl-2-picolinaldehyde or 2-quinolinecarboxaldehyde to yield the title 
ligands for complexes 2-6Me and 2-Q. 
N-(2-(benzylamino)ethyl)acetamide. N-acetylethylenediamine (2 g, 19.6 mmol) 
was dissolved in 40 mL of dichloromethane, and 2.02 g of benzaldehyde (20.7 
mmol) was added to the solution, turning the solution cloudy. This was followed by 
excess of MgSO4. (≈ 4 g, 33 mmol). The solution became clear after five minutes 
but allowed to stir for another 2 hours under argon to allow for a complete formation 
of imine. The solution was decanted carefully and filtered out from the magnesium 
sulfate, and subject to rotary evaporation, leaving behind a clear colorless oil. This 
oil (imine) was dissolved in 30 mL methanol and brought under argon and an ice 
bath, followed by slow addition of NaBH4 (1 g, 26.4 mmol). Vigourous bubbling 
was observed, which died which died within ten minutes of addition, and after three 
hours of addition, 10 mL of water was added to quench the reaction. The organic 
layer was extracted with dichoromethane, dried with MgSO4 and solvent was 
removed in vacuo to give a clear slightly-gray oil (3.52 g, 93% yield), which was 
used without further purification for the next step. 1H NMR (CD3CN, 400 MHz): δ 
7.35-7.24 (m, 5H, Ph-H), 6.52 (br, 1H, NH-amide), 3.76 (s, 2H, Ph-CH2), 3.24 (q, 
J = 8 Hz, 2H, BnNHCH2), 2.65 (t, J = 8 Hz, 2H, CH3CONHCH2), 2.25 (br, 1H, NH-
Bn), 1.86 (s, 3H, NHCOCH3). 
N-(2-(benzyl(pyridin-2-ylmethyl)amino)ethyl)acetamide. The product (3.52 g, 
18.3 mmol) from previous reaction was dissolved in 30 mL of 1,2-dichloroethane, 
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followed by addition of 2-pyridinecarboxaldehyde (1.96 g, 18.3) to form a yellow 
solution. The reductant sodium triacetoxyborohydride (5 g, 23.6 mmol) was then 
added to the mixture to give a cloudy solution which was stirred under argon for 3 
hours. The solution was quenched with 5 M NaOH solution, followed by extraction 
into dichloromethane (3 × 40 mL). The combined organic layers were dried with 
magnesium sulfate and the filtered solution was subject to rotary evaporation to 
yield a light brown oil (96%, 5 g). 1H NMR (CDCl3, 400 MHz): δ 8.52 (d, J = 8 Hz, 
1H, -py-H), 7.61 (td, 1H,  -py-H), 7.35-7.19 (m, 6H, Ph-H, 1 -py-H), 7.15 (td, J 
= 8 Hz, 4 Hz, 1H, -py-H), 6.79 (br, 1H, NH-amide), 3.74 (s, 2H, py-CH2), 3.64 (s, 
1H, CH2Bn), 3.25 (q, J = 8 Hz, 4 Hz, 2H, PhCH2NCH2), 2.60 (t, J = 8 Hz, 2H, 
CH3CONHCH2), 1.90 (s, 3H, NHCOCH3). 
N-benzyl-N-(pyridin-2-ylmethyl)ethane-1,2-diamine (2-precursor). The 
product from the previous reaction (5 g, 17.5 mmol) was dissolved in 110 mL of 5 
M HCl, and refluxed for 24 hours, and then allowed to cool under ice bath. 2 M 
NaOH was slowly added to quench the reaction mixture in an ice bath. The basic 
solution was then extracted with dichloromethane (3 × 40 mL), and dried with 
MgSO4. The solvent was removed using rotary evaporation, and the leftover highly 
viscous light brown oil was evacuated under high vacuum to yield a light brown oil 
(2.77 g, 69%). 1H NMR (CDCl3, 400 MHz): δ 8.51 (d, J = 8 Hz, 1H, -py-H), 7.65 
(dt, J = 8 Hz, 4Hz 1H,  -py-H), 7.50 (d, J = 8 Hz, 1H, -py-H), 7.35-7.19 (m, 5H, 
Ph-H), 7.15 (dt, J = 8 Hz, 4 Hz, 1H, -py-H), 6.79 (br, 1H, NH-amide), 3.75 (s, 2H, 
py-CH2), 3.65 (s, 1H, CH2Bn), 2.75 (q, J = 8 Hz, 4 Hz, 2H, PhCH2NCH2), 2.59 (t, J 
= 8 Hz, 2H, CH3CONHCH2), 1.53 (br, 3H, NH2). 
 




ylmethyl)ethane-1,2-diamine. (6Me2BnTPEN). 0.736 g (3 mmol) of 2-precursor 
was dissolved in 20 mL of 1,2-dichloroethane to give a yellow solution, to which 
the 6-methyl-2-pyridinecarboxaldehyde (6 mmol, 0.750 g) was added. The solution 
was brought under argon, and sodium triacetoxyborohydride (2 g, 9.3 mmol) was 
then slowly added to the mixture to form a cloudy solution, which was left stirring 
for 15 hours. The next day the reaction was quenched slowly with sodium 
hydroxide dissolved in 40 mL (1.2 g, 30 mmol) in an ice bath. The reaction mixture 
was then extracted into dichloromethane (3 × 50 mL) from the aqueous layer, and 
the mixture was dried with magnesium sulfate, which was filtered out to yield a light 
yellow solution. This was concentrated using rotary evaporation, and then high 
vacuum to give an yellowish white solid, which was recrystallized using hexanes 
to give an off-white solid. 1H NMR (CDCl3, 400 MHz): δ 8.47 (d, J = 8 Hz, 1H, -
py-H), 7.55 (dt, J = 8 Hz, 4 Hz, 1H, -py-H), 7.47 (dt, J = 8 Hz, 4 Hz, 1H, -py-H), 
7.45 (td, J = 8 Hz, 4 Hz, 2H, -py-H), 7.31-7.23 (m, J = 8 Hz, 5H, Ph-H), 7.19 (dt, 
J = 8 Hz, 4 Hz, 1H, py-H), 7.09 (dt, J = 8 Hz, 4 Hz, 1H, py-H), 6.95 (d, J = 8 Hz, 
2H, py-H), 3.73 (s, 4H, pyCH2), 3.70 (s, 2H, PhCH2), 3.58 (s, 2H, 6Me-py-CH2), 
2.71 (m, J = 8 Hz, 4H, en CH2CH2), 2.49 (s, 6H, 6Me-H). 13C NMR (101 MHz, 
CD2Cl2) δ 159.9, 158, 149.3, 136.88, 136.62, 129.3, 128.6, 127.3, 123.1, 122.2, 
121.6, 120.0, 61.41, 61.04, 59.4, 52.7, 52.5, 24.7. An alternative synthesis route 
involves dissolving the amine in 20 mL of MeCN, followed by addition of 6-methyl-
2-(chloromethyl)-pyridyl hydrochloride (2 eq). To this mixture, 6 equivalents of 
sodium hydroxide solution in 20 mL water is added, to give a 1:1 MeCN:H2O 
mixture. This light grayish mixture is stirred under a nitrogen purge for 24 h, after 
which all the acetonitrile has evaporated, and light brown oily droplets are 
observed floating in the solution. To this mixture 5 mL of acetonitrile can be added 
and further stirring for 3 hours, and then 10 mL of water is added. The mixture is 
stirred for another 5 hours and at this point the ligand crashes out as an off-white 
solid in the solution. It can be filtered, washed with water, and dried under vacuum 




Scheme 3.7 Synthesis of DQBnPEN 
N-benzyl-N-(pyridin-2-ylmethyl)-N’,N’-bis(quinolin-2-ylmethyl)ethane-1,2-
diamine (DQBnPEN). 0.5 g (2.07 mmol) of 2-precursor was dissolved in 30 mL 
of acetonitrile to which the 0.886 g (4.14 mmol) of (2-chloromethyl)-quinoline 
hydrochloride. Sodium hydroxide solution (25 mmol) was added to 30 mL water 
and the solution was then slowly added to the solution. The solution mixture was 
heated to 50 ºC for 24 hours in air, and then extracted with dichloromethane (3 × 
40 mL). The combined organic extracts were combined and dried with magnesium 
sulfate. Magnesium sulfate was filtered out and the filtrate was subject to rotary 
evaporation. The orange yellow solid that formed was recrystallized twice with 
hexanes to give 0.355 g of final ligand as a solid (35% yield). 1H NMR (CDCl3, 400 
MHz): δ 8.41 (d, J = 8 Hz, 1H, -py-H ), 8.04 (d, J = 8 Hz, 2H, 4-Q-H), 8.01 (d, J = 
8 Hz, 2H, 9-Q-H), 7.78 (d, J = 8 Hz, 2H, 6-Q-H), 7.68 (td, J = 4 Hz, 8 Hz 2H, 8-Q-
H), 7.61 (d, J = 8 Hz, 2H, 3-Q-H), 7.50 (td, J = 8 Hz, 4 Hz, 2H, 7-Q-H), 7.41 (d, J = 
8 Hz, 1H, 4-py-H () ), 7.36 (d, J = 8 Hz, 1H, 4-py-H () ), 7.25-7.19 (m, 5H, Ph-H), 
7.01 (td, J = 8 Hz, 4 Hz, 2H, 5-py-H () ), 3.95 (s, 4H, QCH2), 3.69 (s, 2H, pyCH2), 
3.56 (s, 2H, QCH2), 2.76 (m, J = 8 Hz, 4H, en CH2CH2). 13C NMR (CD2Cl2) δ 160.6, 
160.1, 148.64, 147.56, 139.4, 136.06, 136.04, 129.2, 128.94, 128.75, 128.04, 
127.5, 127.4, 126.8, 126.0, 122.6, 121.7, 121.1, 61.6, 60.4, 58.9, 52.5, 51.9. 
Syntheses of Trisubstituted Ligands 
Syntheses of triply-substituted ligands for 3-6Me and 3-Q involved a single step 
reaction, using N-benzylethylenediamine and hydrochloride salts of 6-methyl-2-
picolylchloride (for 6Me3BnTPEN), or (2-chloromethyl)-quinoline (for BnTQEN) in 




Scheme 3.8 Synthesis of 6Me3BNTPEN 
N-benzyl-N,N’,N’-tris((6-methylpyridin-2-yl)methyl)ethane-1,2-diamine 
(6Me3BnTPEN). 6-methyl-2-pyridinecarboxaldehyde (2 g, 16.5 mmol) was 
dissolved in 10 mL of 1,2-dichloroethane, followed by N-benzylethylenediamine 
(0.827 mL, 5.55 mmol) in 40 mL of DCE, followed by sodium triacetoxyborohydride 
(4 g, 18.8 mmol). The solution was stirred under argon for 3 hours. The reaction 
was quenched with 50 mL, 3 M NaOH solution, and then extracted with 
dichloromethane (3 × 50 mL). It was then dried with magnesium sulfate, and the 
decanted solution was subject to rotary evaporation to give a pale yellow oil, which 
solidified in air into an off-white solid. This solid was recrystallized using hexanes 
to yield 0.92 g of ligand in 67% yield.  1H NMR (CD2Cl2, 400 MHz): δ 7.50 (dt, J = 
8 Hz, 4 Hz 3H, 4-py-H), 7.50 (dt, J = 8 Hz, 4 Hz 3H, 4-py-H), 6.97 (d, J = 8 Hz, 3H, 
5-py-H), 7.30 (overlapping d, J = 8 Hz, 3H, 3-py-H), 3.67 (s, 4H, pyCH2), 3.63 (s, 
2H, pyCH2), 3.57 (s, 2H, PhCH2), 2.68 (m, 4H, en CH2CH2), 2.45 (s, 9H, 6-Me-
CH3). 13C NMR (CDCl3) δ 159.7, 159.3, 157.5, 157.3, 139.4, 136.58, 136.56, 
128.7, 128.1, 126.8, 121.3, 121.2, 119.4, 119.4, 60.9, 60.7, 59.0, 52.2, 51.9, 24.4.  
 
 




chloromethyl)-quinoline hydrochloride (3.66 g, 17.1 mmol) was dissolved in 10 mL 
of water to give a brownish red solution. 50 mL of 3 M NaOH (60 mmol) in water 
was then added, followed by 10 mL of dichloromethane, to give a biphasic milky 
white and brown mixture. N-benzylethylenediamine (0.85 g, 5.65 mmol) in 5 mL of 
dichloromethane was then added to the solution to give an orange cloudy mixture. 
An additional 50 mL of 3 M NaOH was added to the solution over the course of 4 
hours (which turned the solution lighter in color). The solution was allowed to stir 
under argon for 2 days, after which a white solid precipitated out of the solution, 
which was filtered off, and washed with acetone to give a pure white solid. 1H NMR 
(CDCl3, 400 MHz): δ 8.01 (d, J = 8 Hz, 2H, 4-Q-H ), 7.98 (d, J = 8 Hz, 1H, 4-Q-H), 
7.95 (d, J = 8 Hz, 2H, 9-Q-H), 7.84 (d, J = 8 Hz, 1H, 9-Q-H), 7.73 (d, J = 8 Hz 2H, 
6-Q-H), 7.69 (d, J = 8 Hz 1H, 6-Q-H), 7.66 (dt, J = 8 Hz, 4 Hz 3H, 8-Q-H), 7.55 (d, 
J = 8 Hz, 2H, 3-Q-H), 7.49 (d, J = 8 Hz, 4 Hz, 3H, 7-Q-H), 4.00 (s, 4H, QCH2), 3.86 
(s, 2H, QCH2), 3.6 (s, 2H, QCH2), 2.82 (m, J = 8 Hz, 4H, en CH2CH2). 13C NMR 
(CDCl3) δ 161.3, 160.9, 147.95, 147.86, 139.5, 136.63, 136.56, 129.77, 129.70, 
129.46, 129.31, 128.6, 127.93, 127.75, 127.37, 126.5, 126.4, 121.43, 121.34, 
62.2, 61.8, 59.7, 53.0, 52.7. 
Deuteration of ligands 6MeBnTPEN, 6Me2BnTPEN, and 6Me3BnTPEN 
An adapted procedure53 was used to deuterate the benzylic positions of the 
ligands. There are 11, 14 and 17 benzylic protons in 6MeBnTPEN, 6Me2BnTPEN, 
6Me3BnTPEN respectively, that were deuterated with over 80% deuterium 
incorporation. 5-10 mL of deuterated DMSO-d6 was stirred under argon and 
heated to 80 °C for five minutes. Once oxygen was removed, the title ligand (0.5-
0.6 mmol) was added and dissolved completely in this solvent. While still under 
argon, 0.05 mmol of potassium tert-butoxide was introduced into the solution. The 
solution turned dark pink in a minute, and was stirred for 1-2 h at 80 °C. The mixture 
was then cooled, and 10 mL of D2O was added to yield a yellow murky solution, 
which was extracted with ethyl acetate (20 mL × 3). The combined organic layers 
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were then dried with magnesium sulfate and concentrated under high vacuum to 
give off-white crude ligand. This crude solid was recrystallized from hot hexanes 
to give the title ligands, which were characterized using 1H NMR spectroscopy. 
3.5.1.2 Syntheses of Iron(II) Complexes 
Iron(II) complexes in this report are named with a prime letter (’) after the name of 
the ferryl complex to distinguish them. The general procedure for the syntheses of 
iron(II) precursor complexes is as follows: equimolar amounts of 
Fe(OTf)2(CH3CN)2 and ligands are stirred in dichloromethane for over 12 h under 
nitrogen and subsequently concentrated in vacuo. The resulting residue is stirred 
in diethyl ether for 1-2 hr and filtered to obtain a powder. Recrystallization of the 
powder from slow diffusion of diethyl ether into its dichloromethane or acetonitrile 
solutions gives the title compounds as crystalline materials, which are filtered and 
washed with diethyl ether, and dried under high vacuum. The specific syntheses 
of the precursor iron(II) complexes 1-Q’, 1-6Me’, 1-B’, 2-Q’, 2-6Me’, 3-Q’, and 3-
6Me’ are shown below. 
[FeII(6MeBnTPEN)(OTf)]OTf (1-6Me’): 
This complex involved addition of 6MeBnTPEN (400 mg, 0.912 mmol) in 
dichloromethane (1 mL) to a stirred suspension of Fe(OTf)2(CH3CN)2 (398 mg, 
0.912 mmol) in dichloromethane (1 mL) under an inert atmosphere, to give a brown 
solution. The mixture was stirred overnight, and the solvent was then removed in 
vacuo. Stirring the resultant yellow precipitate in ether (8 mL) yielded a dark yellow 
powder, which was recrystallized from slow diffusion of diethyl ether in 
dichloromethane to give the title compound as light brown crystals in 89% yield. 
Anal. calculated for C30H31F6FeN5O6S2•H2O, [Fe(6Me-BnTPEN)OTf]OTf•H2O: C, 
44.51; H, 4.11; N, 8.65; F, 14.08. Found: C, 44.48; H, 3.83; N, 8.59; F, 14.20. A 
similar procedure was employed for the synthesis of the deuterated 1-6Me’, and 




[FeII(6Me2BnTPEN)(OTf)]OTf (2-6Me’):  
6Me2BnTPEN (375 mg, 0.83 mmol) in dichloromethane (1 mL) was transferred to 
a stirred suspension of FeII(OTf)2•2CH3CN (367 mg, 0.83 mmol) in 
dichloromethane (1 mL) under an inert atmosphere, to give a yellow solution. The 
mixture was stirred overnight, and the solvent was then removed in vacuo. Stirring 
the resultant light-yellow precipitate in ether (8 mL) yielded a dark yellow powder, 
which was recrystallized from slow diffusion of diethyl ether in dichloromethane to 
give the title compound as light yellowish green crystals in 68% yield. Anal. 
calculated for C31H33F6FeN5O6S2•H2O, [Fe(6Me2-BnTPEN)OTf]OTf•H2O: C, 
45.21; H, 4.28; N, 8.50; F, 13.84. Found: C, 45.25; H, 4.11; N, 8.52; F, 14.03. A 
similar procedure was employed for the synthesis of the deuterated 2-6Me’, and 
the corresponding salt [57FeII(6Me2BnTPEN)OTf)](OTf) was synthesized using 
57Fe(OTf)2(CH3CN)2. 
[FeII(6Me3BnTPEN)(OTf)]OTf (3-6Me’): 
This synthesis of the complex involved addition of 6Me3BnTPEN (247.5 mg, 0.532 
mmol) in dichloromethane (1 mL) to a stirred suspension of Fe(OTf)2(CH3CN)2 
(232 mg, 0.532 mmol) in dichloromethane (1 mL) under an inert atmosphere, to 
give a yellow solution. The mixture was stirred overnight, and the solvent was then 
removed in vacuo. Stirring the resultant light-yellow precipitate in ether (8 mL) 
yielded a yellowish white powder, which was recrystallized from slow diffusion of 
diethyl ether in dichloromethane to give the title compound as white crystals in 68% 
yield. Anal. calculated for C32H35F6FeN5O6S2•H2O, [Fe(6Me3-
BnTPEN)OTf]OTf•H2O: C, 45.89; H, 4.45; N, 8.36; F, 13.61. Found: C, 46.31; H, 
4.40; N, 8.41; F, 13.62. A similar procedure was employed for the synthesis of the 
deuterated 3-6Me’, and the corresponding salt [57FeII(6Me3BnTPEN-




Under nitrogen atmosphere, the iron(II) salt Fe(OTf)2(CH3CN)2 (92 mg, 0.211 
mmol) was dissolved in 1 mL of dichloromethane and BBnDPEN (100 mg, 0.211 
mmol) in 1 mL of dichloromethane was transferred slowly to the solution to give a 
brownish-red solution. The solution was removed using high vacuum, and the 
resulting solid was stirred in diethyl ether for fifteen minutes to give a muddy yellow 
slurry that was filtered to give a yellow solid; this slurry was recrystallized by slow 
diffusion of diethyl ether into a solution in dichloromethane to give greenish yellow 
crystals in 79% yield. Anal. calculated for C32H32F6FeN6O6S2•2H2O, [Fe(B-
BnDPEN)OTf]OTf•2H2O: C, 44.35; H, 4.19; N, 9.70. Found: C, 44.28; H, 3.84; N, 
9.46.  
[FeII(QBnDPEN)(OTf)]OTf (1-Q’): 
A 1 mL dichloromethane solution of iron(II) salt Fe(OTf)2(CH3CN)2 (505 mg, 1.16 
mmol) in O2-free atmosphere and QBnDPEN (549 mg, 1.16 mmol) solution in the 
same solvent were stirred together to give a red solution. The solvent was then 
evacuated, and the resulting solid was stirred in diethyl ether for fifteen minutes to 
give a muddy orange slurry, which was filtered to give a dull yellow solid. This solid 
was recrystallized twice by slowly diffusing diethyl ether into its dichloromethane 
solution to give orange-yellow crystals in 79% yield. Anal. calculated for 
C33H31F6FeN5O6S2•0.5H2O, [Fe(QBnDPEN)OTf]OTf•0.5H2O: C, 47.38; H, 3.86; N, 
8.37. Found: C, 47.26; H, 3.79; N, 8.26. The corresponding salt 
[57FeII(QBnDPEN)OTf)](OTf) was synthesized using 57Fe(OTf)2(CH3CN)2. 
[FeII(DQBnPEN)OTf]OTf (2-Q’): 
To a suspension of iron(II) salt (295 mg, 0.68 mmol) in dichloromethane under the 
atmosphere of nitrogen, a yellow solution of the ligand DQBnPEN (355 mg, 0.68) 
in dichloromethane was added dropwise. This resulted in a dark green colored 
solution which was stirred overnight. The solvent was then removed, after which 
the addition of diethyl ether was carried out to leave behind a yellowish green solid. 
This was solid was recrystallized from dichloromethane using slow diffusion of 
ether into the solution to give orange crystals. Anal. calculated for 
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C37H33F6FeN5O6S2•1.5H2O, [Fe(DQBnPEN)OTf]OTf •1.5H2O: C, 48.16; H, 4.15; 
N, 7.59. Found: C, 48.06; H, 3.79; N, 7.52. The corresponding salt 
[57FeII(DQBnPEN)OTf)](OTf) was synthesized using 57Fe(OTf)2(CH3CN)2. 
[FeIII(BnTQEN)(OTf)]OTf (3-Q’): 
Fe(OTf)2(CH3CN)2 (228 mg, 0.523 mmol) can be suspended tetrahydrofuran or 
dissolved in dichloromethane (1 mL), followed by slow addition of the insoluble 
white slurry of ligand BnTQEN (300 mg, 0.523 mmol) in the same solvent, to give 
a yellow colored suspension. It is stirred at room temperature overnight, to give a 
yellow precipitate in an orange solution. Diethyl ether is then added to precipitate 
out more solid from the solution which can be then filtered and washed with more 
diethyl ether, to give a bright yellow powder in 77% yield (371 mg). Anal. calc. for 
C41H35F6FeN5O6S2•1.5H2O, [Fe(BnTQEN)OTf]OTf•1.5H2O: C, 51.58; H, 4.01; N, 
7.34. Found: C, 51.87; H, 3.89; N, 7.33. The corresponding salt 
[57FeII(BnTQEN)OTf)](OTf) was synthesized using 57Fe(OTf)2(CH3CN)2. 
3.5.1.3 Synthesis and Generation of Oxoiron(IV) Complexes 
The iron(IV) complexes crystallographically characterized in this report were 
generated from their respective iron(II) precursors in a 1:3 mixture of acetonitrile 
and water, using 4 equivalents of ceric ammonium nitrate as oxidants. Once 
generated, excess sodium perchlorate salt provided the counterions to precipitate 
out the complex, which was then further used to obtain crystals for X-ray 
diffraction.54 The remaining complexes were generated at given temperatures in 
situ from the corresponding iron(II) solutions in acetonitrile (1 mM, unless 
otherwise stated), using 2 equivalents of 1-(tert-butylsulfonyl)-2-iodosylbenzene 
dissolved in minimal amount of 2,2,2-trifluoroethanol. 
[FeIV(O)(BnTPEN)](ClO4)2 (0): 
NaClO4 (314 mg, 2.57 mmol) and ceric ammonium nitrate (CAN) (133 mg, 0.243 
mmol) were dissolved in 3 mL water to give a yellow solution. This solution was 
then transferred to a solution of [FeII(BnTPEN)(OTf)]OTf (50 mg, 0.064 mmoles) 
 
144 
in 1 mL acetonitrile to yield a dark green solution which was kept at 2-8 °C 
overnight to yield dark green crystals in a yellowish green mother liquor. This solid 
was filtered, and washed with 2 mL water, and the resulting solid was dried 
overnight under high vacuum to yield a greenish black crystalline material (30 mg, 
67% yield). The solid is stable for months as a crystalline material at room 
temperature. This crystalline material was also suitable for X-ray diffraction 
analysis. Anal. calcd. for C27H29Cl2FeN5O9, [FeIV(O)(BnTPEN)](ClO4)2: C, 46.71; 
H, 4.21; N, 10.09. Found: C, 46.52; H, 4.27; N, 10.06. 
[FeIV(O)(B-BnDPEN)](ClO4)2 (1-B): 
NaClO4 (314 mg, 2.57 mmol) and ceric ammonium nitrate (CAN) (133 mg, 0.243 
mmol) were dissolved in 3 mL water to give a yellow solution. This mixture was 
then transferred to a solution of [FeII(B-BnDPEN)(OTf)]OTf (50 mg, 0.060 mmoles) 
in 1 mL acetonitrile to yield a brown solution, which precipitated to give a burgundy 
solid. This mixture was kept for 2 h at 2-8 °C to allow further precipitation. The 
solution was then filtered, and washed with 2 mL water, and the resulting burgundy 
solid was dried overnight in high vacuum to yield a burgundy powder (30 mg, 62% 
yield). Crystals suitable for X-ray crystallography were grown by dissolving 10 mg 
of the solid in 0.2 mL acetonitrile and adding a water solution of NaClO4 (50 mg in 
1.8 mL). Slow evaporation of acetonitrile at 2-5 °C over the course of 8 h formed 
crystals suitable for X-ray diffraction. Anal. calcd. for C30H32N6O9FeCl2•0.5H2O, 
[FeIV(O)(B-BnDPEN)](ClO4)2•0.5H2O: C, 47.64; H, 4.40; N, 11.11. Found: C, 
47.54; H, 4.41; N, 11.48. About 30 mg of unlabeled solid was used for Mössbauer 
analysis. 
 
3.5.2 Crystallographic Details for 0 and 1-B 





A crystal (approximate dimensions: 0.150 x 0.120 x 0.100 mm) was placed onto 
the tip of a 0.5 mm MiTeGen loop and mounted on a Bruker photon-II CPAD 
diffractometer for a data collection at 123(2) K.55 A preliminary set of cell constants 
was calculated from reflections harvested from three sets of 12 frames.  These 
initial sets of frames were oriented such that orthogonal wedges of reciprocal 
space were surveyed.  This produced initial orientation matrices determined from 
258 reflections.  The data collection was carried out using MoKα radiation (graphite 
monochromator) with a frame time of 30 seconds and a detector distance of 6.0 
cm.  A randomly oriented region of reciprocal space was surveyed to the extent of 
one sphere and to a resolution of 0.70 Å.  Six major sections of frames were 
collected with 1º steps in ω at four different φ settings and a detector position of -
28º in 2θ.  The intensity data were corrected for absorption and decay.56 Final cell 
constants were calculated from the xyz centroids of 9988 strong reflections from 
the actual data collection after integration.57 Please refer to Table 3.6 for additional 
crystal and refinement information.  
The structure was solved using SHELXS-97 (Sheldrick 2008)58-59 and refined using 
SHELXL-2018/3 (Sheldrick, 2018).60 The space group P-1 was determined based 
on systematic absences and intensity statistics.  A direct-methods solution was 
calculated which provided most non-hydrogen atoms from the E-map.  Full-matrix 
least squares / difference Fourier cycles were performed which located the 
remaining non-hydrogen atoms.  All non-hydrogen atoms were refined with 
anisotropic displacement parameters.  All hydrogen atoms were placed in ideal 
positions and refined as riding atoms with relative isotropic displacement 
parameters. Two atoms of a perchlorate ion were disordered and modeled as 
individual atoms. A possible water atom is H-bonded to the non-disordered 
perchlorate counterion.  This is common with perchlorate salts.  In addition to 
better ellipsoids, modeling the disordered perchlorate helps make the water 
molecule visible on the difference map.  Because it is on an inversion center, only 
one corner out of four corners in the unit cell has a water molecule.  It is on/near 
an inversion center and it accounts for only about 0.125 (0.25 × 0.5) 
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occupancy.  The H-bonds to the perchlorate ion are reasonable and has been seen 
before with other ferryl complexes too, but it does not require extensive modeling. 
The final full matrix least squares refinement converged to R1 = 0.0452 and wR2 







Table 3.6 Crystal data and structure refinement for complex 0 and 1-B. 
Crystallographic details 0 1-B 
CCDC Identification code 15247 18111 
Empirical formula C27H29Cl2FeN5O9 C30H32Cl2FeN6O9 
Formula weight 694.30 747.36 
Temperature 123(2) K 123(2) K 
Wavelength 1.54178 Å 0.71073 Å 
Crystal system Triclinic Triclinic 
Space group P-1 P-1 
Unit cell dimensions 
a = 9.3710(2) Å 
α = 79.5650(10)° 
a = 9.489(7) Å 
a = 80.32(3)° 
b = 10.3626(2) Å 
β = 79.1540(10)° 
b = 10.496(10) Å 
b = 79.83(3)° 
c = 16.4140(3) Å 
γ = 65.5000(10)° 
c = 16.943(10) Å 
g = 68.23(3)° 
Volume 1415.00(5) Å3 1533(2) Å3 
Z 2 2 
Density (calculated) 1.630 Mg/m3 1.619 Mg/m3 
Absorption coefficient 6.576 mm-1 0.734 mm-1 
F(000) 716 772 
Crystal color, morphology Dark green, block Brown, needle 
Crystal size 0.20 x 0.10 x 0.10 mm3 
0.200 x 0.100 x 0.050 
mm3 
Theta range for data 
collection 
2.76 to 74.50° 2.313 to 26.324° 
Index ranges 
-11 ≤ h ≤ 10, -12 ≤ k ≤ 
12, -20 ≤ l ≤ 20 
-11 ≤ h ≤ 11, -13 ≤ k ≤ 
13, -21 ≤ l ≤ 21 
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Crystallographic details 0 1-B 
CCDC Identification code 15247 18111 
Empirical formula C27H29Cl2FeN5O9 C30H32Cl2FeN6O9 
Formula weight 694.30 747.36 
Temperature 123(2) K 123(2) K 
Wavelength 1.54178 Å 0.71073 Å 
Crystal system Triclinic Triclinic 
Space group P-1 P-1 
Reflections collected 35216 23884 
Independent reflections 5763 [R(int) = 0.0938] 6214 [R(int) = 0.0421] 
Observed reflections 4881 5374 









squares on F2 
Full-matrix least-
squares on F2 
Data / restraints / 
parameters 
5763 / 50 / 419 6214 / 0 / 434 
Goodness-of-fit on F2 1.034 1.057 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0452, wR2 = 
0.1045 
R1 = 0.0328, wR2 = 
0.0815 
R indices (all data) 
R1 = 0.0597, wR2 = 
0.1116 
R1 = 0.0405, wR2 = 
0.0856  
Largest diff. peak and hole 0.554 and -0.621 e.Å-3 0.423 and -0.466 e Å-3 
 
3.5.3 Oxidative Reactivity and Kinetics of Oxoiron(IV) Complexes 
To examine the rates of reaction with substrates, the near-IR chromophores for all 
the complexes were followed against time when an excess concentration of a 
given substrate was introduced at any given temperature into 1-mM acetonitrile 
solutions of the complexes. The decay profiles were then followed for different 
concentrations of that substrate and used to obtain second-order rate constants. 
Because these oxoiron(IV) complexes were quite reactive, substrates with C−H 
BDE > 80 kcal/mol were used to measure HAT reactivity. 
HAT reactivity of the complexes was examined at 298 K, except for 3-Q and 3-
6Me which are too thermally unstable at room temperature. Even at 233 K, the 
HAT second-order rate constants could only be obtained for deuterated 3-6Me, 
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which had a longer half-life than that of the parent complex. All OAT second-order 
rate constants are determined at 233 K. The plots for second-order rate constants 
for each of the complexes are shown below, and the second order rate constants 
are enlisted on Table 3.5 in the results section. 
Complex 0: 
 
Figure 3.17 Second-order rate constants for the reaction of thioanisole with 0, 
measured at different temperatures (left) and Eyring plot (right) for the reaction of 





y = 0.6132x + 0.0036
R² = 0.9769
273 K
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y = 2.2946x - 0.0067
R² = 0.9992
283 K













































































Figure 3.18 Second-order rate constants for reactions of HAT substrates at 298 
K, and for thioanisole (OAT) at 233 K with complex 1-B. Eyring plot of 1-B with 
cyclohexane is also shown on the bottom right. The k2 were obtained by reacting 
0.8 M cyclohexane with acetonitrile solution of 1-B at different temperatures. 
 
Complex 1-Q: 

























































































































































































y = 0.0017x + 5E-06
R² = 0.9978
273 K
y = 0.0049x + 0.0008
R² = 0.9434
283 K
y = 0.0095x + 0.0035
R² = 0.8839
293 K
























Figure 3.19 Second-order rate constants for for reactions of HAT substrates at 
298 K (except cyclohexane for which these rates were determined at more than 
one temperature), and for thioanisole (OAT) at 233 K with complex 1-Q. 
Complex 1-6Me: 










































































































































Figure 3.20 Second-order rate constants for reactions of HAT substrates at 298 K 
and for thioanisole (OAT) at 233 K with complex 1-6Me. 
Complex 2-Q: 























   
















































































































Figure 3.21 Second-order rate constants for reactions of HAT substrates at 298 K 
(except cyclohexane for which these rates were determined at more than one 
temperature), and for thioanisole (OAT) at 233 K with complex 2-Q. 
Complex 2-6Me-d: 
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R² = 0.9859
283 K
































































Figure 3.22 Second-order rate constants for reactions of HAT substrates at 298 K 
and for thioanisole (OAT) at 233 K with deuterated complex 2-6Me-d. 
Complex 3-6Me-d: 
































































































Figure 3.23 Second-order rate constants for reactions of HAT substrates and 
thioanisole (OAT) at 233 K with deuterated complex 3-6Me-d. 


















































































































Figure 3.24 Eyring plots for the reactions of cyclohexane with different oxoiron(IV) 
complexes. Owing to the thermal instability or reactivity of different complexes, a 
temperature range of 263 K. to 318 K was used to get the rate constants.  
 
The Table 3.7 shows the Eyring parameters for each of the reactions and their 








y = -8580.2x + 15.116
R² = 0.9958
Complex 1-B
y = -8492.3x + 15.83
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Complex 1-Q
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R² = 0.9923
Complex 2-Q



















Table 3.7 Eyring parameters for the reaction of different oxoiron(IV) complexes 






Rate at 233 K 
(M−1 s−1) 
Cyclohexane  
FeIV(O)(N4Py)]2+ 68.1 −98.4 1.9 × 10−8 
FeIV(O)(N2Py2B)]2+ 68.1 −53.2 4.5 × 10−6 
FeIV(O)(N2Py2Q)]2+ 64.1 −61.3 1.3 × 10−5 
0, FeIV(O)(BnTPEN)]2+ 71.3 −71.9 1.6 × 10−7 
1-B, FeIV(O)(BBnDPEN)]2+ 71.3 −65.9 2.30 × 10−7 
1-Q, FeIV(O)(QBnDPEN)]2+ 52.9 −102.3 3.0 × 10−5 
2-Q, FeIV(O)(DQBnPEN)]2+ 67.1 −30.2 1.2 × 10−4 
FeIV(O)(Py5Me2)]2+ 56.5 −119 8.20 × 10−7 
Thioanisole  
FeIV(O)(N4Py)]2+ 70.7 −10.8 2.0 × 10−4 
0, FeIV(O)(BnTPEN)]2+ 73.5 +21.8 0.002 









Figure 3.25 1H NMR spectra of Q-BnDPEN (top) in acetone-d6, and 6MeBnTPEN 





Figure 3.26 1H NMR spectra of 6Me2BnTPEN (top) in acetone-d6, and DQBnPEN 







Figure 3.27  1H NMR spectra of 6Me3BnTPEN (top) in DCM-d2, and BnTQEN 







Figure 3.28  1H NMR spectra of iron(II) precursors with quinolines in CD2Cl2, 








Figure 3.29  1H NMR spectra of [FeII(6MeBnTPEN)OTf]OTf (top) and 





Figure 3.30  1H NMR spectra of [FeII(6Me2BnTPEN)OTf]OTf in in CD2Cl2. The top 




Figure 3.31  1H NMR spectra of [FeII(6Me3BnTPEN)OTf]OTf in CD2Cl2. The top 
spectrum has deuterated benzylic methylene and methyl protons. 
 
3.7.1 XAS Analyses of 1-6Me, 2-6Me, 1-Q and 2-Q: 
Because complexes 1-6Me-d and 1-Q, have short lifetimes with t½ < 1 h at 298 K 
for 1-mM MeCN solutions, growth of single crystals and structural analysis via XRD 
diffraction methods was not successful even at low temperatures. The doubly 
substituted complexes 2-Q and 2-6Me-d are even more unstable with 1-mM 
acetonitrile solutions of both complexes having half-lives of less than 5 minutes at 
room temperature! Therefore, structural information on these intermediates was 
obtained using X-ray absorption spectroscopy (XAS) experiments.  
Preparation of XAS samples 
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Samples of the mononuclear oxoiron(IV) intermediates 1-Q and 1-6Me-d were 
generated by the addition of the appropriate oxidant (excess ArIO in 100 μL of 
2,2,2-trifluoroethanol) to a pre-cooled 5-mM acetonitrile solution of the appropriate 
iron(II) precursor complex at 243 K. Formation of the intermediate was followed by 
UV-visible spectroscopy (which yielded absorbance for its chromophore of λmax = 
777 nm, with over 80(5) % yields), and 1.5 mL of this solution was transferred using 
pre-cooled 9” pipettes, into a pre-cooled tandem XAS cup, covered with Kaptan 
tape. This solution was then frozen and submerged in liquid nitrogen. The 4-5 mM 
samples for 2-Q and 2-6Me-d were prepared at 263-273 K, as higher yields were 
obtained at higher temperatures for these complexes. The ligands of 2-6Me and 
1-6Me were deuterated in their benzylic positions to increase their stability. 
The lower yields and thermal instability of 3-Q and 3-6Me did not make them 
amenable for XAS analyses unfortunately. 
XAS analyses for 1-Q and 1-6Me-d 
The X-ray absorption near edge structure (XANES) of complexes 1-Q and 1-6Me 
reveal an Fe K-energy of 7123.9 eV, similar to that reported for 0 at 7123.7 eV.61 
Both the complexes have a single pre-edge feature due to 1s→3d transitions at 
about 7114.2 eV, with a pre-edge energy for 1-Q and 1-6Me-d of 22.4 and 24.7 
units respectively (Figure 3.32), suggesting that these complexes’ environment 
deviates from centrosymmetry, likely due to the short FeIV=O bond, as well as the 
asymmetric ligand environment. These areas are smaller than the 29.3(4) units 
reported for the parent complex 0, but within range of a +4-oxidation state expected 
for ferryl complexes. 
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Figure 3.32 Fe K-edge X-ray absorption near-edge structures (XANES, 
fluorescence excitation) of iron(IV) complexes 1-6Me-d (top) and 1-Q (bottom) 
 
The Fourier transformed EXAFS spectrum of the oxoiron(IV) complex 1-Q in 
Figure 3.33 shows two prominent features at R + Δ ~ 1.5 and 2.9 Å. The first shell 
is best fit with 1 N/O scatterer at 1.66 Å (arising from the Fe=O unit) and N/O 
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scatterers at 1.97 and 2.10 Å arising from the ligating atoms of polydentate ligand 
containing two pyridines, a quinoline and amines. The outer shell is best fit with C 
scatterers at 2.85 and 3.04 Å, which are associated with carbon atoms on the 































R +  (Å)  
Figure 3.33 Fourier-transformed k-space EXAFS data of 1-Q at 10 K. Inset shows 
the k-space spectrum. 
 
 
3.7.2 Crystal structures of iron(II) complexes: 
 
Crystal structures of 4 of the 7 new complexes reported in this chapter were obtained 
(Figure 3.34), by slowly diffusing diethyl ether into concentrated acetonitrile or 
dichloromethane solutions of iron(II) precursors to the ferryl complexes. In all cases, one 
triflate was found to be bound on the sixth coordination site. The unique heterocycles in 
the mono-substituted crystallographically characterized iron(II) complexes are a quinoline 
or 6-methylpyridine, and are found to be lifted partially above the plane defined by the 
equatorial ligands, so that quinoline H8 protons, and 6-methyl group’s protons are about 
2.21 and 2.31 angstroms away respectively, from the mean plane defining the pyridine 
parallel to the 6th coordination site. Their orientation prevents any significant steric 
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interactions with the sixth coordination site where the oxo is bound upon oxidation of the 
iron(II) center. However, the N-Fe-OTf angle is at 162°. But this angle is even smaller 
angle in the iron(II) crystal structure of the parent complex, and the effects of the single 
substitution on the parent complex are not clearly borne out in the iron(II) solid state 
structures supported by monosubstituted ligands.  
 
Figure 3.34 Crystal structures of iron(II) complexes supported by alpha-
substituted BnTPEN framework. 50% probability ORTEPS were shown for the 
heterocycles that were modified, and the remaining part was shown as sticks for 
clarity, as was the removal of all H-atoms, solvent molecules and counterions. 
 
When substitutions are made on the heterocycles parallel to the 6th coordination site, the 
N-Fe-OTf angles range from 170 to 173°. It is possible that the flexibility of the BnTPEN 
ligand framework mitigates the steric effects of the alpha-substitutions introduced. 
 
 
Table 3.8 shows the bond lengths for the complexes. Interestingly, the typical Fe—N bond 
lengths are 2.2 Å. It isn’t possible to discern trends in the bond lengths with increasing 
number of substitutions, because all of Fe—N bond lengths are equivalent within the error. 
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However, with introduction of each alpha-methyl substitution, there is a slight increase in 
the average Fe—N bond lengths going from parent complex to the complex with two 
substitutions. This trend however, breaks at the third methyl substitution, possibly because 
the compensating effects from the bends of heterocycles (which can be represented by 
torsion angles of the pyridine rings’ plane with the Fe—O centers) also counter any steric 
effects imposed by the methyl groups.  
 
Given the trends with the alpha-methyl substituted iron(II) complexes, one could expect 
similar patterns with the quinolyl-substituted iron(II) complexes. With the crystal structure 
of the [Fe(QBnTPEN)OTf]OTf, one can observe that the Fe—N bond lengths are not 
significantly different from [Fe(6MeBnTPEN)OTf]OTf,and there aren’t many differences in 
the crystal structures. Owing to this observation, the iron(II) complexes for doubly and 
triply substituted quinolyl complexes were not examined through determination of their 
solid-state structures. The most important reason in lack of lengthened bond length can 
be attributed to the binding triflate counterion. If a solvent molecule such as acetonitrile 
replaced it, as has been reported the parent iron(II) complex,62 one can observe Fe—Npy 
bond lengths around 2.0 Å range, that are reflective of a low-spin iron(II) complexes. The 
binding of triflate however, enforces a high-spin state in the solid-state structures with all 

















Table 3.8 Bond metrics (in Å) and angles (in °) of [FeII(BnTPEN)(X)]+ structures.  
Bond 
Lengths 
0’ (X = 
MeCN) 
0’ 1-6Me’ 2-6Me’ 3-6Me’ 1-Q’ 
Fe–N⊥ 1.994(4) 2.236(3) 2.221(2) 2.253/2.242 2.271(2) 2.197(3) 
Fe–N
||
 1.975(4) 2.189(3) 2.185(2) 2.323/2.300 2.235(2) 2.178(3) 
Fe–N
||




 1.999(4) 2.215(3) 2.205(2) 




 2.077(4) 2.234(3) 2.267(1) 2.262/2.260 2.261(2) 2.275(3) 
Fe–X 1.925(4) 2.032(3) 2.081(1) 2.084/2.104 2.091(1) 2.086(2) 
average 
Fe–Npy 
1.980(4) 2.193(2) 2.236(1) 2.244 2.240(2) 2.212(2) 
average 
Fe–N 
2.003 2.206 2.221 2.254/2.244 2.236 2.220 
N-Fe-X, ° 179.3 158.4 162.0 172.1/170.6 171.2 161.9 
[Fe(BnTPEN)(X)]+, X = OTf unless otherwise indicated. 
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In many non-heme oxygenases, oxoiron(IV) intermediates in the quintet (S = 2) 
spin state have been trapped as key species that oxidize strong C−H bonds.1 A 
similarly reactive oxoiron(IV) species in the S = 2 spin state has been recently 
characterized in an iron-containing zeolite, and like soluble methane 
monooxygenase, it can also oxidize methane to methanol.2 However, an 
overwhelming majority of the 90 or so synthetic molecular analogs of these 
intermediates contrasts the enzymatic and zeolitic intermediates with their triplet 
(S = 1) ground spin state and lower reactivity.3 
Typically, characterization of oxoiron(IV) intermediates is done through the use of 
Mössbauer, XAS (X-ray Absorption Spectroscopy), X-ray crystallography, 
resonance Raman, IR, and UV-vis absorption spectroscopies. NMR-based studies 
that rely on differences in paramagnetic shifts to investigate spin states and spin-
crossover behavior in solution state of molecules have only been recently applied 
to some coordination complexes of nickel, iron and cobalt.4 However, despite their 
relative accessibility, 1H NMR studies have traditionally not been an important part 
of characterizations usually done for S = 1 oxoiron(IV) complexes, and not reported 
at all for any S = 2 oxoiron(IV) complexes. 
This is likely owed to some non-trivial challenges associated with this technique 
that need to be addressed with this goal: 1) some of these intermediates are highly 
unstable and require low temperature NMR spectroscopy and careful handling to 
obtain such data; 2) complications in the interpretation of the NMR data prevent 
accurate assignments, and if line broadening is high due to slow electronic 
relaxation, these peaks are not even observable; and 3) presence of additives such 
as oxidants and solvents leads to complex mixtures of already short-lived 
intermediates, increasing uncertainty in the assignments.5-7 Although Evan’s 
method can be successfully used to determine solution-state spin states of 
inorganic complexes at given temperatures (provided they’re pure, have 
insignificant decay, and their exact concentrations are known), it is quite unreliable 
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and rarely carried out for unstable oxoiron(IV) intermediates and should be treated 
with caution.  
Interestingly, over half of the oxoiron(IV) molecules reported so far incorporate 
heterocycles in their ligand structures. While many of these complexes have not 
been crystallographically characterized, their S = 1 iron(IV) centers possess 
electronic relaxation properties that give rise to relatively sharp and well-resolved, 
paramagnetically shifted peaks in their 1H NMR spectra.8-10 Earlier studies have 
used NMR spectroscopy to study patterns of resonances displayed by pyridyl 
protons in oxoiron(IV) complexes to glean important structural insight into their 
liquid solution-state structures.10-11  But its potential to provide additional 
information on spin states (typically determined through variable field and 
temperature Mössbauer spectroscopy) has not been realized. Therefore, it is 
critical to investigate the NMR properties of these complexes to provide the 
bioinorganic community a relatively more accessible tool in addition to Mössbauer 
spectroscopy that can help determine such information at higher temperatures. 
Recently Borgogno et al. have successfully benchmarked DFT methods to address 
this potential opportunity, and their calculated NMR spectra for S = 1 oxoiron(IV) 
complexes supported by TPA (TPA = tris tris(pyridyl-2-methyl)-amine), TMC (TMC 
= 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetra-decane) and its variants are in 
agreement with some experimentally observed data.12-17 Despite reports of a few 
S = 2 oxoiron(IV) species supported by various ligands,18-21 none have been 
characterized by 1H NMR spectroscopy. 
The most reactive pair of oxoiron(IV) complexes reported thus far incorporate 
quinolines or benzimidazoles in their structures, and have different spin states. 
[FeIV(O)(Me3NTB)(L)]2+ is one of these oxoiron(IV) complexes, where Me3NTB  
(tris(N-methylbenzimidazolyl-2-methyl)amine) is a tripodal ligand (with three 
pendant N-methylbenzimidazoles).22 The high reactivity of this complex has been 
a subject of recent intense curiosity, and it has also been proposed to have 
different geometry and spin states at 233 K and at 4 K.23-24 NMR spectroscopy 
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may be useful in probing this proposed spin-crossover behavior, which has been 
shown for many ferrous and ferric complexes.25 This example highlights a potential 
use of NMR spectroscopy as a convenient tool to not only assess liquid-solution 
state structure, but also assign spin states on these intermediates at different 
temperatures. However, thermal instability (few minutes at 233 K) of this complex 
has prevented any experimental information from being obtained. 
In contrast to the pyridine and N-methylbenzimidazole donors, the steric effects of 
quinoline donors have been crystallographically shown to increase the Fe−N bond 
lengths in a ferryl complex (see Chapter 2).26 In the S = 1 oxoiron(IV) complex 
supported by TPA (tris(2-pyridylmethyl)amine), namely [FeIV(O)(TPA)(L)]2+ (0), 
replacement of the three pendant pyridines with quinolines (or alpha-substituents) 
changes the spin state of the parent complex to S = 2, resulting in a very reactive 
complex, [FeIV(O)(TQA)(L)]2+ (3), where TQA = tris(2-quinolyl-methyl)amine.18 Our 
efforts to figure out the point at which this spin change occurs has led us to 
introduce alpha-substituents on pyridines and/or replace pyridines with quinolines 
systematically on the TPA framework, and study the resulting complexes with 1H 
NMR spectroscopy and also probe their structure. Our findings, described herein, 
also highlight the potential of 1H NMR spectroscopy as an alternative tool to 
Mössbauer spectroscopy, to determine the spin state for oxoiron(IV) complexes 
containing quinolines at higher temperature or in liquid solution state. We also use 
this technique to identify a spin-crossover behavior in one of the resulting 




Figure 4.1 Oxoiron(IV) complexes examined in this work that contain increasing 
number of quinolines or pyridine donors with alpha-substituents. 
The sequential introduction of alpha-methyl substituents on pyridines, or 
replacement of pyridines with quinolines in 0 results in newer mono-, di- and tri-
substituted complexes, [FeIV(O)(QBPA)(L)]2+ (1) (QBPA = (2-quinolylmethyl)bis(2-
pyridylmethyl)amine) and [FeIV(O)(6MeTPA)(L)]2+ (1a) (6MeTPA = (6-methyl-2-
pyridylmethyl)bis(2-pyridylmethyl)amine), [FeIV(O)(BQPA)(L)]2+ (2) (BQPA = (2-
pyridylmethyl)bis(2-quinolylmethyl)amine), and [FeIV(O)(TQA)(L)]2+ (3). These 
modifications can generally be classified as alpha-substituents on pyridines. All 
complexes except 2 have been reported before.18, 27-28 The notations of the 
complexes indicate the number of quinolines or alpha-substituents in each 
complex (Figure 4.1). In order to gain better insight into the complexes, an 
additional variant of 2 is also examined, where the ferryl complex is only different 
from 2 in that it has an alpha-methyl substituent introduced on the lone pyridine 
donor (as represented by complex 3a, [FeIV(O)(6MeBQPA)(L)]2+, where 
6MeBQPA = (6-methylpyridyl-2-methyl)bis(2-quinolylmethyl)amine). A variant of 3 
and 3a which replaces all the quinolines with 6-methylpyridines is also examined, 




The complexes studied in this report were examined via 1H NMR spectroscopy at 
233 K to examine effects of their spin states on chemical shifts, and via Mössbauer 
spectroscopy at cryogenic temperatures to shed light on their spin state in frozen 
solution states. Our results, described below, lead us to identify 2 as the first 
oxoiron(IV) complex with spin-crossover behavior via NMR spectroscopy, and its 
variants 3a and 3b are characterized as S = 2 oxoiron(IV) complexes, similar to 
the triply substituted complex [FeIV(O)(TQA)(L)]2+ (3). 3a and 3b also represent the 
first characterized S = 2 complexes containing pyridines with alpha-methyl 
substituents. 
4.2 Results 
4.2.1 Generation of oxoiron(IV) complexes and their thermal stability 
All complexes in this series can be generated from their ferrous precursors in 
acetonitrile at appropriate temperatures. Complexes 0, 1 and 1a are generated 
upon addition of 1-1.2 equivalents of either peracetic acid in acetonitrile,27-28 or 2-
(tBuSO2)-C6H4IO (ArIO) in 2,2,2-trifluoroethanol or dichloromethane-d2.  The 
remaining complexes can only be generated upon addition of 2 equivalents of ArIO 
in 2,2,2-trifluoroethanol or CD2Cl2. 
Complexes 0, 1 and 1a are relatively stable at 233 K, with half-lives of at least a 
few hours depending on which oxidant is used to generate the complex.  Complex 
0 has a half-life of over 24 h at 233 K, but 1 and 1a are stable for a few hours at 
233 K (Table 4.1). The remaining complexes 2, 3, 3a and 3b are not particularly 
stable at 233 K with half-lives of only a 2, 15, 5, and 4 minutes respectively, which 
makes studies of their properties quite challenging at 233 K. 
4.2.2 Mössbauer and Absorption Spectroscopy of Ferryl Complexes 
UV-Visible Absorption Spectroscopy 
Complexes 0, 1, 1a and 2 exhibit near-IR absorption bands typical of S = 1 FeIV(O) 
complexes, which can be assigned to d-d transitions (Figure 4.2). For each 
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pyridine replacement with quinoline or each introduction of an alpha-methyl 
substituent on pyridine in this series of tetradentate oxoiron(IV) complexes, the 
characteristic ferryl bands red-shift by about 50-65 nm when an alpha-substituent 
is introduced on the pyridine. Similar but smaller red-shifts are observed on 
BnTPEN (see Chapter 3) and the N4Py (Chapter 2) ligand frameworks at about 
30-40 nm per alpha-substituent.29 So the λmax values for the near-IR features in 
complex 1 are at 775 nm (λmax value for complex 1a is 770), and at 840 nm for 
complex 2. This series of complexes shows a larger progressive weakening of the 
ligand field strength as pyridine donors are replaced with quinolines (or alpha-
methyl substituents are introduced on pyridines) successively. The extinction 
coefficient of the bands at their respective λmax values in the cases of 0, 1 and 1a 
is 300 M−1 cm−1 but becomes smaller in 2 (about 200 M−1 cm−1). Lowered extinction 
coefficients are also seen in the oxoiron(IV) complexes supported by the BnTPEN 
framework, when a single alpha-substituion is introduced on its parent complex 
[FeIV(O)(BnTPEN)]2+. The near-IR bands of 0 and 1, and 1a are typical for bona 
fide S = 1 complexes. While 2 represents near-IR bands and Mössbauer 
parameters that indicate an S = 1 oxoiron(IV) complex, it has high absorption 
features below 550 nm, in contrast to 0, 1 and 1a, which only have such absorption 
features below 450 nm. 
The absorption features of the complexes 3, 3a and 3b are very different from 
those seen in 0, 1, and 1a. Complexes 3a and 3b have absorption features like 
those of 3 (λmax = 650 nm) (Figure 4.2), with λmax of their bands at 640 nm and 630 
nm respectively. The extinction coefficients of these complexes at their respective 










































Figure 4.2 UV-visible spectra of 1-mM acetonitrile solutions of oxoiron(IV) 
complexes 0 (light gray), 1 (gray) and  2 (black) on the left; and 3 (light gray), 3a 
(gray) and 3b () on the right at 233 K. 
Table 4.1 Properties of oxoiron(IV) complexes evaluated in this work. 
Complexes 0 1 1a 2 3 3a 3b 
λmax, nm 



















δ, mm/s 0.01 0.02 - 0.04 0.24 0.22 0.24 
ΔEQ, mm/s 0.92 0.75 - 0.87 −1.05 0.94  
*S at 4 K 1 1 1 1 2 2 2 
**S at 233 K 1 1 1 2 2 2 2 
t½, min 
















*based on Mössbauer spectroscopy. **based on NMR analysis.  
 
Mössbauer Spectroscopy: 
Complexes 1 and 2 exhibit Mössbauer spectra obtained at 4 K with parameters 
like those of 0, with isomer shifts at 0.01 to 0.04 mm/s, and quadrupole splitting in 
the range of 0.75 to 0.95 mm/s. Their behavior in applied magnetic fields also 
indicates an S = 1 spin-manifold, typical of most non-heme oxoiron(IV) complexes 
described in the past fifteen years. In contrast, complex 3, 3a and 3b have much 
larger isomer shifts at 0.22 to 0.24 mm/s compared to those of 0, 1 and 2. This 
increase in isomer shift reflects a change in spin state to S = 2, as confirmed by 
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variable field and variable temperature Mössbauer studies. Their electronic 
properties are like those of the enzymatic intermediates.  
 
Figure 4.3 Mössbauer spectra of 1, 2 and 3a.  
4.2.3 NMR spectroscopy of Oxoiron(IV) Complexes 
4.2.3.1 NMR Assignment of S = 1 complexes 0, 1 and 1a 
Complex 0: 
The S = 1 complexes discussed in this series are relatively stable and have 
favorable relaxation properties for their heterocyclic protons. Figure 4.4 shows that 
the sharp resonances in the 1H NMR spectrum of 0 at 233 K can be assigned by 
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comparison to [FeIV(O)(N4Py)]2+ (where N4Py = N,N-bis(2-pyridylmethyl)-N-bis(2-
pyridyl)methylamine). This is a bona fide S = 1 complex with an axial amine and 
four equatorial pyridines, each of which is aligned roughly parallel to the ferryl unit. 
The mirror symmetry in this complex (established from its solid-state structure) 
allows this complex to have two sets of paramagnetically shifted peaks, in which 
each set has a β, γ and β’ resonance between 50 to –30 ppm at 298 K (Figure 
4.4). 
 
Figure 4.4 Stacked 1H NMR spectra of 0 (top) at 233 K, [FeIV(O)(N4Py)]2+ (middle) 
at 298 K and [FeIV(O)(BnTPEN)]2+ (bottom) at 298 K, with pyridines and 
corresponding shifts highlighted in red. 
The NMR spectrum of complex 0 is resembles that of [FeIV(O)(N4Py)]2+. A C3-
symmetric trigonal bipyramidal [FeIV(O)(TPA)]2+ complex 0 should exhibit only one 
set of pyridine ring proton peaks, while a six-coordinate complex with Cs symmetry 
should give rise to two sets of peaks with a 2:1 intensity ratio, arising from the two 
pyridines trans to each other and from the pyridines trans to the bound solvent. 
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The 233 K 1H NMR spectrum of 0 reveals its Cs symmetric nature. The pyridines 
trans to each other have intensities of 2H each for the β-, γ-, and β’-H protons at 
53, 8 and −21 ppm. The remaining sharp resonances at 45, 10 and −25 ppm 
correspond to the β-, γ-, and β’-H of the pyridine trans to the solvent, each with 
unit intensity. The α and CH2 protons for all S = 1 complexes have broad linewidths 
and are not explicitly assigned, due to their proximity to the paramagnetic center. 
The assigned NMR spectrum of 0 also agrees with the DFT-calculated NMR 
spectrum reported for this isomer.17 
There is a possible 6-coordinate isomer of 0 which would have two of its pyridines 
perpendicular to the FeIV=O unit, and the remaining pyridine would be trans to the 
oxo atom instead of the amine. While 1H NMR spectrum of this isomer has been 
predicted using DFT and the predicted shifts do not align with the spectrum 
observed17, we can additionally rule it out by using experimental data from the 1H 
NMR spectrum of [FeIV(O)(BnTPEN)]2+ complex (where BnTPEN is a pentadentate 
ligand abbreviated from N-benzyl-N’,N’,N’-tris(2-pyridylmethyl)-1,2-
diaminoethane).10 This complex has an axial amine, and three equatorial 
pyridines, two of which are parallel and one perpendicular to the ferryl axis. The 
latter pyridine can help us in ruling out this isomer of 0. The resonances of this 
“perpendicular” pyridine in [FeIV(O)(BnTPEN)]2+ are distinct from those of the 
pyridines aligned parallel to the ferryl unit and exhibit smaller paramagnetic shifts 
(Figure 4.4). Its β and β’ peaks are shifted upfield (below 0 ppm) and the γ peak is 
shifted slightly downfield in the diamagnetic region, a pattern of shifts quite different 
from that of the pyridines parallel to the ferryl axis. The different shift patterns 
reflect a different interaction between the pyridine π and π* with the Fe d-orbitals 
that have differing amounts of unpaired spin density.  The NMR spectrum of 0 does 
not show such a pattern of resonances, thus ruling out this possible six-coordinate 





Our assignment of the resonances of complex 1 is significantly facilitated by the 
1H NMR spectrum of [FeIV(O)(N2Py2Q)]2+, a ferryl complex supported by the 
pentadentate ligand N2Py2Q (N2Py2Q = 1,1-di(pyridin-2-yl)-N,N-bis(quinolin-2-
ylmethyl)methanamine), which contains 2 quinolines and 2 pyridines parallel to the 
Fe=O unit that are held together by an amine trans to the oxo atom.29 The 1H NMR 
spectrum of the complex generated in situ from its iron(II) precursor has been 
previously reported but were not unequivocally assigned.6, 8 We have been able to 
confidently assign the peaks more accurately using the isolated sample, as it has 
a relatively clean diamagnetic region. This complex also has a mirror plane of 
symmetry that gives rise to a relatively simple 1H-NMR spectrum with eight sharp 
peaks corresponding to protons on the heterocyclic ligands. All eight peaks have 
unit intensity, so that each represents a heterocyclic proton. At 298 K, the peaks 
at 31.3, 8.0 and −17.7 ppm can be assigned respectively to pyridine β-, γ-, and β’-
protons by analogy to peaks in the spectrum of [FeIV(O)(N4Py)]2+, as shown in 
Figure 4.5. 
The remaining five peaks at 23.7, 20.8, 19.1, 14.6 and −19.1 ppm can thus be 
associated with quinoline C7-H, C5-H, C6-H, C4-H and C3-H protons respectively, 
by comparing their T1’s and linewidths, which reflect their varying distances from 
the metal center as derived from its crystal structure. The quinoline C3-H and C4-
H are also assigned based on their similarity to the pyridine β’ and γ protons in 
terms of chemical shifts, distances from the ferryl center, their linewidths and T1’s 
(see Table 4.2). Moreover, the assignments of C5-H and C6-H are supported by 
the cross peak between these two signals observed in the COSY spectrum of the 
complex (Figure 4.6). The quinoline C8-H and the pyridine α-H atoms likely have 
broader signals due to their increased proximity to the Fe=O unit, thus preventing 
conclusive assignments. So, it is possible to assign five of the six possible 





Figure 4.5 Stacked 1H NMR spectra of [FeIV(O)(N4Py)]2+ (top) and 
[FeIV(O)(N2Py2Q)]2+ (bottom) at 298 K, with quinolines shifts in red. Inset shows 
the expanded region from 0 to 21 ppm. # = solvent. Corresponding structures of 











Table 4.2 1H NMR spectroscopic properties for complex [FeIV(O)(N2Py2Q)]2+ 
obtained in acetonitrile-d3 at 298 K. 
Legend  H3 H4 H5 H6 H7  py- py-’ py- 
δ (ppm)  –12.7 13 17.7 16.2 19.4  8 –11.9 25.9 
FWHM (Hz)  140 30 25 20 190  58 117 46 
T1 (ms)  8 24 34 77 5  36 32 15 
*d (Fe•••H) (Å)  4.9 5.8 6.4 6.6 5.2  5.7 4.8 5.0 







Figure 4.6 1H COSY NMR spectrum of complex [FeIV(O)(N2Py2Q)]2+ in 
acetonitrile-d3 at 233 K from 0 to 35 ppm. Only the peaks at 19 and 20.8 ppm are 
found to have relaxation properties at this temperature that allow them to talk with 
each other. The lower temperature was chosen to minimize the self-decay of 
[FeIV(O)(N2Py2Q)]2+ over the course of data collection time (over 12 h) on a 10 
mM sample.  
The NMR spectrum of 1 shows two sets of pyridine protons, thereby excluding a 
Cs symmetric 5-coordinate or 6-coordinate structure, which would show a 2:1  
intensity ratio of pyridine:quinoline protons (equivalent pyridines trans to each 
other and quinoline trans to the potentially solvent bound sixth-coordination site). 
Instead, two distinct β proton signals at 58 and 45 ppm and two distinct β’ proton 
signals at –18 ppm and –26 (Figure 4.7) are observed in the spectrum of 1. The γ 
protons are likely between 0 to 10 ppm but cannot be clearly assigned owing to 
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the interfering peaks from presence of additives like peracetic acid, water, acetic 
acid or ArIO or trifluoroethanol that can be all in the mixture for generating these 
complexes. 
 
Figure 4.7 Stacked 1H NMR spectra of [FeIV(O)(QBPA)(L)]2+ (1, top) and 
[FeIV(O)(N2Py2Q)]2+ (bottom) at 233 K, with quinolines shifts in red. Inset shows 
the expanded region from 0 to 24 ppm. 
 
The 1H NMR spectrum of [FeIV(O)(N2Py2Q)]2+ now defines our expectations for 
the quinoline protons of 1 (Figure 4.7). The quinoline signals in 1 can be 
distinguished from those of the pyridines as an even sharper set of resonances. 
The C5-H and C7-H resonances likely overlap at 20 ppm (with a relative integration 
of 2H), and peaks at 18 and 14 ppm correspond to C6-H and C4-H, respectively. 
The C3-H proton can then be assigned to the peak at –26 ppm, which integrates 
to 2Hs because of its overlap with a pyridine β’-H signal. [FeIV(O)(N2Py2Q)]2+ and 
1 have their quinoline heterocycles aligned parallel to the ferryl unit and have 
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observable resonances in the range of the –30 to 30 ppm regime for C3-H to C7-
H protons, typical for S = 1 oxoiron(IV) complexes. 
Complex 1a: 
Complex 1a is related to 1 by the substitution of quinoline with a 6-methylpyridine 
donor. The introduction of even one alpha-methyl substituted pyridine affects its 
1H NMR spectrum and shows proton signals that are distinct from those of the 
unsubstituted pyridines in 0, 1a, [FeIV(O)(N4Py)]2+ and [FeIV(O)(N2Py2Q)]2+. In 
order to interpret this complex 1a’s spectrum, a clearer picture can be obtained by 
comparison with that of a recently reported complex, [FeIV(O)(6Me2N4Py)]2+, 
where 6Me2N4Py = N,N-bis(6-methylpyridin-2-methyl)-N-bis(2-
pyridyl)methylamine.5 Unlike [FeIV(O)(N2Py2Q)]2+, this complex is not isolable, 
because of its short half-life (30 minutes at 298 K). However, it can be generated 
from its starting iron(II) precursor using excess solid pentafluoroiodosylbenzene 
(PFIB) and stabilized at low temperatures (Figure 4.8). The use of PFIB allows for 
eliminates signals from the added oxidant and gives rise to a clean diamagnetic 
region. Its spectrum is also further simplified by the mirror symmetry provided by 
the N4Py framework, so there are only six peaks corresponding to the 
unsubstituted and substituted pyridines, four of which have unit intensity, and two 
overlap with each other. At 233 K, the broad signals of the alpha-methyl protons 
can be clearly identified near 58 ppm. The β’, γ and β proton signals of the 
unsubstituted pyridines can be respectively assigned at −18, 9, and 30 ppm. The 
β’ proton signals of the 6-methylpyridines overlap with the those of unsubstituted 
pyridine at −18 ppm, and the γ proton of the 6-methylpyridines can be identified as 
the sharp peak at 12 ppm. Finally, the β protons of the 6-methylpyridines are found 
in the diamagnetic region at 0.5 ppm, making the pattern of associated with the 
alpha-substituted pyridines clearly different from that of the unsubstituted 
pyridines. This is further verified by the COSY spectrum of this complex obtained 
at 233 K (Figure 4.9), which shows a cross peak between the γ and β signals, thus 
highlighting the effects of alpha-substituents on pyridines. Similar effects of alpha-
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substituents were reported by Sahu et al.7 although the β signal was not identified 
in that case due to a relatively crowded diamagnetic region. 
 
Figure 4.8 1H NMR spectra of 1a (top, 233 K), [FeIV(O)(6Me2N4Py)]2+ (middle, 233 
K; inset zooms into diamagnetic region of spectrum to reveal the signals of β 
proton), and [FeIV(O)(N4Py)]2+ (bottom, 298 K). 
 
Figure 4.9a 1H COSY NMR spectrum of complex [FeIV(O)(6Me2N4Py)]2+ in 
acetonitrile-d3 at 233 K from -2 to 35 ppm. T cross peaks, between the β and γ 





Figure 4.9b Zoomed 1H COSY NMR spectrum of 10 mM [FeIV(O)(6Me2N4Py)]2+ 
complex in acetonitrile-d3 from -2 to 15 ppm at 233 K (lower temperature was 
chosen to minimize the self-decay over 12 h). 
 
The assignments of peaks in the 1H NMR spectrum of [FeIV(O)(6Me2N4Py)]2+ can 
now be used to clarify the spectrum of 1a. The alpha-methyl substituted pyridine 
is responsible for its C1 symmetric nature in solution, as verified by its 1H NMR 
spectrum. It shows two sets of unsubstituted pyridine protons, thereby excluding a 
Cs symmetric 5-coordinate or 6-coordinate structure, which would show a 2:1 ratio 
of pyridine:6-methylpyridine proton signals with equivalent unsubstituted pyridines 
trans to each other and a 6-methylpyridine trans to the sixth-coordination site 
bound to a solvent. Instead there are two distinct β proton signals at 58 and 46 
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ppm, and two distinct β’ proton signals at –18 ppm and –26 (Figure 4.8) are 
observed in the spectrum of 1a, arising from the unsubstituted pyridines, which we 
assign first in the spectrum of 1a. The γ proton signals from all three pyridines in 
1a are likely between 0 to 10 ppm but cannot be clearly assigned owing to the 
presence of peaks from additives like peracetic acid, water, acetic acid or ArIO or 
trifluoroethanol that are part of the mixture used to generate 1a. Now that the sharp 
signals from unsubstituted pyridines in this complex are assigned, we assign the 
only aromatic peak of a 6-methylpyridine at –26 ppm, which overlaps with the β’ 
signal from 6-methylpyridine donor, as also observed in [FeIV(O)(6Me2N4Py)]2+. 
The signals of alpha-methyl group protons are paramagnetically shifted downfield 
to 70 ppm, just like in the case of [FeIV(O)(6Me2N4Py)]2+ where they are found near 
58 ppm. The β and γ proton signals of the 6-methylpyridine donor are likely in the 
diamagnetic region and are not identifiable due to flooding of signals from additives 
in this region. Complexes 1a and [FeIV(O)(6Me2N4Py)]2+ have their 6-
methylpyridines aligned parallel to the ferryl unit and have observable resonances 
in the range of –30 to 12 ppm regime for γ, β and β’ protons, and define the 
expectations for typical S = 1 oxoiron(IV) complexes with these alpha-
substitutions. 
4.2.3.2 NMR Peak Assignment for S = 2 complexes  3, 3a, 3b and 2 
Doubling the number of unpaired electrons in going from S = 1 to S = 2 
configuration in the iron(IV) center results in a threefold increase in its magnetic 
susceptibility, and the S = 2 complexes would be expected to exhibit significantly 
larger paramagnetic shifts. Unlike for S = 1 iron(IV) complexes, there are no 1H 
NMR spectra of S = 2 iron(IV) complexes. Fortunately, like the S = 1 oxoiron(IV) 
complexes, the ligand protons of the S = 2 oxoiron(IV) complexes also exhibit 
generally favorable relaxation properties. However, these complexes are also very 
reactive and thermally unstable at 233 K with much shorter lifetimes than the S = 
1 complexes. Thus we also investigate the NMR of the decayed species to ensure 
that we are correctly identifying the signals arising from the oxoiron(IV) center. 
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We have chosen to first discuss the NMR data of bona fide S = 2 complexes 3, 3a 
and 3b, which can then help in the assignments of peaks in the NMR spectrum of 
2. This is because Mössbauer parameters of complex 2 at 4 K reveal 
characteristics of an S = 1 complex, but its 1H NMR spectrum at 233 K shows 
peaks that are much more paramagnetically shifted than those of the quinolines 
and pyridines in 0, 1, [FeIV(O)(N2Py2Q)]2+ and [FeIV(O)(6Me2N4Py)]2+, suggesting 
that spin crossover to an S = 2 state might occur for 2 at temperatures higher than 
the ones used for Mössbauer spectroscopy. 
 
Figure 4.10 Stacked 1H NMR spectra from top to bottom: 3, 3a, 2 and 3b obtained 
at 233 K in CD3CN. Quinoline signals are colored red. 
 
Complex 3: 
There are two possible isomeric forms of the complex 3. A C3-symmetric isomer of 
3 without any bound solvent would be expected to show six quinoline proton 
signals at 233 K (and two methylene protons) in its 1H NMR spectrum. The other 
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isomer would be six-coordinate with a bound solvent, which would show at least 
15 peaks (6 from the quinolines trans to each other and 6 from the quinolines trans 
to the solvent, in addition to methylene peaks). The C3-symmetric configuration 
can be discarded by the observation of more than 10 paramagnetically shifted 
peaks in its 1H NMR spectrum, many of which have unit relative integrations. These 
peaks disappear upon decay, indicating that they most likely arise from the ferryl 
complex (Figure 4.11). This observation leads us to conclude that complex 3 is 
likely 6-coordinate at 233 K, which further disproves recent DFT-derived 
conclusions about its geometry.24 Closer scrutiny of its spectrum in Figure 4.10 
also shows that all quinolines are unique, likely because of a slight distortion of the 
six-coordinate FeIV=O center by a twist of the two trans quinoline planes relative 
to each other along the N–Fe–N axis. The steric constraints provided by the 
quinoline protons may contribute to this asymmetric nature of 3. Thus, the NMR 
data point to a six-coordinate C1-symmetric solution-state structure with a bound 
solvent as the dominant species for 3 at 233 K, with no detectable evidence for a 
C3-symmetric isomer. 
The peaks in 3 are not conclusively assigned owing to its thermal instability. DFT 
methods can help to fill this knowledge gap and predict the paramagnetic shifts of 
3 in the S = 2 state using a protocol that Borgogno et al. have successfully applied 
in reproducing the paramagnetic shifts observed for some S = 1 oxoiron(IV) 
complexes.17 The C8-H protons are likely too broad to be observed owing to their 
proximity to the S = 2 ferryl center. Using the DFT methods, we find that the most 
downfield shifted signals observable in 3 likely arise from C5-H at 92.6, 86 and 
83.6 ppm, pending confirmation by using the C5-substituted quinoline variant of 
complex 3. 
While the complex can be stabilized at a much lower temperature of 193 K in 
acetone-d6, attempts to obtain COSY or selective TOCSY data at 193 K are not 
successful because of unfavorably fast relaxation times for the S = 2 species under 
these conditions. The 1H NMR spectrum of obtained 3 in acetone at 193 K and in 
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acetonitrile at 233 K are not too different from one another, but the latter has more 
impurities at this temperature, further highlighting the challenges associated with 
accurately obtaining this data (Figure 4.19). 
Complexes 3a and 3b 
3a represents a “hybrid” version of alpha-substituted oxoiron(IV) complex 
containing two quinolines and a pyridine with an alpha-methyl substituent, whereas 
3b contains only pyridine donors with 6-methyl substituents. It makes more sense 
to describe the complexes 3a and 3b together and start analyzing the 1H NMR 
spectrum of 3a by pointing out its similarities and differences with 3 and 3b (Figure 
4.10). Therefore, the quinoline signals in 3a can be identified by comparisons with 
the quinoline signals in the parent complex 3, and absence of those signals in 3b. 
Similarly, the two 6-methylpyridine protons (one pair of which is trans to each other 
and the other is trans to the solvent) in complex 3a can be identified by 
comparisons with 3b and their absence in 3 (because it has no 6-methylpyridines). 
The two 6-methylpyridine protons in 3a are likely near 120 ppm, and are also found 
in 3b; they are not found in 3 because it only has quinolines. The quinoline signals  
in 3a are likely near 70-90 ppm, because that is where these signals are found in 
parent complex 3, and they are not found in 3b. However, we have not determined 
their identity as β, β’ or γ protons. 
Closer scrutiny of the spectrum of 3b in Figure 4.10 reveals its six-coordinate Cs-
symmetric solution-state structure with a bound solvent as the dominant species 
for 3b at 233 K, which gives rise to 11 dominant peaks. No detectable evidence 
for a C3-symmetric isomer is found, which would give rise to only 5 peaks (one 
methylene peak, one methyl peak and three pyridyl proton peaks in the intensity 
ratio 2:3:1:1:1). The methyl groups of the 6-methylpyridines trans to each other are 
found paramagnetically shifted upfield to about –50 ppm in a Cs-symmetric 
structure. The geometry of 3a is likely Cs geometry in solution, because quinoline 
proton signals between 70-90 ppm relative to a single pyridine proton signal near 




Figure 4.11 Stacked 1H NMR spectra of oxoiron(IV) complexes and after it has 
decayed (bottom spectrum in each panel) for complexes 3 (a), 2 (b) and 3a (c). 





Despite its Mössbauer parameters having parameters characteristic of S = 1 
species, the 1H NMR spectrum of 2 at 233 K more closely resembles the spectra 
of its S = 2 counterparts 3, 3a and 3b. The three peaks observed in 1H NMR 
spectrum of 2 at around 75-85 ppm are also found in the 1H NMR spectrum of 3 
and 3a, and likely belong to quinolines. Complex 3a is analogous to 2, except that 
its pyridine contains an alpha-methyl substituent, which make it an unambiguously 
S = 2 complex based on Mössbauer spectroscopy.  In complex 2 at 118 ppm, only 
one resonance is observed, in contrast with the two peaks observed near 120 ppm 
for 3a and 3b. This may be attributed to differences in alpha-substituted and 
unsubstituted pyridines in an S = 2 oxoiron(IV) complex, and how they experience 
the spin density of their respective paramagnetic centers. The missing pyridine 
signal is likely at –26 ppm and such a signal does not exist in 3a and 3b. Alpha-
substituted and unsubstituted pyridines behave differently in the NMR spectra of 
S = 1 FeIV(O) complexes as well, as explained above using the NMR spectra of 1a 
and [Fe(6Me2N4Py)]2+, which contain both at least one alpha-substituted and 
unsubstituted pyridine.5, 7, 30 
Furthermore, if the patterns of quinoline and pyridine proton peaks in 2 and 3a are 
compared with those of the pyridines in the S = 1 ferryl complexes, one can 
conclude that 2 may be S = 2 in nature at higher temperatures of 233 K which is 
where its NMR spectrum is obtained, and reactivity also determined (see a later 
section). This is also substantiated by its S = 2 analogs 3a (which is unambiguously 
S = 2 at all temperatures), indicating much more paramagnetically shifted set of 
protons compared with S = 1 complexes discussed in this and related reports. 2 is 
also found to show fewer peaks than any of the other S = 2 complexes, which can 
be an indication that it might have Cs symmetry (which may or may not be bound 
by a solvent) at 233 K. Both 5- and 6-coordinate Cs symmetric 2 would be expected 
to show 2:1 ratio of peaks for quinolines:pyridines. Thus, pending a further 
absolute liquid-solution structural characterization, complex 2 exhibits an S = 2 
character at 233 K. 
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4.2.3 Computed NMR Chemical Shifts for Oxoiron(IV) Complexes 
Borgogno et al. have used DFT methods to predict NMR spectra for previously 
reported S = 1 complexes 0 and [FeIV(O)(TMC)]2+ (TMC = 1,4,8,11-tetramethyl-
1,4,8,11-tetraazacyclotetradecane).17 We have used these methods to predict the 
NMR shifts for complexes [FeIV(O)(N2Py2Q)]2+, 2 and 3. Our complexes serve as 
a direct way to validate the chemical shifts observed for S = 1 and S = 2 
configuration of complexes 2 and 3. Interestingly, the chemical shifts predicted for 
the S = 1 complex [FeIV(O)(N2Py2Q)]2+ agree with the shifts observed 
experimentally, but its S = 2 isomer are predicted to have much more 
paramagnetically shifted peaks than those of the S = 1 counterpart (Table 4.3). 
Interestingly, for complex 2, the chemical shifts predicted for an S = 1 isomer are 
similar to those for [FeIV(O)(N2Py2Q)]2+, but for its S = 2 isomer (Table 4.4), these 
chemical shifts are closer in line with what is observed, further confirming our spin-
state assignment at 233 K, at which all of these chemical shifts are calculated. 
Table 4.3 Theoretical chemical shifts predicted for [FeIV(O)(N2Py2Q)]2+ (in ppm) 
at 233 K. 
H ex . δ  al . δ 
 S = 1 S = 2 
α ≈ −50 −54 202 
β 31.3 (1) 40 170 
β' −17.7 (1) −18.3 82 
γ 8 (1) 8.4 −4.1 
H3 −19.1 (1) −21.7 81 
H4 14.6 (1) 14.2 −5 
H5 20.7 (1) 24.2 89 
H6 19.1 (1) 24.5 29 
H7 23.2 (1) 33.6 41 








Table 4.4 Theoretical chemical shifts predicted for complexes 2 and 3 (in ppm) at 
233 K. 
H ex . δ  al .δ H ex . δ  al . δ 
Complex 2 S = 2 S = 1 Complex 3 S = 2 S = 1 
α br* 201.6 −69.3 H3 54.1 (1) 52.3 −20.6 
β br* 197.1 48.8 H3 29.6 43.6 −21.3 
β' 117 (1) 92.9 −25.6 H3 92.7 114.9 −17.8 
γ −26.3 (1) −28.7 5.9 H4 br* -33.5 12.3 
H3 76 (2), 77 
(2), 83 (2) 
85.5 −20.4 H4 7.2 (1) 4.9 11.1 
H3 87.3 −19.5 H4 −5.3 (8) -6.5 8.5 
H4 −8 (over-
lapped) 
−11.1 15.1 H5 83.6 (1) 74.5 11.9 
H4 5.5 13.8 H5 86 (1) 102.5 7.4 
H5 76 (2), 77 
(2), 83 (2) 
70.4 14.4 H5 19.9 (1) 26.5 23.4 
H5 92.4 24.8 H6 20.3 (1) 24.2 23.5 
H6 27 (2), 25 
(1), 23 (1) 
29.4 23.8 H6 23.3 (1) 35.4 29.9 
H6 33.9 28.4 H6 17.7 (2) 28.7 17.3 
H7 27 (2), 25 
(1), 23 (1) 
30.0 20.8 H7 26.7 (1) 40.5 33.0 
H7 44.4 35.9 H7 −5.3 (8) 2.5 29.4 
H8 
br* 
199.7 175.8 H7 26.3 (1) 42.4 6.2 
H8 226.4 135.5 H8 
br* 
198 142.1 
*br = broad, or not observed. 
H8 172.6 177.3 
H8 281.6 115.3 
 
4.2.4 Reactivity of Oxoiron(IV) Complexes 
Complex 0 is inert towards strong C-H bonds at 233 K. At 273 K however, upon its 
generation with ArIO from starting iron(II) acetonitrile solution, it can abstract the 
C−H bonds of cyclohexane. Complex 1 is about an order of magnitude higher in 
its ability to abstract C-H bonds at this temperature. As can be seen from the plot 
of log(k2’) (where k2’ = k2/number of equivalent substrate C−H bonds) versus C−H 
bond dissociation energies (BDE), the logarithms of the rate constants are found 
to decrease linearly with an increase in the C−H bond strength, indicating that HAT 
transfer is involved in the rate-determining step. This reasonably linear correlation 
has been shown for a number of oxoiron(IV) complexes.31-32 The thermal instability 
of 2 and 3 prevents us from obtaining reactivity data at 273 K, and thus we have 
resorted to 233 K to obtain this information. 
 
201 
Interestingly, complex 2 has rates higher than those of 0 and 1, but very close to 
those of 3. Note however, that rates for 0 and 1 are measured at 273 K. Typically, 
introduction of quinoline donors on ferryl complexes parallel to the ferryl unit, 
increases the C-H bond abstraction ability of the complexes by an order of 
magnitude. This is also seen from the case of 0 and 1. The increased Fe-N bond 
lengths from the quinoline increases the electrophilicity of the ferryl center, thus 
resulting in higher rates of reaction. If one were to apply a typical temperature 
correction for 40 K difference in temperatures at which reactivity is measured 
between the pair of S = 1 (0 and 1), and S = 2 complexes (2 and 3), the rate would 
be expected to change by just over an order of magnitude. This difference already 
allows us to conclude that 2 and 3 have a much higher reactivity than 0 and 1. The 
introduction of second quinoline in the TPA framework lends it some high-spin 
character, although it does not drastically increase its ability to react with C−H 
bonds, and the rate enhancement is just by over an order of magnitude. The rate 
differences among the three complexes become larger for substrates with stronger 
bonds, resulting in a decrease in the slopes of the Evans-Polanyi correlations 
shown in Figure 4.12, in going from 0 to 3. 
 
Figure 4.12 Evans-Polanyi plots for complexes 0 and 1 (rate constants obtained 
























This work explores the effects of systematically introducing alpha-substituents on 
the tetradentate ligand frameworks supporting oxoiron(IV) complexes. While 
quinolines or alpha-substituents such as methyl group on the TPA framework can 
change the spin state of the oxoiron(IV) complexes, we wanted to explore at what 
point does this change occur. While introducing a single quinoline on the TPA 
framework retains the S = 1 spin state at all temperatures, introducing the second 
quinoline ends up imparting a potential “spin-crossover” behavior in complex 2. 
Interestingly for oxoiron(IV) complexes supported by pentadentate ligands, 
incorporation of two alpha-substituents such as quinolines retains the triplet spin 
state. However, in the TPA framework examined in this work, introduction of the 
second quinoline results in a well-documented spin-crossover behavior, which has 
been shown only for iron(II) and iron(III) complexes,25 and not for iron(IV) 
complexes, to the best of our knowledge. 
We have used NMR spectroscopy in combination with Mössbauer spectroscopy 
to determine that the complex 2 likely possesses some spin crossover behavior. 
NMR spectra for S = 1 complexes has a much smaller range of peaks for 
identifiable resonances of heterocycles compared with that of S = 2 complexes. 
Additionally, while we are unable to  
This has broad implications in terms of access to the quintet state for an oxoiron(IV) 
complex. The hydrogen-atom abstraction carried out by oxoiron(IV) complexes is 
often thought to proceed via access to a low-lying excited quintet transition state 
during the reaction with the substrate. However, observation of such a transition 
state is very challenging. This particular hypothesis is the foundation of two-state 
reactivity (TSR).33 It is often postulated that non-heme enzymatic ferryl 
intermediates possess a ground quintet spin state because it is likely required for 
all hydrogen-atom abstraction reactivity. This is often used to explain why S = 1 
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complexes are typically less reactive, and to explain their reactivity, an access to 
S = 2 spin state state must occur during the hydrogen-atom abstraction reactions. 
Unfortunately, transition states are not observable using any methods so far.  
Overall, a larger picture would also look at the thermodynamics of the HAT reaction 
whereby the energy difference between the reactants and products should also be 
taken into account.34 But our work demonstrates that a ground spin state can be 
accessed at higher temperatures for reactive oxoiron(IV) complexes. 
and therefore our work makes this oxoiron(IV) complex very unique. 
4.4 Conclusion 
In the process of examining the NMR properties, we have reported the NMR 
spectra of quintet oxoiron(IV) complexes for the first time, and their much more 
paramagnetically shifted peaks are in alignment with what is expected for the ferryl 
complexes. Interestingly the S = 2 iron(IV) complexes have an observable range 
of chemical shifts spanning about 200 ppm, and this is comparable to the NMR 
shifts in S = 2 iron(II) complexes, although the assignments of peaks to the protons 
are likely very different due to different propogation of spin as well as the d-orbital 
configuration. Our observation of an oxoiron(IV) complex which has different 
ground spin states at different temperatures is unprecedented, and was only 
recently proposed using DFT methods for one of the complexes (and later 




4.5 Experimental Section 
Instrumentation and physical methods: 
NMR (nuclear magnetic resonance) spectra for iron(II) complexes as well as 
iron(IV) complexes were recorded on a Bruker 400 or 500 MHz spectrometer at 
temperatures stated. NMR spectra to characterize the ligands were obtained at 
298 K. 8" Wilmad-LabGlass 528-PP-7-5 NMR tubes were used to collect NMR 
spectra for iron(IV) and iron(II) complexes. For all the variable temperature spectra, 
the lower temperatures were calibrated using a sealed NMR tube containing a 
solution of tetramethylsilane (TMS) and methanol as a standard. For details on 
how the NMR spectra were obtained, see the NMR section outlined in a later 
section. 
Elemental analyses were carried out by Atlantic Microlab (Norcross, GA). 
UV-vis spectra were recorded on a HP8453A diode array spectrometer equipped 
with a cryostat from Unisoku Scientific Instruments (Osaka, Japan).  
Mössbauer spectra were recorded with two spectrometers, using Janis Research 
(Wilmington, MA) SuperVaritemp dewars that allow studies in applied magnetic 
fields of up to 7.5 T in the temperature range from 1.5 to 200 K. A LakeShore Model 
331A temperature controller was used to control the temperature in experiments. 
Mössbauer spectral simulations were performed using the WMOSS software 
package (SEE Co, Edina. Minnesota). Isomer shifts are quoted relative to α-Fe 
metal at 298 K. The spectra were plotted by SpinCount developed by Prof. Michael 
Hendrich at Carnegie Mellon University. 
Materials:  
All materials were bought from Sigma Aldrich, Fischer Scientific or TCI Chemicals, 
unless otherwise noted. The substrates cyclohexane, cyclooctane, 2,3-
dimethylbutane, toluene, ethylbenzene, and cumene used in kinetic experiments 
were passed through a plug of silica before use; triphenylmethane was 
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recrystallized from ethanol, and its stock solutions were made in dichloromethane-
d2 in a nitrogen-filled glovebox. 
 
All ligands and iron(II) complexes were synthesized as reported, except that iron(II) 
triflate was used exclusively to synthesize the iron(II) precursors, to avoid 
explosion risks associated with perchlorate salts. 
4.5.1 Syntheses and Characterization 
All ligands reported in this work were synthesized using reported methods. All 
iron(II) complexes except for the precursor for 3a were prepared according to the 
methods reported here, except that iron(II) triflate was used to make the 
compounds to avoid explosion risks associated with perchlorates. 
[FeII(6MeBQPA)(CH3CN)(OTf)]OTf An equimolar acetonitrile solution of iron(II) 
triflate and 6MeBQPA ligand was combined and stirred to give a light yellow 
solution. This solution was stirred for a couple of hours, followed by a slow diffusion 
of diethyl ether, which gave yellow crystals of iron(II) salt. This solution was then 
filtered, and dried with ether. Anal. calculated for C31H27F6FeN5O6S2, 
[FeII(6MeBQPA)(CH3CN)(OTf)]OTf: C, 46.57; H, 3.40; N, 8.76. Found: C, 46.41; 





4.5.2 Preparation of NMR Samples and Characterization 
Generation of the ferryl complexes for NMR spectroscopic analysis: 
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4-mM stock solutions of starting iron(II) precursors were made inside the air-free 
nitrogen-filled glovebox in acetonitrile-d3 or acetone-d6. 0.5 mL of these 4-mM 
solutions was transferred into the NMR tube for each experiment. All oxoiron(IV) 
complexes were generated by first precooling 4-mM iron(II) starting solutions to a 
given temperature in the NMR instrument (where it was also locked to the 
deuterated solvent, tuned to the intended nucleus, and then shimmed to make the 
make the magnetic field uniform around the sample). Once the temperature had 
equilibrated, the 1H NMR spectrum of the iron(II) was obtained at this point. The 
following three steps were then performed in quick succession: 1) the NMR tube 
was ejected from the instrument, 2) 2 equivalents of ArIO in either 2,2,2-
trifluoroethanol (TFE) or DCM-d2 were quickly injected to generate the oxoiron(IV) 
intermediate, the tube was capped with either a septum or its plastic cap, and (to 
minimize decay of the species) 3) the tube was immediately inserted back into the 
instrument for data collection. Because the instrument had been locked to the 
solvent as well as tuned to the nucleus of interest, only shimming was performed 
again before collection of NMR data for the oxoiron(IV) species. To obtain the 
spectrum of the decayed species, the complex was warmed to room temperature 
by ejecting the NMR tube from the instrument, and after the species had decayed, 
it was inserted back into the instrument and NMR data was obtained again at 
lowered temperature. 
General parameters for data collection and processing: 
The following parameters were used to acquire the 1H NMR data for paramagnetic 
compounds: Acquisition time = 0.064 s; relaxation delay = 0.03 s; sweep width = 
400 ppm offset (centered) at 6 ppm; line broadening factor = 10-30 Hz. Chemical 
shifts (ppm) were referenced to residual protic solvent peaks. The NMR spectra 
obtained were processed either using either the NMR processing software 





4.5.3 Reactivity and Kinetics of Oxoiron(IV) Complexes 
All experiments were conducted with 1 mL solutions of 1 mM iron(II) complexes in 
acetonitrile solutions at given temperatures for HAT (hydrogen-atom-transfer) 
substrates, unless otherwise stated. The oxoiron(IV) complexes were generated 
using 1-2 eq. ArIO in 2,2,2-trifluoroethanol or DCM-d2. The pseudo-first order 
decay curves from absorption-time profiles were obtained by monitoring the 
decrease in absorbance for the oxoriron(IV) complexes with time. These profiles 
at various concentrations were fit with an exponential decay. The rates (kobs) were 
plotted against different concentrations of substrates, and their slopes represent 

















































































Figure 4.13 k2 plots for the reactions of different HAT substrates with 
[FeIV(O)(TPA)(L)]2+. The slopes of the fitted red lines represent the second-order 
rate constants (k2) at 273 K. The oxoiron(IV) complex was generated using 1.2 eq 
of ArIO in TFE, followed by addition of substrate. 
  






























































Figure 4.14 k2 plots for the reactions of different HAT substrates with 
[FeIV(O)(QBPA)(L)]2+. The slopes of the fitted red lines represent the second-order 
rate constants (k2) at 273 K. The oxoiron(IV) complex was generated using 1.2 eq 
of ArIO followed by addition of substrate. 
 
 
Figure 4.15 k2 plots for the reactions of different HAT substrates with 
[FeIV(O)(BQPA)(L)]2+. The slopes of the fitted red lines represent the second-order 
rate constants (k2) at 233 K. The oxoiron(IV) complex was generated using 2 eq 
of ArIO followed by addition of substrate.  
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Figure 4.16 Stacked 1H NMR spectrum of complexes (top) [FeIV(O)(N2Py2Q)]2+ 
and (down) [FeIV(O)(N2Py2B)]2+ in CD3CN at 298 K from –70 to 70 ppm, along 
with assignments. Peaks for pyridines are in black and quinolines and 
benzimidazoles are in red. 
Comparisons of complexes containing benzimidazoles and quinolines: 
In these oxoiron(IV) complexes, quinolines’ H3 and H4 protons appear at similar 
chemical shifts to pyridines’ γ and β’ protons, indicating that these sets of protons 
experience similar paramagnetism from the S = 1 FeIV center as pyridines. This is 




H5/H6 in [FeIV(O)(N2Py2Q)]2+ and H4/H5 in [FeIV(O)(N2Py2B)]2+ belong to the 
fused phenyl ring on the respective heterocycles, and have the sharpest 
resonances, allowing for relaxation properties that make them amenable to COSY 
spectroscopy for these heterocycles so that their cross-peak can be observed at 
233 K. The most broad and observable fused heterocyclic proton peaks in the 
NMR spectra of these ferryl complexes belong to H7 in [FeIV(O)(N2Py2Q)]2+ and 
H6 in [FeIV(O)(N2Py2B)]2+. However, H7 in [FeIV(O)(N2Py2Q)]2+ is more downfield-
shifted than H6 in [FeIV(O)(N2Py2B)]2+. H6 in [FeIV(O)(N2Py2B)]2+ is also 0.5 Å 
farther from the iron(IV) center than H7 in [FeIV(O)(N2Py2Q)]2+ and may explain 
the differences observed in their paramagnetic shifts. When pyridines, 
benzimidazoles and quinolines are viewed together, assignment of quinoline 
protons in the S = 1 iron(IV) center is greatly facilitated, and parallels between 
pyridines, benzimidazoles and quinolines can be drawn, even though the 




Figure 4.17 Similarities between NMR peaks of different heterocycles aligned 
parallel to the ferryl unit in oxoiron(IV) complexes. 
Table 4.5 1H NMR spectroscopic properties for complexes containing 
benzimidazoles or quinolines in the N4Py framework, obtained at 298 K. 
  quinolines  benzimidazoles 
Legend  H3 H4 H5 H6 H7  H4 H5 H6 
δ (ppm)  –12.7 13 17.7 16.2 19.4  12 10 6.2 
FWHM (Hz)  140 30 25 20 190  56 44 96 
T1 (ms)  8 24 34 77 5  36 59 13 
**d (Fe•••H) (Å)  4.9 5.8 6.4 6.6 5.2  6.3 6.8 5.7 
*Distance obtained from the crystal structures, shown from cross-section.29 
      
 
Assignments of NMR spectra on S = 1 oxoiron(IV) complexes with differently 
substituted pyridines: 
The resonances of the pyridines: 
The orientation of pyridines around the iron center can change the pattern of 
chemical shifts observed for protons of the pyridines. There are broadly three 
potential ways (Scheme 4.1) a bound pyridine can orient around the FeIV=O unit: 
1) axially on the iron center (trans to the oxo atom), and either aligned between, or 
with the equatorial ligands; 2) equatorially, perpendicular to axis of the FeIV=O unit, 
(where the ring is) in the plane defined by the equatorial ligands; and 3) 




Figure 4.18 Possible orientations of the pyridine heterocycle around the FeIV=O 
unit. 
For the well-studied case of the “parent” complex [FeIV(O)(N4Py)]2+  where 
pyridines are parallel to the oxoiron(IV) center, the β, γ and β’ protons can be 
assigned using methyl and methoxy group substitutions on the pyridines, which 
results in disappearance of the signals from the parent complex with concomitant 
appearance of methyl signals in the diamagnetic region for the resulting newer 
complexes. These assignments have also been previously confirmed through 1H 
COSY NMR spectroscopy on the parent complex with unsubstituted pyridines.10 
(Figure 4.J) The resonances of α protons of pyridines are very broad owing to their 
proximity to the metal center. They can be assigned in two ways: 1) a unique 
complex called [FeIV(O)(Py5Me2)]2+ has four pyridines roughly parallel to the 
FeIV=O unit, with no methylene and methine protons which often give rise to broad 
signals (Figure 4.I). Therefore, most protons for this complex exhibit sharp 
resonances which are all assigned using integration, except one set of broad 
signals in the upfield region, likely from the α protons.  2)  The broad α protons in 
the upfield region can also be assigned using substitutions to generate a new 
complex, which eliminates the corresponding broad signal in the upfield region. In 
this case, if a 6-methyl substitution is introduced on the parent complex, the 6-
methyl protons’ chemical shifts are paramagnetically shifted to the downfield 
region (near 60 ppm) as a broad signal due to their proximity to the iron(IV) center. 
For all methyl or methoxy group substitutions made on the 5-, 4- and 3-H protons 




Lastly the 6-methylpyridine parallel to the ferryl center is different from an 
unsubstituted pyridine parallel to the ferryl center. β (5-H) proton of the pyridine 
substituted with 6-Me substitution experiences a different spin from the metal, as 
has also been seen in cases where aryl substitutions are introduced on the 
pyridines on the 6th position.36 γ (4-H) and β’ (3-H) protons in this 6-methylpyridine 
appear in the same region as in the pyridine without any alpha-substituents. β 
proton’s chemical shift deviates from the expected resonance in the downfield 
region near 30 to 50 ppm and is instead assigned using COSY spectroscopy to be 
closer to 1 ppm (Figure 4.D). 
 
The patterns for each of the pyridines in different orientations for β and γ protons 
can be seen in the figure below. For the pyridine perpendicular to the oxoiron(IV) 
unit, the resonances were assigned using 1H COSY spectroscopy as well as 
substitution on the β position of the corresponding proton. The protons on the 
pyridine bound trans to the oxo atom have been assigned using integrations in the 
case of [FeIV(O)(Py5Me2)]2+.   
 
Figure 4.19 1H NMR resonances for an equatorial pyridine oriented parallel to the 
S = 1 FeIV=O unit in [FeIV(O)(N4Py)]2+ (top, left); an equatorial pyridine oriented 
perpendicular to the oxoiron(IV) unit in [FeIV(O)(BnTPEN)]2+ (top, right); and an 
axial pyridine trans to the oxo atom in [FeIV(O)(TMC-Py)]2+ (bottom, left) and 
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[FeIV(O)(Py5Me2)]2+ (bottom, middle). All resonances are highlighted, along with 
respective pyridines of these complexes. 
 
 
Figure 4.20 1H NMR spectra of complex 3 in acetonitrile-d3 at 233 K (top), and in 
acetone-d6 at 193 K (bottom). 
 
 
4.2.1 Spin State Splitting Energies of Ferryl Complexes 
For a series of oxoiron(IV) complexes based on the TPA ligand framework with 
varying number of quinoline substitutions (Figure 4.1), spin state splitting energies 
were computed for the S = 1 and S = 2 spin state gaps (Table 4.6). For complexes 
with one or two quinolone substituents, QBPA and BQPA, both C1 and Cs 
conformations were considered. Notably, no geometrical constraints regarding 
symmetry were imposed during the geometry optimization and the labels C1 and 





Figure 4.21 Structural depictions of the oxoiron(IV) complexes studied. Structures 
corresponding to the S = 1 spin state are shown. Geometries were obtained at the 
PW6B95/def2-TZVP level of theory in the gas phase. Depictions were made using 
IboView.37-38  
 
Table 4.6 Computed spin state splitting energies at the PW6B95/def2-TZVP level 
of theory. 
Complex ΔE(Q-T) [kcal mol-1] ΔEZPE(Q-T) [kcal mol-1] 
0 4.9 3.5 
1 (C1) 3.4 2.3 
1 (Cs) 1.4 0.5 
2 (C1) 0.2 -0.8 
2 (Cs) 1.4 0.1 
3 -1.5 -2.5 
 
A plot of the computed spin state splitting energies reveals a direct correlation with 
the number of substitutions made and the spin state splitting energies (Figure 4.22, 
red dots). In a similar study on the effect of quinoline substitutions to the Bn-TPEN 
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framework such a trend was also observed. The data is also shown in Figure 2 for 
comparison (black squares).    
 
Figure 4.22 Plot of the computed spin state splitting energies at the PW6B95/def2-
TZVP level of theory and the number of quinoline substitutions made. Red dots 
show data for the TPA ligand framework (C1 and CS symmetric structures were 
considered for QBPA and BQPA ligands, respectively). Data computed for an 
analogous series of quinoline substitutions to the BnTPEN ligand framework (black 
squares) are shown for comparison. 
 
In case of the complex 1 the role of C1 and Cs isomers is rather clear. Here the C1 
conformation is clearly favored (Table 4.7). For the isomers of the complex 2, this 
analysis is less obvious, especially when comparing zero-point vibrational energy 
(ZPE) corrected electronic energies or free energies (298 K) these isomers are 
energetically very similar.  
Table 4.7 Comparison of the relative energies of the C1 and Cs isomers of 
complexes 1 and 2 at the PW6B95/def2-TZVP level of theory. All energetics are in 
kcal mol-1. 
Complex Spin State ΔE  ΔEZPE  ΔG298 
1 (C1) S = 1 0.0 0.0 0.0 
1 (C1) S = 2 3.4 2.3 1.4 
1 (CS) S = 1 2.9 2.7 2.7 
1 (CS) S = 2 4.3 3.2 2.3 
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2 (C1) S = 1 1.1 0.7 0.5 
2 (C1) S = 2 1.3 -0.1 -1.1 
2 (CS) S = 1 0.0 0.0 0.0 
2 (CS) S = 2 1.4 0.1 -0.8 
 
Computational Experimental Details: 
All calculations were performed using Turbomole v7.0.1.39-41 The PW6B95 
functional42 and the def2-TZVP basis set43 were used in all calculations. All 
calculations were carried out in the gas phase and numerical second derivatives 
were computed to confirm that a minimum was reached, showing no imaginary 
frequencies. For ZPE corrections small frequencies (< 100 cm-1) were raised to 
100 cm-1.44-45 Calculations were accelerated by the MARI-J approach46 using 
Weigend’s fitting basis sets.47 Grid m5 was used throughout. 
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This thesis has detailed work on the generation, characterization, and reactivity of 
a series of reactive high-valent nonheme oxoiron(IV) complexes. Well-known 
pyridine-rich ligand frameworks (which have been known to support oxoiron(IV) 
complexes since 2004) were chosen as starting points, namely BnTPEN, N4Py 
and TPA (Figure 5.1), and modified to support new oxoiron(IV) complexes with 
enhanced reactivity, bringing the total unofficial count of oxoiron(IV) complexes 
known to the Que lab from 92 to just past a 100! 
 
Figure 5.1 Ligand frameworks that were modified to form newer oxoiron(IV) 
complexes. N4Py: 1,1-di(pyridin-2-yl)-N,N-bis(pyridin-2-ylmethyl)methanamine, 
BnTPEN: N-benzyl-N,N’,N’-tris(2-pyridylmethyl)ethylenediamine, TPA: tris(2-
pyridylmethyl)amine. 
However, the underlying goal of the pursuit to make new oxoiron(IV) complexes 
was driven by two motives that still piqued the interest of bioinorganic chemists 
with respect to oxoiron(IV) complexes. The first motive was to obtain structural 
information on oxoiron(IV) complexes that are very reactive in nature. The most 
successful attempt at making S = 2 oxoiron(IV) complexes, which functionally and 
electronically mimic enzymatic intermediates, is represented by 
[FeIV(O)(TQA)(L)]2+, which was reported over a decade after the first oxoiron(IV) 
complexes were reported.1 This complex contains quinolines, and is the most 
reactive oxoiron(IV) complex reported. While the hypothesis that quinoline 
heterocycles are sterically encumbering is generally accepted, the best proof 
would come from structural information on oxoiron(IV) complexes containing 
 
225 
quinoline heterocycles that can be structurally characterized. Typically direct 
evidence of such interactions was only available for iron(II), manganese(II) and 
zinc(II) complexes supported by complexes containing quinolines or alpha-methyl 
substituents on pyridines.2-4 These first-row transition metal complexes show that 
introduction of alpha-substitutions on pyridines or replacement of pyridines with 
quinolines increased the M−N bond lengths, owing to increased steric interactions 
from the quinolyl or alpha-methyl protons.4-5 In this thesis, an oxoiron(IV) complex 
containing quinoline heterocycles was crystallographically characterized.6 While it 
retains its S = 1 spin state, it does show increased average Fe-N bond lengths 
compared with the parent complex that only contained pyridines, and the steric 
interactions additionally also tilt the oxoiron(IV) unit by about 10° off the z-axis. 
This is because the H8 protons of the quinolines encounter steric interactions with 
the ferryl unit, and this increases the distance of the quinoline donors from the iron 
center and forces the oxo unit to tilt sideways. This is the first time that we can 
experimentally show that these steric trends persist in the higher-oxidation state 
for a first-row transitional metal complex. Since the increased M−L bond lengths 
also increase the electrophilicity of the metal center, up to a 1000-fold increase in 
the reactivity of the resulting complexes is demonstrated compared with the parent 
pyridine-rich complex (Figure 5.2).  
 
Figure 5.2 Some of the oxoiron(IV) complexes containing quinolines examined in 
this thesis. The complex on the left was structurally characterized. 
The second motive was to develop structural and spectroscopic correlations with 
reactivity of oxoiron(IV) complexes. To pursue this goal, this thesis further expands 
on the BnTPEN ligand framework with similar substitutions that were made on 
N4Py, although in BnTPEN, one of the substituted pyridines is perpendicular to the 
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oxoiron(IV) unit, and would arguably have different steric interactions with the ferryl 
unit. In this process, crystallographic data on two oxoiron(IV) complexes was 
obtained, and we were able to characterize additional oxoiron(IV) complexes that 
are stable enough at room temperature to allow measurements of their rate 
constants, but not stable enough to be crystallized. In making these substituted 
complexes, we were also able to measure the fastest rates for reactions of 
cyclohexane with oxoiron(IV) complexes at room temperature, and this was 
achieved without having fully ‘saturated’ the ligand supporting the ferryl complex 
with alpha-substitutions. Overall, the examination of effects of the number of 
substitutions, the type of substituents and the orientation of the substituent was 
further enabled by BnTPEN framework. 
This series of oxoiron(IV) complexes supported by these pentadentate ligands is 
shown to  encompass reaction rates that span at least 7 orders of magnitude (with 
OAT at 233 K) and at least 5 orders of magnitude in the rates of reactions with 
HAT substrates both at 298 or 233 K. This has enabled development of reactivity 
correlations with structural features that are represented by average Fe-N bond 
lengths. This change in Fe−N bond lengths may help us define where to expect 
average Fe−N bond lengths for the thermally unstable S = 2 complex 





Figure 5.3 Spectroscopic (top) and structural (bottom) correlations of oxoiron(IV) 
complexes with reactivity measured by second-order rate constants at 233 K. The 
value represented by × represents the complex [FeIV(O)(Me3NTB)(L)]2+. 
 
We have also developed some unprecedented spectroscopic correlations with 
reactivity, as represented by isomer shift and absorption bands in Figure 5.3, both 
of which are measurements of electronics around the iron center. Interestingly 
isomer shifts and Fe-N bond lengths would be considered to have a role in defining 
the spin state of the oxoiron(IV) complexes, but would not be correlated linearly 
with the reactivity.  
If a sufficient number of substitutions is made on oxoiron(IV) complexes, a ground 
spin state change of the complexes can result from S = 1 to S = 2 as demonstrated 
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by the complex [FeIV(O)(TQA)(L)]2+. In the process of sequentially introducing 
these substitutions, we were able to identify a unique oxoiron(IV) complex with 
properties of S = 1 and S = 2 complexes at different temperatures, thus showing 
for the first time experimentally that an oxoiron(IV) species can have temperature-
dependent spin states, which is formally a spin-crossover behavior. 
Lastly this thesis examines the NMR properties of complexes, and reports spectra 
of quintet oxoiron(IV) complexes for the first time, and their much more 
paramagnetically shifted peaks are in alignment with what is expected for the ferryl 
complexes with more unpaired spin. Interestingly the S = 2 iron(IV) complexes 
have an observable range of chemical shifts spanning about 200 ppm, and this is 
comparable to the NMR shifts in S = 2 iron(II) complexes, although the 
assignments of peaks to the protons are likely very different due to different 
pathways for unpaired spin propagation as well as the d-orbital configuration. 
5.2 Future Challenges 
Oxoiron(IV) complexes containing alpha-methyl substituents generally have lower 
stability compared with their quinoline containing counterparts. If one can 
deuterate the benzylic positions, it might be possible for us to stabilize reactive 
species for longer periods, and obtain structural information on oxoiron(IV) 
complexes containing alpha-methyl substituents, just like the case where structural 
information is available on complexes containing quinolines. 
While the two tetragonal oxoiron(IV) complexes in the quintet spin state reported 
so far are found to be very reactive,1, 7 there is a striking exception of a tetragonal 
complex in the triplet spin state, namely [FeIV(O)(Me3NTB)(L)]2+,8-11 that has 
somewhat comparable reactivity to that of the most reactive oxoiron(IV) complex, 
namely [FeIV(O)(TQA)(L)]2+. While most complexes that we have reported in this 
thesis exhibit reactivity trends that are in line with their observed isomer shift and 
absorption features, we have found that this complex is an exception to the rule. 
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This highlights some challenges and need for more perspectives on reactivity of 
oxoiron(IV) complexes. 
When the isomer shift (0.03 mm/s), absorption features (λmax = 770 nm), and 
averaged Fe-N bond lengths (2.06 Å) of the complex [FeIV(O)(Me3NTB)(L)]2+ are 
plotted on the correlations, the correlations predict a much lower reactivity than 
what is observed. This complex contains benzimidazole donors which actually 
have higher basicity than pyridines, and the trends observed in reactivity indicate 
that we should consider other factors in addition to the structural and spectroscopic 
properties of oxoiron(IV) complexes in determining the reactivity of complexes. 
The typical explanation for reactive S = 1 oxoiron(IV) complexes relies on a 
theoretical model that cannot be directly experimentally verified, namely two-state 
reactivity, as first postulated by Shaik.12 This idea was applied to 
[FeIV(O)(Me3NTB)(L)]2+ when it was first reported, and suggests that during the 
hydrogen atom abstraction reaction, a spin crossover to a more reactive and 
excited S = 2 reaction surface occurs as the FeIV=O unit interacts with a substrate’s 
C–H bond along the reaction coordinate. As these are events postulated to occur 
in the transition state, experimental confirmation is not possible. The only indirect 
way to measure this excited spin state’s contribution into the S = 1 ground spin 
state is to measure the zero-field splitting parameter of the complexes. A higher 
value reflects a greater contribution of excited spin state into the ground spin state. 
While a higher zfs parameter can be used to explain the high reactivity of the 
complex, it does not verify TSR directly because this model only talks about access 
during a transition state. Furthermore, the accurate measurement of this parameter 
requires access to the solid samples, which are not accessible for unstable 
intermediates like this one. We can estimate this value using Mössbauer 
spectroscopy however, and for this complex, we do find that this value is among 
the highest ZFS parameters determined for any complex. Still, zfs parameters do 
not directly probe the HAT reaction, and are likely only part of a kinetic argument. 
Potentially thermodynamic factors should also be considered, as favoured by 
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Mayer in comparing HAT reactivity.13 A correlation between the HAT reactivity of 
a metal-oxo species with the strength of the MO–H bond formed has been 
demonstrated based on ideas developed by Bordwell and Mayer for which the 
MO–H bond strength would reflect the driving force for the HAT reaction.14-17 To 
obtain this number, one needs to have access to be able to measure reduction 
potential of the oxidized metal oxo species, as well as pKa of the reduced MO–H 
bond. This value has been successfully measured for Cu(III) hydroxides, but only 
in one case has this value been measured for iron(III) hydroxides.18 
This is why future approaches to explain reactivity of oxoiron(IV) complexes should 
also look at thermodynamic driving forces that drive the reaction rates, in addition 
to spectroscopic and structural correlations. 
Lastly, all synthetic non-heme oxoiron(IV) complexes reported so far are either 
supported by pyridines, quinolines and/or amines,19 with some exceptions of 
ligands supported by carboxylates in addition to pyridines/amines.20 Many 
enzymatic non-heme mononuclear oxoiron(IV) intermediates are supported by 2-
His-1-carboxylate facial triad, and are thus not directly represented by the synthetic 
model complexes. The closest we get to histidine in synthetic model complexes 
are benzimidazole groups which were employed by Nam on the tripodal ligand that 
supports the complex [FeIV(O)(Me3NTB)(L)]2+, and subsequently by others.21 
There is one possible variant of this ligand that contains 2-histidines and 1-
carboxylate center, but formation of oxoiron(IV) complex with this ligand has not 
been attempted.22 
Below are two possible examples of oxoiron(IV) complexes that can be supported 
by BnTPEN-like framework. The ligands for these are easily accessible using the 
same synthetic routes that are employed to make substitutions on BnTPEN 
frameworks (Figure 5.4). 




Figure 5.4 Oxoiron(IV) complexes containing a facial-triad like ligand framework. 
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Summary of Qualifications 
• PhD Candidate in chemistry, with collaborative research projects with over 
4 different institutes 
• Experienced in syntheses of inorganic and organic compounds, and use of 
various spectroscopic techniques such as UV-Vis, XRD and vibrational 
spectroscopies and mass spectrometry, and in mechanistic and kinetic studies 
• Organized active lab member with a focus on advancing lab safety, and 
operation/design of experiments/equipment 
• Led and co-authored publications in high-impact peer-reviewed journals 
such as Angew. Chem. Int. Ed. with two more in preparation 
• Presented work to technical and non-technical audience, at university 
symposia and national conference 
Education 
Ph.D. Chemistry 
Sep 2013 – May 2019 
University of Minnesota, Minneapolis, MN        
B.S. Chemistry  
Sep 2009 – Jun 2013 
Lahore University of Management Sciences, Lahore, Pakistan  
Academic Research Experience 
Research Assistant, Que Research Group 
Sep 2015 – Present  
Department of Chemistry, University of Minnesota 
• Synthesized diverse new inorganic compounds, with up to 1,000,000-fold 
improved ability to break C—H bonds 
• Characterized unstable (t½ < 2 min) and unique inorganic intermediates with 
advanced spectroscopic techniques 
• Used X-ray crystallography to characterize several thermally unstable and 
air-sensitive inorganic compounds  
• Employed low-temperature NMR spectroscopy as a useful technique to 
benchmark expensive Mössbauer studies 
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• Directly mentored an undergraduate student, 2 international visiting 
scholars from Korea, and an incoming grad student. Two of my mentees are now 
pursuing PhD at Princeton University and in the Netherlands. 
• Initiated an improved glove box management of my lab, wrote several safety 
operating procedures regarding inert glove box maintenance, and handling of 
inert gas cylinders and cryogenic dewars 
• Created and scripted the group’s internal website management system to 
consolidate group inventory, waste manifestation, group calendars to book 
instrumentation, safety operating procedures, and exit checklists 
Technical Skills 
Laboratory: Organic and inorganic syntheses, inert environment handling 
(Schlenk-line, glove box), analytical techniques (multinuclear and variable 
temperature NMR, EPR, IR, Raman, Mössbauer, X-ray absorption, UV-visible 
spectroscopies, ESI mass spectrometry (ESI-MS), gas chromatography (GC/GC-
MS), X-ray crystallography (XRD), cyclic voltammetry) 
Computer: SHELX (XRD), MestReNova and TopSpin Bruker (NMR), ChemDraw, 
Origin Graphing, Adobe Suite (Dreamweaver, Flash, Photoshop), Drupal Lite, 
Weebly, Pixelmator, Microsoft Office Suite, Web- and graphic design 
Coding: Basic HTML, ActionScript, Basic Python, Matlab, Google Script 
Professional Development 
Equity and Diversity Certificate, U of Minn.      
Nov 2017 – Present 
Participated in 36/48 h of workshops geared to improve equity and diversity in all 
aspects of professional and personal lives 
Joint Safety Team, U of Minn. & The Dow Chemical Company   
Aug 2017 – Present 
Public Relations Committee Member. Wrote monthly newsletters for safety 
practices, and designed posters and stall wall moments pasted throughout the 
chemistry and chemical engineering department 
SciMentors, U of Minn. and Open-Door Learning Center             
Jan 2015 – Present 
Head of Web Development, taught and trained for GED classes, designed logo 
and experiments to teach topics covering concepts like heredity to acid-base 




Community of Chemistry Graduate Students, U of Minn.             
Sep 2016 – Present 
Designed logo of the organization and mental health posters for the chemistry 
department 
Pakistani Student Association, U of Minn.               
Sep 2013 – May 2018 
Co-founder, head of website design, advisor, organizer of events to promote 
awareness about Pakistani traditions and cultural values, in addition to holding 
sessions to promote dialogues, and writing many resources at 
psaumn.weebly.com 
 
Publications and Presentations 
Journals: 
• *VIP: Rasheed, W.; Draksharapu, A.; Banerjee, S.; Young, V. G.; Fan, R.; 
Guo, Y.; Ozerov, M.; Nehrkorn, J.; Krzystek, J.; Telser, J.; Que, L., Jr. Angew. 
Chem. Int. Ed. 2018, 57, 9387 
“Crystallogra hi  Eviden e  or a Steri ally Indu ed Ferryl tilt in a Nonheme 
Oxoiron(IV) Com lex” 
• *VIP: Draksharapu, A.; Rasheed, W.; Klein, J. E. M. N.; Que, L., Jr. Angew. 
Chem. Int. Ed., 2017, 56, 9091 
“Fa ile and Reversible Formation of Iron(III)–Oxo–Cerium(IV) Adducts from 
Nonheme Oxoiron(IV) Com lexes and Cerium(III)” 
• Chen, J.; Draksharapu, A.; Harvey, E.; Rasheed, W.; Que, L., Jr.; Browne. 
W. R. Chem. Commun., 2017, 53, 12357 
“Dire t Photo hemi al A tivation of Nonheme FeIV=O Com lexes” 
• Rasheed, W.; Fan, R.; Abelson, C. A.; Peterson, O. P.; Ching, W-M.; Guo, 
Y.; Que, L., Jr. Chem. Eur. J., 2019, Just Accepted (not online) 
• Banerjee, S.; Rasheed, W.; Fan, R.; Draksharapu, A.; Oloo, W. N.; Guo, 
Y.; Que, L., Jr. J. Biol. Inorg. Chem., 2019, Just Accepted (DOI:  
10.1002/chem.201902048) 








• Oral: Rasheed, W.; Que, L. Jr. Structural Insight into the Reactivity and 
Spin State of Oxoiron(IV) Complexes. UMN Metalloprotein Interest Group (MPIG) 
– Invited Lecture, Minneapolis, MN, May 2018 
• Poster: Rasheed, W.; Puri, M.; Klein, J. E. M. N.; Que, L. Jr. Using Steric 
Bulk to Improve Reactivity of Oxoiron(IV) Complexes. International Student 
Research Showcase, University of Minnesota, Minneapolis, MN, Sep 10th, 2017 
• Poster:  Rasheed, W.; Puri, M.; Draksharapu, A.; Klein, J. E. M. N.; Que, 
L. Jr Tuning the C-H Bond Cleavage Ability of an Oxoiron(IV) Complex. 253rd 
American Chemical Society National Meeting, San Francisco, CA., April 3rd, 2017 
• Poster: Puri M.; Rasheed, W.; Que, L. Jr., Ligand Dependence on the 
Reactivity of Synthetic Non-Heme FeIV(O) Complexes. Bioinorganic Headwaters 
Symposium, University of Minnesota, Minneapolis, MN. Aug 1st, 2014 
 
Teaching Experience 
Teaching Assistant, Organic Chemistry Lab 
Sep 2013 – Jun 2015 
Department of Chemistry, University of Minnesota    
• Recipient of Honorable Mention for Excellence in Teaching Chemistry 
award 
• Created pairing system in the labs to allow unique pairings, and created 
online tools for the lab to help students keep tab of their performance, and 
developed a mechanism for students to get self-driven anonymous feedback 
 
Head Teaching Assistant, General and Organic Chemistry 
Sep 2011 – Sep 2013 
Department of Chemistry, Lahore University of Management Sciences 
• Used embedded animations and online forums on the learning 
management systems, in addition to conducting live demonstrations as an 






Chemists in the Library, Minnesota Section of American Chemical Society 
2013 – Present  
Demonstrating science experiments to children aged 4-16 in libraries throughout 
Twin Cities and Hennepin county suburbs 
Volunteering with the Association of Multicultural Scientists 
2014 – 2018 
Showcasing chemistry experiments and creating interest in science amongst 
children 
2nd Twin Cities Science Fair 
Feb 2017 
Judged and scored over 10 high-school science projects 
3M Visiting Wizards Super Science Saturday, 3M 
Oct 2014 – Oct 2016 
Managed booths demonstrating science experiments to more than 200 children at 
3M campus 
 
